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Abstract
In order to coordinate brain development with the growth of the organism, neurogenesis is
highly dependent on the organism’s nutritional intake. The transition between neural stem
cell (NSC) quiescence and reactivation is a key point of regulation during neurogenesis,
and in Drosophila, this process is tightly coupled to nutrient availability. Post-embryonic
NSCs in Drosophila only exit quiescence when larvae are fed a diet containing essential
amino acids. The fat body, a functional homologue of the liver and adipose tissue, acts as
a systemic nutrient sensor. Existing evidence from both in vivo and in vitro studies suggest
that upon sensing dietary amino acids, the fat body secretes unknown factor(s) that induce
glial secretion of insulin/IGF-peptides, which are sensed by underlying NSCs to trigger their
reactivation.
Despite recent work on nutritional regulation of NSC reactivation, key questions still
remain: what are the signal(s) from the fat body, and how do they interact with the glial
cells to induce glial production of DIlps? In addition, a number of glial subtypes are closely
associated with the NSCs, but each subtype’s individual contribution to NSC reactivation
remains elusive. In order to search for the unknown fat body factor(s) and investigate how
they interact with the glial cells, I compared the transcriptome of the fat body under fed and
starvation conditions during the time window of NSC reactivation. I identified an extracellu-
lar matrix protein (ECM), Collagen IV, as a secreted fat body signal whose deposition on the
CNS is required for NSC reactivation. Collagen IV recruits glial-derived PerlecanTrol, an-
other ECM protein and a known requirement for NSC reactivation, to the vicinity of NSCs.
Both ECM proteins are indispensable for the induction of glial insulin/IGF signalling.
NSCs are separated from the hemolymph by a blood brain barrier (BBB). In collabo-
ration with Pauline Speder and Jessie Van Buggenum (Andrea Brand lab), we confirmed
crucial roles of the two BBB glial populations as a nutrient-sensitive NSC niche and iden-
tified each subpopulation’s contribution to NSC reactivation. Transcriptional profiling re-
vealed that both BBB glial populations transcribe Dilp6 and perineurial glia is the source
of PerlecanTrol. Together, Collagen IV and PerlecanTrol trigger NSC reaction via binding to
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Chapter 1
Introduction
1.1 An Overview of Mammalian Neural Development
1.1.1 Prenatal Neurogenesis and the Emergence of NSCs
The central nervous system (CNS) is the part of the nervous system consisting of the brain
and the spinal cord. It exists in all bilaterally symmetric multicellular animals, such as in-
sects and mammals, and it is considered the commanding centre of the organism. The CNS
integrates information that it receives from the rest of the body, while exerting influences
on its activities in response to the organism’s internal needs and stimuli from the environ-
ment. The brain, in particular, exerts many higher cognitive functions such as thinking,
learning, and decision making, which are hallmarks for higher organisms such as mam-
mals. Therefore, the normal functions and well-being of an animal are highly dependent
on a well-formed CNS and the maintenance of its health throughout life. The formation
of the mammalian CNS is a complex process. The emergence of the neuronal tissues, or
neural differentiation, occurs during early stages of embryogenesis, soon after germ layer
differentiation. The tissues of the CNS are derived from a clearly defined neuroectoderm,
called the neural plate, which lies along the dorsal midline of the embryo. For a review,
see (Kennea & Mehmet, 2002). The neural plate is formed by the local suppression of sig-
nalling molecules that induce non-neural differentiation. Such molecules include the bone
morphogenetic proteins (BMPs), which instruct epidermal differentiation and other trans-
forming growth factor-beta (TGF-beta) superfamily molecules (Kintner, 2002; Wilson &
Edlund, 2001).
The neural plate then gives rise to all cell types of the mature CNS. This process is pre-
cisely regulated, both spatially and temporally, by a variety of intrinsic factors and external
2signalling molecules such as BMP signalling and sonic hedgehog signalling (Briscoe &
Ericson, 2001; Lee & Pfaff, 2001). Cellular growth and proliferation of the neural plate
gradually lead to the closure of the neural groove, which then forms the neural tube. The
cavity of the neural tube later gives rise to the ventricular system, while the epithelial layer
of the neural tube give rise to stem cells that will then produce the neuronal and glial cells
of the developing CNS (Kennea & Mehmet, 2002).
Initially, the single layer of neuroepithelial lining consists of morphologically similar
stem cells. These cells are defined as neural stem cells (NSCs) due to their ability to self-
renew and their potential to generate all CNS cell types of the mature brain. They can
divide asymmetrically, in which one daughter cell retains self-renewing capacity, while the
other differentiates into specific cell types (Götz & Huttner, 2005). In addition, NSCs often
produce intermediate progenitors that exist transiently and amplify the number of daughter
cells through symmetric division, as reviewed in (Götz & Huttner, 2005). The NSCs and
NSCs-derived progenitor cells eventually produce all three major cell types of the CNS:
neurons, astrocytes and oligodendrocytes (Jan & Jan, 1998).
Because NSCs exhibit branched, astrocytes-like morphology, and express certain glial
markers such as glycogen granules, astrocyte glutamate transporter (GLAST), glial fibrillary
acidic protein (GFAP), they have been widely referred to as radial glia (Alvarez-Buylla &
Garcia-Verdugo, 2002).
1.1.2 Mammalian Neurogenesis Continues Into Postnatal Life
In mammals, neurogenesis occurs mostly prenatally. But in addition to embryonic NSCs,
multipotent and self-renewing NSCs also exist in the adult cerebral cortex. The cerebral
cortex is arguably one of the most important areas of the mammalian CNS, which is the
outermost layered structure. It contains approximately half of all neurons in the human
brain and executes higher brain functions such as memory, attention, perceptual awareness,
thought, language, and consciousness. For a review, see (Bystron et al. , 2008).
Neurons necessary for postnatal cortical functions are generated prior to birth. After
the completion of prenatal cortical neurogensis program, most NSCs migrate to the cortex
surface where they differentiate into astrocytes and lose their neurogenic potential. How-
ever, some NSCs remain in the postnatal/adult cerebral cortex in two specific regions: the
subventricular zone (SVZ) and hippocampal subgranular zone (SGZ). These NSCs have
been found to retain their neurogenic properties in the postnatal life (Götz & Huttner, 2005;
Song et al. , 2002). Therefore, the existence of adult NSCs has important implications for
3the maintenance, plasticity, and pathogenesis of the adult mammalian brain.
1.1.3 Quiescence Is a Physiologically Important State for the Adult
NSCs
Adult NSCs can transit between states of quiescence and proliferation. The SVZ is a paired
brain structure situated throughout the lateral walls of the lateral ventricles, whereas the
SGZ is a narrow layer of cells situated between the granule cell layer and hilus of the dentate
gyrus (Figure 1.1.1). NSCs of the SVZ and SGZ become quiescent (mitotically inactive)
for most of adult life. However, in response to intrinsic and extrinsic stimuli, such as injury
and exercise, they are able to exit quiescence to re-enter the cell cycle in postnatal animals
(Ahn et al, 2005; Doetsch et al 1999, 2009; Morshead et al, 1994). Whereas quiescent NSCs
exhibit radial-glia like morphology, activated NSCs retract their processes prior to re-entry













Fig. 1.1.1 Schematic of adult mammalian neurogenic zones. Schematic of mouse brain (sagittal
view) shows the positions of two neurogenic zones, the subventricular zone (SVZ) of the lateral
ventricle wall and subgranular zone (SGZ) of the hippocampal dentate gyrus. Modified from Ma et
al, 2009
Quiescence is a physiologically important state for the NSCs as it helps to promote long-
term maintenance and prevent stem cell exhaustion. Quiescence is a hallmark of adult stem
4cells across diverse tissues, such as the brain, blood, muscles and the gut (as reviewed in
(Orford & Scadden, 2008)). The view that quiescence state is a functionally important char-
acteristic for adult stem cells was largely developed from experiments in the haematopoietic
system, which is the most extensively studied adult stem cell system in mice and human
(as reviewed in (Orford & Scadden, 2008)). Compelling evidence suggests that quiescence
is essential for preventing the premature exhaustion of self-renewing haematopoietic stem
cell (HSC) populations. Although adult stem cells are often considered immortal, they have
clear limitations in their functions, and these limitations appear to be worsened by prolif-
erative stress. For example, HSCs can give rise to the entire haematopoietic system upon
transplantation, but after serial transplantation, HSCs gradually decline. Studies using ge-
netic models that disrupt stem cell quiescence showed that proliferation results in stem cell
exhaustion (Harrison et al. , 1978; Kamminga et al. , 2006). Cyclins and CDKs are impor-
tant positive regulators of cell cycle progression, whereas cyclin-dependent kinase inhibitors
(CDKI), such as P21, inhibit cell cycle progression and promote quiescence (Kippin et al.
, 2005). Forced exit from quiescence and increased proliferation, such as in the case of a
P21 knockout mouse, led to long-term loss of HSCs and increased susceptibility to stress-
induced exhaustion (Cheng et al. , 2000; Yu et al. , 2006). Later studies revealed that the
positive role of P21 on stem cell quiescence and long-term maintenance is also conserved
in NSCs of the adult mammalian CNS (Kippin et al. , 2005; Porlan et al. , 2013). However,
despite mounting evidence that support the idea of ectopic activation/proliferation being
detrimental to adult stem cells maintenance, two HSC genetic models emerged in which
shortened cell cycle/increased proliferation did not lead to stem cell exhaustion. This in-
cludes knockout of p18INK4c (Yu et al. , 2006; Yuan et al. , 2004), a CDKI, as well as
over-expression of HOXB4, a hox transcription factor whose targets involve cell-cycle reg-
ulatory genes (Bowles et al. , 2006; Helgason et al. , 1996).
The mechanisms responsible for the effect of p18INK4c and HOXB4 are unknown,
and moreover, it is unclear whether the mis-regulation of these genes can lead to similar
degree of NSC expansion without compromising their long-term maintenance, as seen in
the HSC system. The majority of studies in mammalian NSCs suggest that exogenously
activating adult NSCs exhausts and diminishes this population long-term, such as via the
activation of BMP signalling (Bonaguidi et al. , 2011; Mira et al. , 2010) or mutation in
FoxO transcription factors (Paik et al. , 2009; Renault et al. , 2009). However, a recent
report with an alternative BMP inactivation regime provided evidence that NSC pool is
not only maintained but can be even increased in response to long-term inhibition of BMP
signalling (Bond et al. , 2014). Although these results await further confirmation, they raise
5the intriguing possibility that different modes of NSC activation, even via the same pathway
(i.e. BMP signalling), can have opposite effects on the long term maintenance of the NSC
pool.
1.2 Changes in Energy Metabolism Have Profound Impact
on the Decision Between NSC Quiescence and Prolifer-
ation in Both Mammals and Drosophila
A dynamic balance must be achieved between states of quiescence and proliferation of the
postnatal NSCs: uncontrolled proliferation can lead to the formation of tumours, whereas
inability to exit quiescence may jeopardise NSCs’ ability to promote regeneration after in-
jury. Recently, a flurry of studies revealed that metabolic alterations due to diverse range
of factors including nutrition, exercise, and diseases such as diabetes, not only affect brain
structure but also cognitive functions in mammals (Lee et al. , 2002; Mehrabian et al. ,
2012; Park et al. , 2010; Stranahan et al. , 2008b; van Praag et al. , 1999) (Figure 1.2.1). In
many instances, such structural and cognitive changes of the brain can be associated with
altered modes of neurogenesis (Lee et al. , 2000, 2002; van Praag et al. , 1999), although
causative relationship between the two remains unproven.
Whereas dietary restriction promotes NSC maintenance (Lee et al. , 2000), excessive
energy intake impairs neurogenesis. For example, a high fat diet impaired hippocampal
neurogenesis in rats (Park et al. , 2010). Overeating as a result of impaired leptin signalling
hampered hippocampal neurogenesis in mice (Stranahan et al. , 2008b). In addition, ex-
ercise enhanced postnatal neurogenesis in the brains of rodents (van Praag et al. , 1999).
Furthermore, mutations in the chromatin remodelling protein, CHD7, which led to impaired
neurogenesis in mice, can be rescued by voluntary exercise (Kim & Roberts, 2013). Im-
portantly, imbalanced energy metabolism can also result from metabolic diseases. Diabetes,
which leads to an imbalance in sugar levels, has been related to compromised memory and
learning ability in rodents. The underlying cause of these cognitive impairments can be at
least in part associated with reduced neurogenesis (Stranahan et al. , 2008a).
6Fig. 1.2.1 Systemic metabolic states affect neurogenesis and neuronal functions. Altered sys-
temic energy metabolism, as a result of diet, exercise or diseases, can have profound influence on the
CNS, including proliferation and homeostasis of the NSCs.
71.3 Drosophila Larval CNS as a Model System for Investi-
gating systemic regulation of NSC Quiescence/Reactivation
Studies in the past decade revealed remarkable similarities between the mammalian and
Drosophila NSCs (also called neuroblasts). They can divide asymmetrically and self-renew.
IN addition, like their mammalian counterparts, Drosophila NSCs extend characteristic pro-
jections during quiescence which are then retracted upon activation (Chell & Brand, 2010).
Furthermore, the switch between quiescence and proliferation is not unique to mammalian
NSCs. Drosophila NSCs transit through a developmentally regulated, stereotypical period
of quiescence after the completion of embryonic neurogenesis program that gives rise to
neurons and glia of the larval CNS. After larval hatching, quiescent NSCs will re-enter the
cell cycle, or “reactivate”, to initiate the onset of larval neurogenesis that produces neu-
rons and glia of the adult CNS (Ito & Hotta, 1992; Truman & Bate, 1988). Importantly,
their decision to exit quiescence and re-enter the cell cycle is critically dependent on the
availability of dietary amino acids (Figure 1.2.2) (Britton & Edgar, 1998). Whereas newly-
hatched larvae cultured on media lacking either nucleotide precursors, lipids, or vitamins
were able to exit NSC quiescence and resume neurogenesis till the late second or early third
instar stage, larvae cultured on medium lacking amino acids did not grow and their NSCs
remained quiescent (Britton & Edgar, 1998). No single amino acid could rescue NSC cell
cycle reactivation, suggesting that protein synthesis is required for this process. Therefore,
like their vertebrate counterparts, Drosophila NSCs’s decision to remain quiescent or reacti-
vate is also heavily influenced by the metabolic state of the organism. This similarity makes
Drosophila an attractive model organism to investigate mechanisms underlying regulation
of NSC quiescence/reactivation, especially in response to changes in diet-induced systemic
metabolic state.
Understanding the changes occurring in NSCs in response to altered global nutritional
and metabolic states as well as the molecular basis of these changes will not only yield
important insights into the maintenance of brain function during development and ageing.
More importantly, it may help to pave the way towards battling the detrimental effects of
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Fig. 1.3.1 Processes of Drosophila NSC reactivation. The Drosophila NSCs transit through a
period of quiescence before the onset of a post-embryonic wave of neurogenesis. If larvae are fed
dietary amino acid, NSCs will first start to enlarge and once they reach a certain size, will proliferate
to self-renew and generate progenies which populate the adult CNS. Reactivation is defined as the
sequential combination of enlargement and proliferation.
1.4 Systemic Energy Sensing in Mammals Involves Insulin/
IGF Signalling
How do proliferating or quiescent NSCs respond to systemic energy state? Recent work
have started to illuminate how signalling from distant organs that sense changes in systemic
metabolic state can communicate such alterations to NSCs in the brain (Rafalski & Brunet,
2011; Spéder et al. , 2011). In mammals, the liver, pancreas and adipose tissue act as major
energy sensing organs. In particular, the liver and pancreas couple the growth of distant
organs with nutrient availability via IGFs (Insulin-like growth factors) and Insulin, respec-
tively. In vertebrates, the pancreas secretes Insulin in response to glucose intake, whereas
IGFs are secreted by the liver (Iresjö et al. , 2013; Livingstone & Borai, 2014) in response
to dietary protein intake (Miura et al. , 2007). NSCs’ response to dietary restriction is a
good example of how systemic IGF/Insulin signalling can alter NSC behaviour in the brain.
Systemic IGF–1 level decreases significantly in response to dietary restriction (Cohen et al.
, 2009). Since IGF–1 is capable of crossing the mammalian blood-brain barrier (BBB)
(Reinhardt & Bondy, 1994), it is possible that by reducing IGF–1 levels, dietary restriction
may promote the maintenance of the NSC pool by preventing excessive proliferation and
premature differentiation.
Recent studies showed that Insulin/IGF signalling pathway plays diverse and critical
9roles during mammalian neurogenesis. IGFs are capable of promoting mammalian neuro-
genesis, including the production of neurons, astrocytes and oligodendrocytes, both in vivo
and in vitro (Aberg et al. , 2003a,b; Arsenijevic et al. , 2001; Mason et al. , 2003). Fur-
ther analysis shows that IGF–1 can shorten the duration of the cell cycle and increase the
number of cells that re-enter the cell cycle (Hodge, 2004). Apart from its mitogenic effect
on NSCs, IGF–1 can also direct differentiation towards specific lineages (Popken et al. ,
2004). In response to exogenous IGF–1 stimuli, cultured NSCs proliferate or differentiate
into mainly neuronal or oligodendrocyte cell types (Arsenijevic et al. , 2001; Brooker et al.
, 2000; Drago et al. , 1991).
1.5 Fat Body-Derived Signals and Glial Insulin Signalling
Control Drosophila NSC Reactivation in Response to
Dietary Amino Acid Intake
Drosophila has recently emerged as a powerful model organism for studying inter-organ
communication and systemic regulation of NSCs reactivation. Previous studies have re-
vealed remarkable similarities between the mammalian and Drosophila NSCs, including
similar division patterns and lineage outputs, as well as characteristic morphologies during
NSC quiescence/reactivation. For a review, see (Brand & Livesey, 2011). Several signalling
pathways govern the proliferation, self-renewal and differentiation of NSCs during devel-
opment. For example, Notch signalling has been found to promote self-renewal and repress
differentiation in Drosophila NSCs (Alexson et al. , 2006). In mammalian brains, activation
of Notch signalling induces the expression of transcriptional repressor genes such as Hes1,
leading to repression of proneural gene expression and maintenance of NSC/progenitor cells
(Imayoshi et al. , 2010). In addition, Insulin/IGF signalling has recently been shown to act
as a potent regulator of NSC proliferation in vivo in both flies and mammals (Chell & Brand,
2010; Lehtinen et al. , 2011; Sousa-Nunes et al. , 2011; Ziegler et al. , 2014, 2012). Fur-
thermore, PTEN and PI3K, the downstream effectors of Insulin/IGF signalling, have been
found to govern the transition from quiescence to proliferation in both systems (Groszer
et al. , 2001, 2006; Peltier et al. , 2007).
Exploiting powerful genetic tools that are available in Drosophila led to the recent dis-
covery that NSCs reactivate via a fat body and glial cell relay (Figure 1.4.1). Functionally
homologous to vertebrate liver and adipose tissue, the Drosophila fat body functions as a
systemic nutrient sensor and it coordinates organismal growth with nutrient availability. It
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stores sugar in the form of glycogen and fat in the form of triacylglycerol. In addition, it
is known to produce a large amount of secreted molecules circulating in the hemolymph,
such as larval serum proteins, adipokines and enzymes. For a review, see (Andersen et al.
, 2013). The fat body coordinates organismal growth with dietary amino acid availability
partly through Slimfast (Slif), an essential amino acid transporter (Colombani et al. , 2003;
Géminard et al. , 2009). In addition to serving as an amino acid passageway, Slif regu-
lates fat body TOR (Target of Rapamycin) signalling. In both invertebrates and vertebrates
(Colombani et al. , 2003), TOR signalling is a conserved strategy by which organisms co-
ordinate nutrient availability with cellular growth and proliferation. Upon sensing dietary
amino acids, TOR phosphorylates S6K (S6 kinase, a ribosome protein) and 4E-BP (Eukary-
otic translation initiation factor 4E-binding protein), thereby activating protein translation
(Abraham, 2002). This ultimately lead to the production and secretion of growth-promoting
factors, known for a long time as “fat body derived mitogens (FBDMs)”, and more recently
as “fat body signals”. Fat body-directed knockdown of Slif leads to fat body-specific TORC
(TOR complexes) inhibition and systemic growth defects (Colombani et al. , 2003).
Compelling evidence suggests that NSCs’ reactivation from quiescence is coupled to
dietary amino acids and larval growth through signals transmitted from the fat body, both
in tissue culture (Britton & Edgar, 1998) and in vivo (Sousa-Nunes et al. , 2011). NSCs
in brains isolated from starved animals remain quiescent in culture even if amino acids
or fat body alone were supplied to the media. NSCs were only able to reactivate when
both factors are present (Britton & Edgar, 1998). This implies that amino acid-induced
fat body factor(s), and not the amino acids themselves, are responsible for triggering NSC
reactivation (Britton & Edgar, 1998). Except for the mushroom body NSCs and one ventral
lateral NSC, the initiation of reactivation for all other NSCs in the brain and ventral nerve
cord (VNC) are dependent on the availability of dietary amino acids and fat body signals
(Britton & Edgar, 1998). A complementary in vivo experiment was carried out by disrupting
fat body vesicle trafficking using a dominant negative dynamin (ShibireDN), which resulted
in reduced EdU labelling (a thymidine analog labelling S phase of cell cycle) in the CNS
in early second instar larvae, indicating impaired NSC reactivation/proliferation (Sousa-
Nunes et al. , 2011). However, even though convincing evidence suggests that the fat body
signals are important for NSC reactivation, their identities remain unknown.
How are fat body signals sensed by NSCs in the brain? Glial cells in the CNS surround
NSCs and insulate them from the systemic environment. In particular, two populations of
glial cells, the perineurial glia and subperineurial glia, make up the Drosophila BBB. Recent
work revealed that glial cells serve as a key relay to regulate NSC reactivation downstream
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of nutrient sensitive fat body signals via the transcription and secretion of local insulin-
like peptides (DIlps) (Chell & Brand, 2010; Sousa-Nunes et al. , 2011). In addition, gap
junction-mediated coordination of DIlps release is essential for efficient NSC reactivation
(Speder and Brand, 2014, accepted).
The insulin/IGF signalling pathway is highly conserved in mammals and flies (Goberd-
han & Wilson, 2003). No homologue of IGF–1 has been identified in Drosophila, but there
are 8 insulin-like peptides (DIlps) (Andersen et al. , 2013). They consist of two major pools:
systemically circulating DIlps in hemolymph (blood equivalent) are secreted by insulin pro-
ducing cells (IPCs, pancreas equivalent), fat body and imaginal discs (Colombani et al. ,
2012; Okamoto et al. , 2009; Wang et al. , 2007). DIlps can also be produced locally and
retained in peripheral tissues such as renal tubules, gut, and the brain (Chell & Brand, 2010;
Garelli et al. , 2012; O’Brien et al. , 2011; Söderberg et al. , 2011). The 8 different DIlps
have diverse spatial temporal expression patterns and serve different functions in the organ-
ism. Four of the DIlps (DIlp1, DIlp2, DIlp3, DIlp5) are expressed in the IPCs that share a
common progenitor lineage (Wang et al. , 2007). They can be secreted into the circulating
hemolymph to promote insulin signalling and tissue growth in many different target organs
during larval stages. During the actively feeding larval stages, impaired growth of imaginal
tissues delays the onset metamorphosis. DIlp8 is a secreted factor from the imaginal discs
which is sufficient to delay metamorphosis without affecting tissue integrity. Therefore, it
was proposed that DIlp8 coordinates the growth status of organs with developmental tim-
ing (Colombani et al. , 2012). DIlp6 is predominantly expressed in the fat body during
the post-feeding pupal stage, and secreted into the hemolymph to instruct appropriate cel-
lular division in distant organs. DIlp6 mutant shows reduced adult body size as a result of
decreased cell number, and the phenotype can be rescued by fat body expression of DIlp6
alone (Okamoto et al. , 2009).
What are the sources and functions of locally-derived DIlps? Recent studies suggest that
DIlp5 is expressed in principal cells of the renal tubule to regulate stress response locally
(Nässel et al. , 2013). DIlp3 expression was detected in the midgut viseral muscle, and it
regulates food-dependent proliferation of midgut stem cells (O’Brien et al. , 2011; Veenstra
et al. , 2008). Although the precise identity of glial-derived DIlp(s) are unclear, evidence
suggests that DIlp2 and DIlp6 are produced locally in the CNS and play a prominent role
in NSC reactivation. This is because these are the only two dIlps whose transcripts are
upregulated in the VNC during the time window of NSC reactivation (Chell & Brand,
2010). The dIlp6 promoter was found to drive expression in glial cells of the CNS surface
overlying the NSCs, suggesting that these glial cells might be the source of the signal that
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reactivates NSCs (Chell & Brand, 2010). Interestingly, NSCs do not respond to systemic
DIlps fluctuation: over-expression of DIlps in the fat body or in the IPCs, which elevate
the level of circulating DIlps, were not able to ectopically reactivate NSCs from quiescent
state (Sousa-Nunes et al. , 2011). Instead, the NSCs are controlled by local DIlps from
the surrounding glial cells (Figure 1.4.1) (Chell & Brand, 2010; Sousa-Nunes et al. , 2011).
Disruption of vesicle trafficking in glia impairs NSC reactivation when larvae are fed an
amino acid rich diet, and forced expression of DIlps in CNS glial cells drive the reactivation












  acid intake
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Fig. 1.5.1 NSC reactivation involves the fat body and a glial relay. Upon sensing dietary amino
acids, the Drosophila fat body is known to secrete unidentified signal(s) into the hemolymph, which
travel to the brain and induce the CNS glial cells to release Drosophila insulin-like peptides (DIlps).
DIlps bind to insulin receptors on the NSC surface, leading to their reactivation
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1.6 Local Insulin/IGF Signalling Also Plays an Important
Role in Mammalian Neurogenesis
Local IGF expression has also been detected in the mammalian brain. As in the case of
Drosophila NSC reactivation, the mammalian IGF-I exhibits peak expression which is tem-
porally and spatially correlated with brain development (Popken et al. , 2004). In rodent
brains, IGF–1 expression increases rapidly during late prenatal and early postnatal devel-
opment and peaks in the first week of postnatal life, as seen with Northern blot analysis of
rodent whole brain. This is a time window before and during rapid proliferation, differen-
tiation and maturation of NSCs (Popken et al. , 2004). Expression of IGF–1 and IGF1R
(IGF1 receptor) were also observed in cultured NSCs derived from both embryos and adults
(Drago et al. , 1991).
The observation that local IGF-I overexpression without elevations in circulating IGF-I
led to brain overgrowth further supports the idea that paracrine/autocrine IGF-I signalling
has a more prominent impact on NSC proliferation than circulating IGF-I, at least during
early phases of neurogenesis when IGF-I level is significantly higher in the brain than in the
circulation (Joseph D’Ercole & Ye, 2008). What cell type(s) in the mammalian brain secrete
IGF-I ligand, and is there an equivalent of insulin/IGF secreting glial niche as in Drosophila?
IGF-I ligand expression has been reported in neurons (Bondy, 1991), astrocytes (Shetty
et al. , 2005), and NSCs (Drago et al. , 1991). Whereas autocrine signalling and neuronal
IGF-I may have an impact on NSCs, recent studies suggest a prominent role of astrocytic
glia as the IGF-secreting NSC niche. Astrocyte-specific overexpression of IGF–1 in the
mouse brain is capable of promoting brain overgrowth in vivo (Yan et al. , 2006; Ye et al.
, 2004). In addition, IGF–1 expression is induced in stellate astrocytes in response to CNS
injuries, and is believed to account for increased rate of NSC division following cortical
ischemia (Yan et al. , 2006).
Until recently, studies of Insulin/IGF signalling and neurogenesis have almost entirely
focused on IGF-I to the exclusion of IGF-II. Whereas fetal IGF-I showed clear expression in
the neurogenic zones of VZ and SVZ, IGF-II expression has been detected predominantly
in the neuroectoderm and was therefore deemed to be less relevant for neurogenesis (Mc-
Donald et al. , 2007). Studies in recent years uncovered a long-neglected neurogenic niche
parallel to the Drosophila NSC niche at the brain-cerebral spinal fluid (CSF) interphase
(Lehtinen et al. , 2011; Ziegler et al. , 2014, 2012). A novel role of local niche-derived IGF-
II signalling in regulating NSC proliferation was uncovered (Figure 1.5.1). The ventricular
system of mammalian CNS contains CSF and is continuous with the central canal of the
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spinal cord. A network of capillaries enveloped by ependymal epithelium, called choroid
plexus, line each of the ventricles. In addition to acting as a barrier to allow selective
passage of particles from the blood to CSF, the choroid plexus ependymal epithelium also
secretes growth factors such as FGF (Fibroblast growth factor), VEGF (Vascular endothelial
growth factor), and IGF-II (Lehtinen et al. , 2011; Stopa et al. , 2001). CSF IGF-II signals
to primary cilia of NSCs/neural progenitors of the surrounding SVZ and instructs cortical
neurogenesis during development (Lehtinen et al. , 2011). The NSCs/neural progenitors
express IGF receptors on their apical surface facing the CSF, which provides optimal spa-
tial orientation to sample the CSF IGF-II ligands. Choroid plexus IGF-II expression is also
developmentally regulated: a transient peak of CSF IGF-II occurs at mid to late embryonic
neurogenesis in rodents (Lehtinen et al. , 2011) (Figure 1.5.1). Therefore, the regulation








Fig. 1.6.1 Schematic of a IGF-II-dependent neurogenic niche at the Brain-CSF-Barrier. The
choroid plexus secretes IGF-II into the CSF, which are sensed by receptors on the primary cilia of
NSCs lining the ventricular wall. IGF-II binding to its receptor induces NSC proliferation.
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1.7 An Emerging Role of CNS Glial Cells as a NSC Niche
Increasing evidence points to the critical role of glial cells as a NSC niche in both mam-
mals and flies. In mammals, astrocytes have been shown to form a NSC niche and promote
NSC proliferation in vitro (Song et al. , 2002), and in vivo by secreting neurotrophic factors
including IGF–1 and FGF (Shetty et al. , 2005). Recently, it has been shown that Clus-
terin, a highly glycosylated protein secreted by astrocytes, is able to promote human neural
precursor cell survival and differentiation in vitro (Cordero-Llana et al. , 2011).
In Drosophila, three types of glial cells are closely associated with NSCs (Figure 1.6.1).
The Drosophila NSCs are isolated from the hemolymph (the equivalent of blood) by two
populations of glial cells that comprise the Drosophila BBB—the subperineurial glia (SPG)
and perineurial glia (PG) (Stork et al. , 2012). The third population, cortex glia (CG), are
located between NSCs beneath the BBB. Subperineurial glial cells form septate junctions
(equivalent of tight junctions) and create a physical barrier. The outermost perineurial glia
are less well characterised, but they have been hypothesised to mediate signalling from the
hemolymph to the CNS due to their localisation at the interface between the two (Stork
et al. , 2008). Cortex glia have similar structures to mammalian astrocytes and may provide
trophic support for the surrounding NSCs (Freeman & Doherty, 2006a).






Fig. 1.7.1 Three major types of CNS glial cells are associated with reactivating NSCs. A closer
look at the NSC niche reveals that NSCs are surrounded by three glial subtypes: the perineurial glia
and subperineurial glia which together make up the blood brain barrier, and cortex glia.
Apart from DIlps, glial cells in Drosophila are known to secrete other factors that reg-
ulate NSC reactivation. The anachronism (ana) gene is expressed in a subset of glial cells
and encodes a secreted glycoprotein whose mechanism of action is unknown (Ebens et al.
, 1993). Loss of Ana function results in precocious NSC reactivation, with NSCs entering
16
their first S phase around eight hours early. However, a recent study provided evidence
that Ana is also expressed in miR–124-expressing neurons/NSCs and that ana transcripts
must be downregulated by the action of miR–124 during neuronal progenitor proliferation
to ensure proper larval neurogenesis (Weng & Cohen, 2012).
1.8 Other Factors Known to Regulate NSC Reactivation
in Drosophila
Apart from the unknown fat body signals, glial derived DIlps and Anachronism, another fac-
tor known to regulate NSC reactivation is Perlecan (called Trol in Drosophila, which stands
for “Terribly reduced optic lobes”, hereafter referred to as PerlecanTrol). In perlecantrol null
mutants, NSC reactivation is severely impaired: NSCs enlarge, but never enter their first S
phase (Datta, 1995). NSC proliferation defect in perlecantrol mutants can be rescued by
overexpression of the positive G1/S regulator cyclin E (Caldwell & Datta, 1998). These re-
sults indicate that growth and proliferation are at least partly uncoupled in larval NSCs. The
ana/perlecantrol double mutant displays the ana mutant phenotype of precocious NSC reac-
tivation (Datta, 1995). This suggests that PerlecanTrol acts downstream of Ana to bypass or
inactivate Ana’s repressive effect on the cell cycle.
Perlecantrol encodes a heparan sulfate proteoglycan (HSPG) (Park et al. , 2003; Voigt
et al. , 2002). It is an important component of the extracellular matrix (ECM) that inter-
acts with other ECM proteins, growth factors and receptors, to regulate cellular signalling
(Lin, 2004a). Null mutations in hedgehog (hh) and branchless (bnl, an FGF homologue)
dominantly enhance the impairment in NSC proliferation in a sensitised perlecantrol mutant
background (Park et al. , 2003). Although the origin of CNS PerlecanTrol protein is un-
clear, it is deposited on the brain surface throughout larval life (Park et al. , 2003), close
to the reactivating NSCs. Thus PerlecanTrol may function to locally modulate Hh and FGF
signalling in a manner important for NSC reactivation.
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1.9 Regulators of NSC Quiescence/Reactivation in Mam-
malian Systems
1.9.1 Regulators of NSC Quiescence in Adult Mammalian Brain: an
Overview
Work in the past decade started to identify the multitude of niche-dependent and intrinsic ef-
fectors of NSC quiescence/reactivation. NSC quiescence and reactivation are controlled by
signalling pathways, niche adhesion, transcriptional factors, epigenetic programs, as well as
neuronal activities. Several morphogens/signalling molecules have been shown to control
the proliferation and NSCs in the SVZ, including Notch, Wnt, FGF–2, IGF-I, VEGF, BDNF,
and BMPs, among others. Wnt (Lie et al. , 2005; Qu et al. , 2010), IGF-I (Aberg et al. ,
2003a; Lichtenwalner et al. , 2001), BDNF (Scharfman et al. , 2005; Zigova et al. , 1998)
and VEGF (Jin et al. , 2002) signalling promote NSC activation/proliferation and stimulate
neurogenesis. In contrast, BMP (Mira et al. , 2010) and Notch (Imayoshi et al. , 2010)
signalling maintains NSCs and/or promote quiescence. Activated by ligands produced by
differentiating neural precursors in the neurogenic niches, BMP and Notch signalling pro-
vide negative feedback signals that maintain the quiescent state of SEZ and hippocampal
NSCs (Ables & Drummond-Barbosa, 2010; Bonaguidi et al. , 2008; Ehm et al. , 2010;
Imayoshi et al. , 2010; Mira et al. , 2010). The mechanisms of BMP signalling in regulating
NSC quiescence will be discussed in further detail. More recently, neuronal activities via
synaptic transmission to NSCs has been shown to regulate the decision between quiescence
and reactivation (Song et al. , 2012). Optogenetical control of GABA release by interneu-
rons in the DG has allowed for the observation that NSCs can respond to the level of GABA,
switching from a quiescence to an activated one (Song et al. , 2012).
1.9.2 Transcription Factors
Among intrinsic factors, a number of transcription factors have been identified to promote
activation of quiescent NSCs. Sox and bHLH factors are among the most extensively stud-
ied transcription factors in mammalian embryonic neurogenesis (Bylund et al. , 2003; Scott
et al. , 2010). Interestingly, recent study by Venere et al demonstrated that Sox1 also regu-
lates in NSC activation/proliferation in adult neurogenic niche. Although the exact mecha-
nism is unknown, Sox1 expression is absent in quiescent NSCs but it marks activated NSCs
in the post-natal DG that are able to produce neuronal precursors and generate astrocytes, as
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shown by lineage tracing (Venere et al. , 2012). Interestingly, the fraction of Sox1-positive
cells within the NSC population decreases with age, correlating with a decrease in neuro-
genesis. The orphan nuclear receptor Tlx is another transcription factor known to promote
the switch from adult NSCs’ switch from quiescence to proliferation. It acts to ensure the
proliferative ability of postnatal NSCs by controlling their activation through genetic inter-
action with p53 and p21 (Niu et al. , 2011) as well as signalling pathways such as Wnt
and BMP signalling (Qin et al. , 2014; Qu et al. , 2010). Ascl1 is a third transcription
factor which has established roles in NSC activation. A recent study showed that when
NSCs of the adult hippocampus receive activating signals, such as upon depletion of Notch
signalling, they first induce the expression of the transcription factor Ascl1 before exiting
quiescence (Andersen et al. , 2014). Moreover, inactivating Ascl1 blocks quiescence exit
completely, rendering them unresponsive to activating stimuli. NSCs in both hippocampus
and SVZ require Ascl1 to exit quiescence, and this is most likely due to the regulatory roles
of Ascl1 on cell cycle genes (Andersen et al. , 2014).
On the other hand, a number of transcription factors promote NSC quiescence, includ-
ing FoxO, Tis21, REST/NRSF and NFIX. The FoxO proteins are the most extensively-
studied transcription factors promoting NSC quiescence and maintenance. In mice mutant
for FoxO1, FoxO3, and FoxO4 or for FoxO3 alone, an initial increase of NSC prolifera-
tion is followed by a depletion of the NSC pool and a decline in long term neurogenesis
(Paik et al. , 2009; Renault et al. , 2009). Recently, another transcription factor, Tis21
(Btg2/PC3), has been identified as a positive regulator of NSC quiescence both in vitro and
in vivo (Farioli-Vecchioli et al. , 2009, 2014). Ablation of Tis21 in the SVZ causes an
increase of proliferation of NSCs/progenitor cells, consistently with its anti-proliferative
activity (Farioli-Vecchioli et al. , 2009). In Tis21 null SVZ and cultured neurospheres, the
expression of BMP4 and its effectors Smad1/8, which are known to promote quiescence, are
strongly reduced (Farioli-Vecchioli et al. , 2014). On the other hand, positive regulators of
proliferation such as cyclins D1/2, A2, and E were strongly up-regulated (Farioli-Vecchioli
et al. , 2014). A third quiescence-promoting transcription factor is the GLI–Kruppel class
C2H2 zinc finger protein repressor element 1 (RE1)-silencing transcription factor (REST),
also known as neuron-restrictive silencer factor (NRSF) (Schoenherr & Anderson, 1995).
A recent study revealed a fundamental role for REST/NRSF in maintaining adult NSCs in
a quiescent state by restraining the neurogenic program (Gao et al. , 2011). In REST/
NRSF conditional knockout mice, hippocampal NSCs exit quiescence and enter neurogenic
program to produce granule neurons. However, loss of REST/NRSF leads to a functional
depletion of the adult hippocampal NSC pool and decreased granule neurons ultimately.
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Mechanistically, REST/NRSF recruits its co-repressor complex to NSC chromatin to con-
trol neuronal target genes and maintain the undifferentiated state (Gao et al. , 2011).
Although a number of quiescence-inducing/maintaining transcription factors have been
identified, no systematic approaches have been undertaken to investigate the transcriptional
mechanisms involved in NSC quiescence/activation until the development of a cell culture-
based NSC quiescence model (?). Martynoga et al first demonstrated that NSC cultures
treated with pro-quiescence BMP signals acquire cellular and transcriptional characteristics
of quiescent NSCs, and in a reversible manner (Martynoga et al. , 2013). Epigenomic pro-
filing was performed on these cells to identify enhancers associated with quiescent state,
and motif-enrichment analysis of these enhancers led to the discovery of NFIX as a key
transcription factor promoting NSC quiescence. NFIX is required to induce the expression
of a large portion of quiescence-specific genes. NFIX simultaneously suppresses a signifi-
cant part of the gene expression program of proliferating NSCs. Furthermore, mutation of
the NFIX gene in vivo results in a loss of quiescence for large proportion of hippocampal
NSCs (Martynoga et al. , 2013).
1.9.3 Adhesion Molecules and ECM Proteins
A flurry of recent mammalian studies started to uncover the crucial functions of adhesion
molecules and ECM proteins in regulating NSC quiescence/activation. Notably, the NSC
microenvironment in the neurogenic subependymal zone of adult mammalian brain is as-
sociated with distinct ECM signatures in its quiescent and reactivated state, respectively
(Kazanis et al. , 2010). ECM proteins including laminins and their integrin receptors are
implicated in regulating NSCs’ transition from quiescence to reactivation (Kazanis et al. ,
2010). Furthermore, a transcriptome analysis of neurogenic regions of human and mouse
fetal neocortex suggests that ECM proteins may be involved in neuronal progenitor self-
renewal (Simone A Fietz, 2012). In this study, transcripts of perlecan, among many other
ECM ligands, were highly enriched in the germinal zones consisting of neuronal progeni-
tors compared to the cortical plates consisting of mature neurons. Other ECM transcripts,
such as collagen IV, were present in the germinal zone and absent from the cortical plate.
Using an unbiased approach in a NSC cell-type specific manner, Martynoga et al per-
formed epigenomic profiling in quiescent NSCs in culture to identify enhancers associated
with quiescent state (Martynoga et al. , 2013). They showed that entry into quiescence
involves major changes in the transcriptional profile of these cells and in particular, in
their expression of cell adhesion and extracellular matrix (ECM) molecules (Martynoga
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et al. , 2013), consistent with previous in vivo studies (Fietz et al. , 2010; Kazanis et al.
, 2010). Another recent study provided convincing confirmation for the importance of ad-
hesion molecules in regulating NSC quiescence/reactivation. Porlan et al showed that N-
cadherin-mediated anchorage of NSCs to their niche in the adult murine subependymal
zone modulates their quiescence in vivo (Porlan et al. , 2014). In addition, they iden-
tified MT5-MMP as a membrane-type metalloproteinase responsible for the shedding of
the N-cadherin ectodomain in this niche. MT5-MMP-mediated cleavage of N-cadherin is
required for proper activation of quiescent NSCs under physiological and regenerative con-
ditions (Porlan et al. , 2014). The mechanisms of N-cadherin’s action are unclear, but it
was postulated that N-cadherin may mediate NSC reactivation via Wnt signalling (Porlan
et al. , 2014).
1.9.4 BMP Signalling
In the past few years, BMP signalling emerged as a major mechanism governing the equi-
librium between NSC quiescence and the cell cycle re-entry. The NSCs in the DG express
BMP-receptor 1A (BMPR–1A) which binds to BMP–2 and BMP–4. This keeps NSCs in a
quiescent state (Mira et al. , 2010). When noggin (a BMP antagonist) is present, it binds to
the BMPs and prevent their binding to BMPR–1A. This in turn causes the NSCs to activate
and enter cell cycle. Blockade of BMPs action with noggin or tissue-specific inactivation
of BMPR-IA led to temporary increased NSC proliferation, but the eventual decline of the
NSCs in hippocampus (Mira et al. , 2010). This suggests that BMP-dependent NSC quies-
cence is essential for NSC maintenance and long term neurogenic potential.
BMP signalling appears to be a key point of regulation in NSC quiescence/activation
upon which many other regulatory factors and pathways converge. Exposure to exercise
and learning promote neurogenesis, and BMP signalling is at least in part responsible for
these effects (Gobeske et al. , 2009). Voluntary exercise reduces levels of hippocampal
BMPs prior to and during NSC activation. Transgenic mice with decreased BMP signalling
showed improved hippocampal cognitive performance and neurogenesis, mirroring the ef-
fects of exercise. In contrast, transgenic mice with increased BMP signalling showed re-
duced hippocampal neurogenesis and impaired cognition, which cannot be rescued by ex-
ercise, suggesting that reduced BMP signalling is required for environmental effects on
neurogenesis (Gobeske et al. , 2009). Exercise and learning can cause a rapid increase in
neurogenesis after as few as 7 days post-stimulation (Dalla et al. , 2007; Vaynman et al.
, 2004). This suggests that mechanisms other than increased activation of quiescent NSCs
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are necessary to generate such a rapid expansion of the new neuronal pool. A recent study
showed that BMP signalling is not only important for the switch between NSC quiescence
and proliferation; it is also involved in fine-tuning neurogenic efficiency at later stages of
the NSC lineages after NSC activation (Bond et al. , 2014). Bond et al attempted to manip-
ulate BMP signalling in vivo using virally mediated misexpression of BMP4 and noggin, or
conditional ablation of BMP receptor type 2 (BMPRII) in different NSC/neural progenitor
cell (NPC) subtypes. BMP signalling inhibition enhances neurogenesis by activating NPCs
at multiple stages of the lineage and by accelerating their maturation (Bond et al. , 2014).
Thus, BMP signalling represents a potential mechanism for rapidly expanding neuronal
pools in response to environmental stimuli.
Intriguingly, altered BMP signalling also acts downstream of several transcription fac-
tors discussed earlier, including Tis21 and Tlx, as well as downstream of a key cyclin-
dependent kinase inhibitor (CDKI), P21. Ablation of Tis21 impairs the expression of BMP4
and of its effectors Smad1/8, which is in part responsible for ectopic NSC activation in SVZ
as well as in neurospheres (Farioli-Vecchioli et al. , 2014). Orphan nuclear receptor Tlx
also regulates NSC activation and astrogenesis by modulating BMP signalling (Qin et al. ,
2014). BMP pathway components such as BMP4, Hes1, and ID3, are transcriptionally up-
regulated in postnatal brains lacking Tlx. Furthermore, Tlx can directly bind the enhancer
region of BMP4, and the downstream effectors Smad1/5/8 are activated in Tlx mutants. P21
is a CDKI and promotes NSC quiescence (Kippin et al. , 2005). Subependymal NSCs lack-
ing P21 exhibit rapid expansion followed by depletion later in life (Kippin et al. , 2005). A
recent study found that BMP2 is under direct transcriptional control by P21 and loss of P21
in NSCs resulted in increased level of secreted BMP2, leading to precocious NSC activation
and proliferation (Porlan et al. , 2013).
1.10 An Overview of ECM Proteins at the Basement Mem-
brane and Their Receptors Regulating CNS Func-
tions
Extracellular matrix (ECM) and their receptors participate in most biological processes, and
they play important roles during development, homeostasis and pathogenesis of the CNS.
The Drosophila ECM are composed of many families of conserved molecules including
collagens, proteoglycans, glycosaminoglycans and other non-collagenous glycoproteins (as
reviewed in (Broadie et al. , 2011)). Drosophila, with its powerful and malleable genetics,
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can serve as an important model system in understanding the principles of ECM-mediated
functions in the CNS.
The basement membrane (BM) is a layer of non-cellular tissue that separates the epithe-
lium, mesothelium and endothelium from underlying connective tissue. ECM proteins, in
particular Collagen IV, Laminin, Nidogen, and Perlecan, as well as their receptors, are the
key components of the BM. In addition to providing structural integrity of the BM and the
underlying organs, ECM proteins and receptors also participate in cellular signalling. In the
scope of this introduction, I will primarily focus on Collagen IV, Perlecan and the Integrin
receptors.
1.10.1 Collagen IV
Type IV Collagen, or Collagen IV, is a unique member of the Collagen superfamily. In ver-
tebrates the Collagen IV family contains 28 members (as reviewed in (Khoshnoodi et al.
, 2008)). Unlike other collagens, Collagen IV only exists in the BM. In fact, it is the most
abundant component of the BM, comprising 50% of its total protein contents (Kalluri,
2003). Collagen IV molecules consist of α chains bound in long helical trimers that as-
semble into a network through lateral and end-domain interactions (Yurchenco & Ruben,
1987). 6 genetically distinct α chains have been identified, which are designated α1 to
α6 (Aouacheria et al. , 2006). In particular, the α1 like subunits and α2 like subunits are
present in BM of all tissues in vertebrates, whereas the other 4 subunits have tissue-specific
distributions, and their expressions are developmentally regulated (Pöschl et al. , 2004).
Collagen IV is a non-fibrillar collagen, which differs from connective tissues’ fibrillar col-
lagens by the presence of globular NC (non-collagenous) domains at their C terminals (as
reviewed in (Ortega & Werb, 2002)). The NC domains are critical because they seem to be
responsible for ensuring that the α chains associate only with their appropriate binding part-
ners, which give rise to only a limited number of heterotrimer combinations (as reviewed in
(Ortega & Werb, 2002)).
In addition to providing a scaffold for assembly of other ECM proteins and mechanical
stability of the BM, collagen IV is important for cellular interaction with the underlying
BM. In vertebrates, this interaction is critical for a variety of processes, such as cell adhe-
sion, migration, survival, proliferation, and differentiation for a large number of cell types
[][Rubin:1981ii,Murray:1979vd,Setty:1998cj]. Collagen IV deficiency was shown to be
involved in the pathogenesis of a variety of disorders, and kidney can be particularly af-
fected by Collagen IV abnormalities. Alport’s and Goodpasture’s syndromes are the two
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major kidney diseases in which Collagen IV deficiency is the main culprit (Borza, 2000;
Mochizuki et al. , 1994). Recently, Collagen IV abnormality has been shown to be involved
in pathogenesis of the CNS in mammals. Mutation in Collagen IV α1 subunit was shown
to cause encephaloclastic porencephaly, which is characterized by structural defects in the
cerebral vasculature and BM, leading to degenerative cavities and cerebral lesions (Gould
et al. , 2005). Milder forms of the disease can cause patients to suffer from recurrent hem-
orrhagic strokes caused by weakened BM of the CNS vasculature (van der Knaap et al. ,
2006).
Collagen IV is highly conserved from humans to Drosophila. In the Drosophila genome,
two genes encode α-like subunits, named viking (vkg) and collagen-at–25C (Cg25C), hereby
referred to as collagen IVvkg and collagen IVcg25C, respectively (Rodriguez et al. , 1996; Ya-
sothornsrikul et al. , 1997). collagen IVvkg encodes the alpha2 subunit and collagen IVcg25C
encodes the alpha1 subunit. A trimer of 2 alpha1 subunits and 1 alpha2 subunit form the Col-
lagen IV molecule. collagen IVvkg and collagen IVcg25C are located head-to-head adjacent to
each other in the genome, an arrangement that is conserved in the α1/2-like pair of Collagen
IV genes in mammals (Rodriguez et al. , 1996). Whereas signalling events regulated by
Collagen IV remains largely unexplored in vertebrates, recent work in Drosophila pioneered
the investigation of a direct involvement of Collagen IV in growth factor signalling (Bunt
et al. , 2010; Sawala et al. , 2012; Wang et al. , 2008). The most well-characterised sig-
nalling pathway mediated by Collagen IV is BMP signalling. Wang et al first demonstrated
that interaction between Dpp (Decapentaplegic, a Drosophila BMP ligand) and Collagen IV
is essential for the development of the Drosophila germarium and in early embryos (Wang
et al. , 2008). In addition, Collagen IV-dependent BMP signalling has been shown to reg-
ulate renal tubule morphogenesis (Bunt et al. , 2010) and midgut stem cell proliferation
(Tian & Jiang, 2014). Recently, Sawala et al showed that Collagen IVVkg facilitates Dpp
gradient formation by physically binding to Dpp (Sawala et al. , 2012). In vertebrates,
Collagen IV binds BMP4 and has been suggested to potentiate signalling in cultured cells
(Wang et al. , 2008). These results suggest that Collagen IV can affect BMP signalling
in both invertebrate and vertebrate development. Whether Collagen IV facilitate BMP sig-
nalling in the context of CNS development and homeostasis has not been explored in either
vertebrate systems and Drosophila to date.
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1.10.2 Perlecan
Perlecan is a heparan sulfate proteoglycan (HSPG) which consists of a 480-kDa protein
core and three to four heparan sulfate chains (Iozzo et al. , 1994). A key feature of Per-
lecan are that it is secreted and a component of the BM, in contrast to other GPI linked or
transmembrane proteoglycans like Dally and Syndecan. In vertebrates, it is produced dur-
ing embryonic stage of development in many organs and is localized in BM, vessel walls,
cartilage matrix and some other extracellular spaces (French et al. , 1999). In mice, defi-
ciency of Perlecan lead to multiple defects and early lethality (Arikawa-Hirasawa et al. ,
1999; Costell et al. , 1999). Major phenotypes include defective BM in the heart muscle and
brain: exencephaly, an impaired endochondral ossification and an unstable cartilage matrix
(Arikawa-Hirasawa et al. , 1999; Costell et al. , 1999). The complex phenotypes may be
due to the fact that Perlecan binds to a diverse array of signalling molecules, as well as other
ECM proteins such as laminins, nidogens and fibulins. Bindings sites with which Perlecan
interacts with other molecules are present in different domains of the protein core as well
as on the heparan sulfate side chains (Hopf et al. , 1999). These binding sites are partic-
ularly abundant in domains IV and V of Perlecan. Perlecan has been well characterised in
the growth and morphogenesis of the skeleton and vascular system, and it is involved in
FGF, PDGF, and VEGF signalling (Melrose et al. , 2008; Segev et al. , 2004; Whitelock
et al. , 2008). Recent studies also revealed its potential role in BMP signalling (DeCarlo
et al. , 2012), and TGF-beta signalling by interacting with the pro-domains of TGF-beta
ligands (Sengle et al. , 2011). Its involvement in a diverse array of signalling pathways
could be at least partly responsible for its essential roles in many aspects of brain functions.
For example, Perlecan is required for mammalian neurogenesis (Girós et al. , 2007), pro-
motes regeneration from ischemic stroke (Roberts et al. , 2012), and protects the brain from
βamyloid fibre-induced neurotoxicity (Parham et al. , 2013).
Perlecan is well conserved in Drosophila and it shares nearly all the main domain struc-
tures of mammalian Perlecan except for domain I (Friedrich et al. , 2000; Voigt et al.
, 2002). The Drosophila Perlecan is encoded by the gene terribly reduced optical lobes
(trol), and I hereby refer to it as perlecantrol. As in mammals, the Drosophila PerlecanTrol
also interacts with other ECM proteins, growth factors and receptors, to regulate cellular
signalling (Lin, 2004a). Early studies on PerlecanTrol focused on its role on NSC reactiva-
tion. In perlecantrol null mutants, NSC reactivation is severely impaired: NSCs enlarge, but
never enter their first S phase (Datta, 1995). Null mutations in hedgehog (hh) and branch-
less (bnl, an FGF homologue) dominantly enhance the impairment in NSC proliferation in
a sensitised perlecantrol mutant background, suggesting that PerlecanTrol may regulate NSC
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reactivation by modulating Hh and FGF signalling pathways (Park et al. , 2003). A re-
cent study supported PerlecanTrol’s role in Hh signalling in a different context. perlecantrol
mutant lymph glands showed disrupted architecture and premature stem cell differentia-
tion, and overexpression of hh in PerlecanTrol mutants was able to rescue the premature
differentiation phenotype (Grigorian et al. , 2013). Another study revealed a novel role
of PerlecanTrol in Wnt signalling. At the Drosophila neuromuscular junction (NMJ), Wnt/
Wingless (Wg) regulates the formation of both pre- and postsynaptic structures. Mutation
in perlecantrol resulted in diverse postsynaptic defects and overproduction of synaptic bou-
tons at the NMJ. The postsynaptic defects of perlecantrol mutants could be rescued by the
postsynaptic activation of the Wnt pathway (Kamimura et al. , 2013). Whether PerlecanTrol
is also involved in BMP/TGF-beta signalling in Drosophila, and especially in the context of
NSC reactivation, awaits further investigation.
1.10.3 Laminin and Nidogen
Laminins consist of the most abundant non-collagenous protein component in the BM.
Laminin isoforms are heterotrimeric glycoprotein chains that are shaped like a three-pronged
fork (reviewed in (Durbeej, 2010)). The heterotrimer consisting of one α , one β , and one γ
chain. In vertebrates, five α , three β , and three γ chains have been identified that represent
distinct gene products (reviewed in (Durbeej, 2010)). Laminins are essential for embryonic
development, and have indispensable functions in major organs including muscle, nerve,
skin, kidney, lung and the vasculature (reviewed in (Durbeej, 2010)).
The two Drosophila Laminins both share common β and γ chains (called LanB1 and
LanB2, respectively), whereas there are two different α chains (LanA, or Laminin A and
Wing blister, or Laminin W). The two α chains have distinct tissue-specific expression and
distribution patterns (Kusche-Gullberg et al. , 1992; Martin, 1999). In Drosophila, defi-
ciency in laminin leads to developmental morphogenesis defects in many organs including
the heart, gut, CNS, and muscles (as reviewed in (Broadie et al. , 2011)). Laminin’s role in
CNS development includes promoting axon outgrowth and guidance both in culture (Takagi
et al. , 1996) and in vivo (Garcia-Alonso et al. , 1996).
Nidogen, also known as entactin, accounts for 2–3% of all BM proteins. It is a glycopro-
tein which contains 10% carbohydrates in its composition (Timpl et al. , 1983). Nidogen
can interact with several other BM components, including Collagen IV, Perlecan, Laminin,
Fibrinogen and Fibronectin (as reviewed in (LeBleu et al. , 2007)). Together with Perlecan,
it helps to structurally connect the BM network by linking Collagens and Laminins to each
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other (as reviewed in (Yurchenco & Patton, 2009)). Despite being an ubiquitous compo-
nent of the BM and having many binding partners, genetic analyses in mammals have shown
that they are dispensable for the overall architecture of the BM (as reviewed in (Ho et al.
, 2008)). Whereas the vertebrates have two Nidogen protein isoforms, only one exists in
Drosophila. Drosophila Nidogen is a prominent component of BM (Wolfstetter & Holz,
2012), but there are few studies that investigated it at the functional level so far.
1.10.4 ECM Receptors
In Drosophila, ECM proteins bind a number of highly conserved ECM-receptors, includ-
ing Integrins, Dystroglycan (Dg), Syndecan, and Glypicans (as reviewed in (Broadie et al. ,
2011)). Dystroglycans are the transmembrane matrix receptor of the dystrophin-glycoprotein
complex (DGC) and they are closely associated with muscular dystrophies (Cohn, 2005;
Michele & Campbell, 2003). The sugar side chains of dystroglycan can mediate binding to
many Laminin G-domain-containing ECM proteins, such as Laminins and Perlecan. The
Drosophila dystroglycan has been shown to genetically interact with a diverse array of sig-
nalling pathways involved in the development and function of the CNS (Kucherenko et al.
, 2008). Another class of ECM receptors belong to the HSPG family of proteins, includ-
ing the glycosulphosphatidylinositol (GPI)-anchored glypicans Dally and Dlp (Van Vactor
et al. , 2006), as well as the transmembrane protein Syndecan (Lin, 2004b). Like Dystro-
glycans, the HSPG receptors have also been shown to be involved in a number of signalling
pathways (Alexopoulou et al. , 2007; Häcker et al. , 2005; Lin, 2004b; Morgan et al. ,
2007).
Among all ECM receptors in Drosophila, most attention has been paid to the het-
erodimeric transmembrane Integrin receptors. Integrins are heterodimers of two single-pass
type I transmembrane proteins, including an α and a β subunit. Integrin heterodimers are
formed in the endoplasmic reticulum, where these two subunits are synthesised (Hynes,
1992). Mammalian genomes contain 18 α subunit and eight β subunit genes, which form
a total of 24 α/β heterodimers that interact with a wide range of ECM proteins (Barczyk
et al. , 2009; Bökel & Brown, 2002; Humphries et al. , 2006a). In comparison to the com-
plexity of mammalian integrins, the Drosophila genome encodes only five α subunits and
two β subunits. In particular, the position specific (PS) integrins βPS (myospheroid, mys),
αPS1 (inflated, if ) and αPS2 (multiple edematous wings, mew) are the most evolutionary
conserved integrin subunits, whereas βν (β Int-ν), αPS3 (scab, volado), αPS4 and αPS5
are less conserved (as reviewed in (Brown et al. , 2000)). Work in Drosophila has mostly
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focused on the PS integrins (Brabant et al. , 1996; Brown, 1993; Gotwals et al. , 1994).
The only βPS subunit, encoded by the mys locus, is likely to form heterodimers with all five
known α subunits (as reviewed in (Brown et al. , 2000)).
In vertebrates, integrins can bind to many ECM ligands. Despite their wide variety, it
is possible to cluster integrin-ligand combinations into four main classes, according to the
structural basis of the molecular interaction (as reviewed in (Humphries et al. , 2006b)).
The first class consists of RGD-binding integrins which have the ability to recognise lig-
ands containing an RGD tripeptide active site, such as in Fibronectin and Vitronectin. The
LDV-binding integrins recognise an acidic motif in their ligands, such as VCAM–1 and
Fibronectin. For the third class, 4 α subunits containing an αA-domain combine with β1
integrin form a distinct Laminin/Collagen binding integrin subfamily. The structural basis
for this interaction lies in a critical glutamate within a collagenous GFOGER motif. Finally,
the fourth class consists of non-αA-domain-containing Lamimin binding integrins. Direct
binding of Collagen IV to integrins has been biochemically confirmed in vertebrates: Puri-
fied α1β1 and α2β1 integrin complexes can directly bind Collagen IV, with α1β1 showing
higher binding affinity (Tuckwell & Humphries, 1996).
In Drosophila, only a small number of ECM proteins have been confirmed as integrin
ligands, which includes two laminins (Henchcliffe et al. , 1993; Martin, 1999), tiggrin
(Fogerty et al. , 1994), thrombospondin (Subramanian et al. , 2007) and tenectin (Fraichard
et al. , 2010). Other ECM proteins, such as Collagen IV (Le Parco et al. , 1986) and tenasin
(Graner et al. , 1998) are important in Drosophila but they have not been confirmed to be
integrin ligands with biochemical assays. Nonetheless, a number of recent in vivo studies
within different developmental contexts support the idea that Collagen IV exert its functions
via its association with integrin receptors (Haigo & Bilder, 2011; Pastor-Pareja & Xu, 2011;
Vanderploeg et al. , 2012).
What functions do integrins play during development? In Drosophila, most attention
has been given to their adhesive and signalling roles in muscle attachment (Brown, 1993;
Bunch et al. , 1998; Nievers et al. , 1999; Prokop et al. , 1998; Volk, 1999), morphogenesis
of the gut (Borkowski et al. , 1995; Martin-Bermudo & Brown, 1999; Reuter et al. , 1993;
Roote & Zusman, 1996), embryonic dorsal closure (Brabant & Brower, 1993; Brower et al.
, 1995; Brown, 1994; Leptin et al. , 1989; Roote & Zusman, 1996) as well as adhesion of the
wing blade (Brabant & Brower, 1993; Brabant et al. , 1996; Brower et al. , 1995; Ramírez-
Weber & Kornberg, 1999). Furthermore, integrins play crucial roles during Drosophila
neural development. Drosophila integrins were first implicated in regulating axon growth
(Donady, 1972). Later, Drosophila laminins were found to act as Integrin ligands. They
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promote axon outgrowth of cultured primary neurons and trigger cell spreading of neuronal
BG2 cell lines and recruitment of βPS integrin into focal adhesion (Takagi et al. , 1996,
1998). These findings were partially confirmed by further in vivo analyses: Motor nerve
patterns in mutant embryos lacking βPS integrin resulted in axonal navigational errors, al-
though the outgrowth capacity of motor neurons were unchanged (Hoang & Chiba, 1998).
A better defined axon-guidance role for integrins was explored in the context of CNS mid-
line axon crossing mediated by the secreted ligand Slit and its receptor Roundabout (Robo).
Loss of function mutation of integrin subunit genes led to phenotypes similar to slit/robo
axon pathfinding defects (Stevens & Jacobs, 2002). Further studies found that Laminin
A and Tiggrin are present in the CNS and may mediate integrin-dependent midline axon
guidance: both lanA and tig genetically interact with slit mutations (Garcia-Alonso et al.
, 1996). In addition to regulating axon guidance, integrins are also known to play a role in
the formation of neural-muscular junctions (NMJ). βPS, βµ , and αPS1–3 subunits are all
present at Drosophila NMJs (Beumer et al. , 1999; Rohrbough et al. , 2000; Tsai et al. ,
2008). Mutation in PS integrin subunits caused strong defects in the morphological differen-
tiation and functional maturation of NMJ during CNS development (Beumer et al. , 1999;
Rohrbough et al. , 2000). Although the exact mechanisms are unclear, it is hypothesised
that integrins at the NMJ are important for interaction with other transmembrane partners
and secreted signals. For example, the immunoglobulin family adhesion molecule Basigin
(Bsg) is expression at the Drosophila NMJ (Besse et al. , 2007) and βPS and bsg mutant
alleles show genetic interaction (Curtin et al. , 2007).
In addition, integrins are known to play major roles in the regulation of mammalian
NSCs during development and homeostasis. Integrin receptors are widely expressed in both
embryonic and adult NSCs. For example, the Laminin receptor α6β1 integrin is present
at high levels on both embryonic NSCs and on proliferating adult NSCs (Kazanis et al. ,
2010; Shen et al. , 2008; Staquicini et al. , 2009). In the embryonic CNS, integrins anchor
NSCs to their niche and maintain NSC polarity, which are important for NSC survival and
proliferation, respectively (Radakovits et al. , 2009). Experiments that removed integrins
in the developing CNS disrupted NSCs’ basal processes’ attachment to the basal lamina.
This disruption in NSC niche architectural ultimately lead to the apoptosis of NSCs, sug-
gesting that integrins are essential for NSC survival (Radakovits et al. , 2009). In addition,
intraventricular injection of β1 blocking antibodies in embryonic CNS caused reduction in
NSC division, as a result of altered division cleavage plane (Loulier et al. , 2009). In adult
neurogenic niche, integrins promote NSC activation and proliferation. For example, loss
of αVβ8 integrin reduced NSC/or precursor cell proliferation in the SEZ (Mobley et al. ,
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2009). Interestingly, another integrin receptor, β1 integrin, is not present on quiescent adult
NSC but upregulated when these cells activate to enter mitotic cell cycle (Kazanis et al. ,
2010; Kokovay et al. , 2010). This suggests that changes in integrin receptor expression may
mediate changes in ECM signalling that contributes to the activation of quiescent. Despite
overwhelming evidence of integrins’ role in mammalian NSC behaviour, whether integrin
receptors play similar roles in Drosophila NSC survival, proliferation and activation remain
undefined.
1.11 Advantage of Using Drosophila as a Model System to
Investigate the Mechanisms of NSC Reactivation in
Vivo
Studies using mammalian models to investigate mechanisms underlying NSC proliferation
in vivo face a number of challenges. First of all, genetic manipulation in a NSC-specific
manner is difficult. For example, the most widely used Nestin-cre mouse lines is not suffi-
ciently specific, as it is expressed in radial glia/NSCs and intermediate intermediate progeni-
tor cells (Gavériaux-Ruff & Kieffer, 2007). An even more problematic aspect of Nestin-cre
has just emerged recently: a report showed that the only commercially available Nestin-
cre line is insufficient for directing recombination in early embryonic NSCs (Liang et al.
, 2012). These challenges can be largely resolved in Drosophila. The availability of mul-
tiple NSC specific GAL4 drivers in Drosophila enables misexpression and knockdown of
candidate effectors in a cell type specific manner, and during any stage of development
when GAL4 is used in combination with GAL80ts (Matsumoto et al. , 1978), a temperature
sensitive inhibitor of GAL4.
The Drosophila model system offers a few other advantages for the study of systemic
regulation of NSC reactivation. A large proportion of NSCs are conveniently localised on
the surface of the VNC and they reactivate within a short time window, which makes ob-
servation and quantification more straightforward than in the rodent models. Due to short
generation time of the organism, experiments that perturb cellular signalling components
related to NSC reactivation can be performed with a speed unmatched by other model sys-
tems.
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1.12 Summary of PhD findings
Despite recent exciting work on nutritional regulation of NSC reactivation, key questions
still remain: what are the signal(s) from the fat body, and how do they interact with glial
cells to induce glial secretion of DIlps? In addition, three glial subtypes are physically
associated with the NSCs, including the perineurial glia, subperineurial glia, and cortex
glia, but each subtype’s individual contribution to NSC reactivation remains elusive.
To search for nutrient-responsive fat body factors and investigate the mechanisms by
which they interact with the glial niche, I used the novel TaDa (Targeted DamID) Pol II
transcriptional profiling technique (Southall et al. , 2013) to map fat body transcriptomes
under fed and starved conditions. I identified Collagen IV as a key fat body factor crucial
for coupling brain growth to the nutrient states of the organism. Secreted from the fat body
in response to dietary amino acid availability, Collagen IV deposits on the CNS surface and
controls NSC reactivation. NSCs are separated from the hemolymph by a BBB. In collab-
oration with Pauline Speder and Jessie Van Buggenum (Andrea Brand lab), we confirmed
crucial roles of the two BBB glial populations as a NSC niche and identified each subpop-
ulation’s contribution to NSC reactivation: DamID glial transcriptional profiling identified
subperineurial and perineurial glia as the source of CNS DIlps and perineurial glia as the
source of PerlecanTrol, an which is recruited to the CNS surface by fat body derived Collagen
IV. Together, Collagen IV and PerlecanTrol trigger NSC reaction and subsequent induction
of insulin signalling from the BBB glia.
Chapter 2
Fat Body Targeted Dam ID (TaDa)
Transcriptional Profiling Identified
Regulators of CNS Development in
Response to Nutrient Availability
2.1 Identification of Fat Body Derived Signals in Vivo Us-
ing TaDa Transcriptional Profiling
To confirm that the fat body secretes signals regulating CNS growth, I first assessed larval
development when fat body secretion was impaired. A previous study showed the in vivo
evidence for the requirement of putative fat body derived growth signals: disruption of vesi-
cle trafficking in the fat body by expressing a dominant negative mutant of shibire (shiDN),
which encodes Drosophila Dynamin (Moline et al. , 1999), led to impaired NSC reactiva-
tion (fewer EdU positive cells) (Sousa-Nunes et al. , 2011). ShiDN impaired endocytosis.
Therefore, I used an approach to knock down secretion more specifically. Syntaxin 5 (Syx5)
is a member of the SNARE complex and it is involved in ER-Golgi transport (Dascher
et al. , 1994). Knockdown of syx5 in Drosophila S2 cells specifically disrupted constitutive
secretion while having little effect on other aspects of S2 cells’ homeostasis (personal com-
munication, Andrew Peden, University of Sheffield). Indeed, in vivo fat body knockdown
(Lpp-GAL4) of syx5 using RNAi resulted in arrested larval growth and reduced size of the
CNS, confirming that fat body secreted signal(s) are required for CNS development (Figure
2.1.1). A second RNAi line against syx5 showed the same phenotype, suggesting that the
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growth phenotypes observed in syx5 knockdown were likely not due to off-target effects of
the RNAi constructs. The RNAi lines used in this experiment are listed in Appendix.
Dlg
Control Fat body>Syx5 RNAi
3rd instar CNS
Fig. 2.1.1 Impairment of fat body secretion led to CNS underdevelopment. Disruption of fat
body exocytosis by knocking down Syntaxin 5 in the fat body (Lpp-GAL4) resulted in CNS under-
development (third instar larval CNS, 72 hph. Dlg: membrane marker).
Fat body derived growth signals may be transcriptionally regulated in response to feed-
ing. Therefore, I assayed fat body transcriptomes in the first instar larvae under fed and
starved conditions. Since dissection of fat body in a consistent manner is technically chal-
lenging from starved first instar larvae, I took advantage of the Targeted DamID (DNA
adenine methyltransferase identification) technique, hereby referred to as “TaDa”, to over-
come this challenge (Southall et al. , 2013). This technique allowed me to obtain RNA
Polymerase II (Pol II) binding profiles in the fat body cells in vivo without the need for
dissection. Three fat body GAL4 drivers were tested, including Cg-GAL4, Lpp-GAL4,
and Fb-GAL4. I expressed UAS-mCD8GFP under these fat body drivers and examined the
expression patterns of GFP in embryonic and larval tissues. Lpp-GAL4 (Brankatschk &
Eaton, 2010) was selected because of its tissue specificity (Figure 2.1.2). Driver specificity
and onset of driver expression for all fat body drivers tested is summarised in Table 2.1.1.
Workflow of the identification of fat body derived growth signals using TaDa is summarised
in Figure 2.1.3.
A stringent fat body GAL4 driver (Brand & Perrimon, 1993) allowed me to obtain fat
body Pol II binding profiles using a whole larval preparation. In addition, temporal con-
trol was achieved by combining the GAL4 system with a temperature sensitive repressor of
GAL4, GAL80ts (Matsumoto et al. , 1978). I expressed the RNA Pol II-Dam fusion pro-
teins in the fat body 0–24 hours post hatching (hph), which coincides with the reactivation
time window of the majority of NSCs. Raw data from the TaDa transcriptional profiling
experiments containing genes upregulated under fed or starved conditions, fold changes
between the two conditions (on Log2 scale), and their corresponding false discovery rates
(FDRs), can be found in my data deposition folder (see Chapter 8).
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Fig. 2.1.2 Fat body transcriptional profiling identified factors that regulate CNS development
in response to dietary amino acids. (A) Previous studies have shown that Drosophila fat body,
the liver and adipose tissue equivalent, acts as a nutrient sensor in response to food in-take. It
sends out unknown fat body signal(s), which induces CNS glial cells to secrete Drosophila insulin-
like peptides (DIlps). The local DIlps in turn trigger NSC reactivation from quiescence. (B) A
schematic workflow of the identification of nutrient-sensitive fat body signals following TaDa fat
body transcriptional profiling.
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Fig. 2.1.3 Tissue specificity of Lpp-GAL4 driver (A-F) UAS-mCD8GFP was expressed under
Lpp-GAL4 driver. GFP expression was assayed in fat body, gut, CNS, muscles, imaginal discs and
salivary gland (A‘-F’), and GFP signal was only detected in the fat body (A’). Larvae were reared
at 25 ºC and dissected 72 hph. DAPI, DNA dye, blue; Lpp-GAL4>UAS-mCD8-GFP, green; Dlg,
membrane marker, red.
Table 2.1.1 Driver specificity and onset of driver expression of all fat body drivers tested for fat
body TaDa transcriptional profiling experiment
CG-GAL4 FB-GAL4 Lpp-GAL4
Onset of GAL4 activity Embryo Embryo Embryo
Expression pattern in fed larvae Fat body, Fat body, Fat body
Hemocytes, Wing disc,
Lymph gland CNS
Expressed in starved larvae? Yes Yes Yes
Driver strength Strong Very strong Strong
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2.2 Fat Body Transcriptional Profiling Identified Nutrient
Sensitive Fat Body Signals and Signalling Pathways
Using a medium stringency threshold, 150 genes were significantly upregulated in the fat
body under fed as compared to starved conditions, whereas 1370 genes were upregulated
under starved conditions (>=1.5 fold change with FDR<=0.01). I found that fat body genes
known to be upregulated under fed condition, such as lsp–1 and sug (Farhadian et al. , 2012;
Higami et al. , 2006), and fat body genes known to be upregulated under starved conditions
such as dIlp6 (Slaidina et al. , 2009) and autophagy genes (Scott et al. , 2004), were regu-
lated as expected. I used two web based functional annotation tools, Gene Ontology (GO)
and Database for Annotation, Visualisation and Integrated Discovery (DAVID) to investi-
gate enriched processes and pathways among the differentially transcribed genes.
I first investigated genes upregulated under fed conditions. Many of the top GO terms
correspond to processes related to the cell cycle, transcription, and translation. In addition,
proteins encoded by genes upregulated under fed conditions form a dense interaction net-
work according to known and predicted interactions, based on STRING (Search Tool for
the Retrieval of Interacting Genes/Proteins) functional protein association network analysis
(Franceschini et al. , 2013; von Mering et al. , 2005) (Figure 2.2.1)(http://string-db.org/).
Recognisable clusters within the protein association network include “regulation of pro-
tein translation”, “protein folding”, “mRNA alternative splicing” and “extracellular matrix
proteins” (Figure 2.2.1).
It is intriguing that significantly higher number of genes were upregulated under starved
conditions compared to the number of genes upregulated under fed conditions in the fat
body. Many of the top GO terms correspond to processes related to metabolism, consistent
with the known role of fat body as a global metabolic sensor and coordinator (Colombani
et al. , 2003). In particular, genes regulating sucrose and starvation metabolism are en-
riched in this gene set. This is consistent given the switch from a standard laboratory food
to pure sucrose diet (Table 2.2.1). Starvation imposes tremendous stress on the organism.
Transcriptome analysis revealed that many genes involved in stress response were upregu-
lated under starved conditions, consistent with previous work describing an essential role
of the fat body in coordinating stress response and the fact that starvation is stress-inducing
(Karpac et al. , 2011) (Table 2.2.2).
In addition, many signalling pathways are enriched in the fat body under starved condi-
tions. This includes the JAK/STAT (Janus kinase/Signal Transducer and Activator of Tran-
scription) pathway, which is also known to be upregulated in response to stress (Dudley
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Extracellular matrix 




Fig. 2.2.1 Known and predicted interactions between the products of 150 genes differentially
transcribed in the fat body under fed conditions. Analysis was performed using STRING with a
medium confidence score of 0.4 and all interaction methods available. Clusters representing selected
pathways and processes are highlighted. Single nodes are not displayed
Table 2.2.1 Genes involved in sugar and starch metabolism upregulated under starved condi-
tions in the fat body.









FBgn0038293 Putative glycogen (starch) synthase
FBgn0010851 sugarless
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Table 2.2.2 Genes involved in stress response upregulated under starved conditions in the fat
body.
Flybase ID Gene Symbol
FBgn0034366 Autophagy-specific gene 7









FBgn0051354 Major heat shock 70 kDa protein Bbb
FBgn0031848 Non-structural maintenance of
chromosomes element 1 homolog
FBgn0014020 Ras-like GTP-binding protein Rho1
FBgn0014018 Relish
FBgn0003462 Superoxide dismutase
FBgn0004436 Ubiquitin conjugating enzyme
FBgn0000097 anterior open
FBgn0000229 basket





et al. , 2004) (Table 2.2.3), and several signalling pathways that have not been previously
explored in the fat body, such as MAP kinase pathway (Table 2.2.4), TGF-beta (Table 2.2.5),
and Wnt signalling (Table 2.2.6).
In summary, TaDa transcriptional profiling identified genes that are differentially tran-
scribed under fed or starved conditions in the fat body during the first 24 hours after larval
hatching. The observed patterns of differential gene expression are consistent with known
functions of the fat body.
38
Table 2.2.3 Genes involved in JAK/STAT signalling pathway upregulated under starved condi-
tions in the fat body.
Flybase ID Gene Symbol
FBgn0010379 RAC serine/threonine-protein kinase
FBgn0016917 Signal-transducer and activator of
transcription protein at 92E
FBgn0041184 Suppressor of cytokine signaling at 36E
FBgn0004638 downstream of receptor kinase
Table 2.2.4 Genes involved in MAP kinase signalling pathway upregulated under starved con-
ditions in the fat body.
Flybase ID Gene Symbol
FBgn0003205 Ras oncogene at 85D
FBgn0000097 anterior open
FBgn0004638 downstream of receptor kinase
FBgn0001137 gurken
FBgn0003079 pole hole
Table 2.2.5 Genes involved in TGF-beta signalling pathway upregulated under starved condi-
tions in the fat body.
Flybase ID Gene Symbol
FBgn0020493 Daughters against dpp
FBgn0025637 CG16983
FBgn0260439, FBgn0005776 Protein phosphatase 2A at 29B
FBgn0014020 Ras-like GTP-binding protein Rho1
FBgn0025800 Smad on X
FBgn0000575 extra macrochaetae
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Table 2.2.6 Genes involved in Wnt signalling pathway upregulated under starved conditions in
the fat body.
Flybase ID Gene Symbol
FBgn0020496 C-terminal Binding Protein
FBgn0030505 CG11172
FBgn0025637 CG16983
FBgn0260439 Protein phosphatase 2A at 29B
FBgn0014020 Ras-like GTP-binding protein Rho1





2.3 Collagen IV Is an Important Regulator of CNS Devel-
opment
Since NSCs are only able to reactivate when the larvae are fed essential amino acids, I hy-
pothesised that the fat body derived growth signals would be upregulated under fed condi-
tions. Among the 150 genes upregulated under fed conditions, I decided to first concentrate
on the genes encoding secreted proteins. Signal P and Secretome P programs (Bendt-
sen et al. , 2004) predicted 61 genes encoding proteins that could be secreted via either
classical Golgi-dependent pathway (Signal P) or Golgi-independent pathway (Secretome
P). The symbols of these genes, as well as their biological processes and cellular localisa-
tions as predicted by GO, are listed in the Appendix. Subsequently, I knocked down the
secreted proteins in the fat body by expressing RNA interference (RNAi) constructs using
Lpp-GAL4, and assessed their requirement for neural development by examining the size
of third instar larval CNS (Dietzl et al. , 2007). Two RNAi libraries were available from the
VDRC (Vienna Drosophila Resource Centre), including the older GD library and the newer
KK library. The GD library was generated by P element–mediated transformation of short
hairpin RNA (shRNA) constructs into the fly genome (Groth et al. , 2004), a technique sus-
ceptible to insertional mutagenesis (false positive results) and insertion into transcriptionally
silent regions in the genome (false negative results). In comparison, the KK collection used
a two-step transformation strategy so that gene-specific shRNA sequences could be inserted
into defined regions in the genome (Dietzl et al. , 2007). This strategy was thought to min-
imise the risk of insertional mutagenesis. Thus, although the KK library also has its own
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limitations such as causing a number of dominant phenotypic effects as discovered recently
(Green et al. , 2014), it was chosen as my preferred method of knockdown because it was the
best available RNAi library at the time of the study. In addition, when I decided to perform
fat body RNAi screen, the KK library was incomplete and did not contain RNAi constructs
against all the genes that I planned to knock down. Therefore, I used RNAi lines from the
GD library for these genes. Gene symbols and VDRC stock numbers for my fat body RNAi
screen are listed in the Appendix.
The functional RNAi screen identified a total of 10 genes that are required in the fat body
for neural development out of the 61 genes initially screened. When knocked down in the
fat body, 6 of the 10 candidates showed severe systemic growth defects: larval growth was
significantly impaired as larvae were noticeably smaller in size and they were all arrested
at early second instar stage until death (Figure 2.3.1). All of these genes are involved in
translational regulation, which include 5 ribosome associated proteins and one translation
elongation factor (Figure 2.3.1). In the fat body, TOR signalling functions as a sensor of
amino acids (Colombani et al. , 2003). It has a well known function to regulate protein syn-
thesis downstream of amino acid sensing via post-translational modification of the transla-
tional machinery (e.g. S6K and 4E-BP) (Andersen et al. , 2013). Studies showed that TOR
signalling can also control the expression of components of the translational machinery,
consistent with my findings: recent work demonstrated a specific role for RNA polymerase
III and tRNA synthesis, as well as for ribosomal biogenesis downstream of TOR signalling
in the control of systemic growth by fat body cells (Elizabeth J Rideout, 2012; Killip &
Grewal, 2012; Marshall et al. , 2012). It was initially surprising that ribosomal proteins
were identified as candidates of secreted fat body signals. Ribosomes can exit in either free
(in cytosol) or membrane-bound (in endoplasmic reticulum) states (Woolford & Baserga,
2013). The SignalP program determines whether a protein is secreted or not by the presence
or absence of a signal peptide in its amino acid sequence. Ribosomal subunits associated
with the endoplasmic reticulum contain signal peptides, which is probably why they were
identified as secreted proteins by the SignalP program. On the other hand, a recent study
showed that it is indeed possible for ribosomal proteins to be secreted extracellularly. The
ribosomal protein S3 (rpS3) is homodimerised and secreted from several human and mouse
cancer cell lines such as human fibrosarcoma and mouse plasmacytoma (Kim et al. , 2013).
The level of secreted rpS3 appeared to correlate with the degree of cancer malignancy. It re-
mains to be investigated whether other ribosomal proteins can also be secreted, and whether
this occurs under normal homeostatic conditions.
In contrast, fat body knockdown of the remaining 4 candidates, including collagen IVvkg,
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Control RpL23 RpL39 RpS5a RpS12 RpS27A Ef2b
Fat body KD
Whole larvae 96hph
Fig. 2.3.1 Fat body factors are required for systemic larval growth. Knockdown of a number of
fat body genes upregulated under fed conditions led to significant impairment of larval growth. Most
of these genes are associated with the ribosome and translation machinery.
collagen IVcg25C, hsc70-C and CG13900, led to viable third instar larvae. These larvae
showed mild systemic growth defects compared to control, but their CNS were reduced in
size. This indicates that these fat body-secreted proteins are important for neural develop-
ment during larval stages. In addition to the secreted proteins, I also carried out a functional
analysis of the remaining 89 upregulated fat body genes via an RNAi screen. All genes
which are required in the fat body for organismal, and especially neural development, are
summarised in Table 2.3.1. This includes a total of 9 predicted secreted proteins and a total
of 9 non-secreted proteins.
Table 2.3.1 Summary of all genes upregulated under fed conditions whose knockdown led to
larval growth defects in the fat body.
CG Number Gene symbol Secreted Comments Reduction in body size GO_BIOLOGICAL_PROCESS
CG4145 Cg25C yes high penetrance,elongated VNC moderate dorsal closure
CG16858 Vkg yes high penetrance, elongated VNC moderate skeletal muscle tissue development;
Malpighian tubule morphogenesis
CG13900 – yes high penetrance moderate nuclear mRNA splicing, via spliceosome
CG4147 Hsc70-3 yes – moderate sleep ; response to heat
CG3661 RpL23 yes arrested at 2nd instar severe translation; mitotic spindle elongation
CG3997 RpL39 yes arrested at 2nd instar severe translation; mitotic spindle elongation
CG8922 RpS5a yes arrested at 2nd instar severe translation; mitotic spindle elongation
CG11271 RpS12 yes arrested at 2nd instar severe translation
CG5271 RpS27A yes arrested at 2nd instar severe translation
CG13360 – no high penetrance moderate -
CG12101 Hsp60 no high penetrance moderate response to heat ; protein folding
CG1242 Hsp83 no high penetrance moderate spermatogenesis ; centrosome cycle ;
regulation of circadian cycle
CG10798 dMyc no low penetrance moderate cell competition; cell proliferation;
positive regulation of cell growth
CG12885 – no low penetrance moderate -
CG6425 – no high penetrance, elongated VNC moderate -
CG8280 Ef1alpha48D no – moderate translational elongation
CG15554 RpII215 no – moderate transcription
DNA damage checkpoint
CG2238 Ef2b no arrested at 2nd instar severe translational elongation
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As a starting point to investigate the role of fat body derived growth signals on NSC re-
activation, I decided to focus on Collagen IV. This is because the two Collagen IV subunits,
Collagen IVVkg and Collagen IVCg25C, are the only proven secreted proteins. I will also
discuss my preliminary investigation of the other two candidates, Hsc70–3 and CG13900,
in Chapter 5.
Collagen IV is an ECM protein and an important component of the basement membrane.
Basement membranes are layered polymers of ECM proteins lining the epithelia. They
surround organs, including muscles, fat, endothelium, and nervous tissue. Collagen IV is
the most abundant component of the basement membrane, comprising 50% of its proteins
(Kalluri, 2003). Collagen IV molecules consist of a chains bound in long helical trimers
that assemble into a network through lateral and end-domain interactions (Yurchenco &
Ruben, 1987). Collagen IV molecules are divided into two subfamilies, the α1 like subunits
and α2 like subunits (Aouacheria et al. , 2006). The most broadly distributed isoform
of collagen IV is a hetero-trimer consisting of two α1 and one α2 chain, designated as
α1(IV)2α2(IV) (Pöschl et al. , 2004). In the Drosophila genome, two genes encode α1-like
subunits, named viking (vkg) and collagen-at–25C (Cg25C), hereby referred to as collagen
IVvkg and collagen IVcg25C, respectively (Rodriguez et al. , 1996; Yasothornsrikul et al.
, 1997). collagen IVvkg and collagen IVcg25C are located head-to-head adjacent to each
other in the genome, an arrangement conserved in the α1-like pair of Collagen IV genes
in mammals (Rodriguez et al. , 1996). Levels of Pol II binding across collagen IVvkg and
collagen IVcg25C loci are significantly higher under fed conditions as compared to starved
conditions in the fat body (Figure 2.3.2).
Collagen IV is highly conserved from Drosophila to humans. Recent work in Drosophila
revealed its direct role in growth factor signalling (Bunt et al. , 2010; Sawala et al. ,
2012). The most well-characterised signalling pathway mediated by Collagen IV is BMP
signalling. Wang et al first demonstrated that interaction between Dpp (Decapentaplegic,
a Drosophila BMP ligand) and Collagen IVVkg is essential for the development of the
Drosophila germarium and in early embryos (Wang et al. , 2008). In addition, Colla-
gen IV-dependent BMP signalling has been shown to regulate renal tubule morphogenesis
(Bunt et al. , 2010) and midgut stem cell proliferation (Tian & Jiang, 2014). Recently,
Sawala et al showed that Collagen IVVkg facilitates Dpp gradient formation by physically
binding to Dpp (Sawala et al. , 2012). In vertebrates, Collagen IV binds BMP4 and has
been suggested to potentiate signalling in cultured cells (Wang et al. , 2008). These re-
sults suggest that Collagen IV can affect BMP signalling in both invertebrate and vertebrate
development.
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Fig. 2.3.2 Collagen IV Alpha–1 subunits are upregulated under fed conditions in the fat body.
(A) RNA Pol II occupancy across collagen IVvkg and collagen IVcg25C loci from fat body TaDa tran-
scriptional profiling (Log2 scale). The experiment was performed 0–24 hph, under fed and starved
conditions. (B) Pol II binding intensities on natural scale were quantified for both collagen IV sub-
units. (C-D) Collagen IVVkg-GFP protein trap shows higher Collagen IVVkg expression in the fat
body under fed conditions (C) as compared to starved (D) conditions (30 hph.)
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Taking advantage of a CollagenVkg-GFP protein trap line (Morin et al. , 2001), I ver-
ified the upregulation of Collagen IVVkg protein in the fat body cells under fed conditions
compared to starvation (Figure 2.3.2). To test whether Collagen IVVkg is required for CNS
development, I knocked down collagen IVvkg in the fat body using a small hairpin-based mi-
croRNA (Ni et al. , 2009, 2011) (hereby referred to as “shmiR”, as compared to “RNAi”)
against collagen IVvkg. This resulted in reduced brain size in third instar larvae but moder-
ately reduced larval size (Figure 2.3.3), developmental delay and pupal lethality when the







Fig. 2.3.3 Fat body Collagen IVVkg knockdown led to CNS underdevelopment and mild systemic
growth defect. (A-B) Third instar whole larvae and larval CNS (72 hph) under control condition
(w1118 X UAS-collagen IVvkg shmiR). (C-D) Third instar whole larvae and larval CNS in fat body-
specific knockdown of Collagen IVVkg (Lpp-GAL4>UAS-collagen IVvkg shmiR). Dlg in red labels
neuronal membranes. This experiment was performed at 25 ºC.
2.4 Chapter Summary
In order to investigate fat body secreted proteins regulating NSC reactivation, I performed
fat body transcriptional profiling using the TaDa technique, during the time window of NSC
reactivation. A subsequent functional RNAi screen of genes upregulated under fed con-
ditions identified a number of candidates, including collagen IVcg25C and collagen IVvkg,
whose knockdown in the fat body results in CNS underdevelopment. I verified the upregu-
lation of Collagen IVVkg protein under fed conditions using a Collagen IVVkg-GFP protein
trap construct.
Chapter 3
Fat Body and Glia Secreted ECM
Proteins Regulate Nutrient-Sensitive
NSC Reactivation
3.1 Fat Body Derived Collagen IV Is Deposited on the Brain
Surface and Controls NSC Reactivation
3.1.1 Fat Body Derived Collagen IV Is Necessary for NSC Reactivation
After a functional RNAi screen of fat body signal candidates, I decided to focus on colla-
gen IVvkg because its knockdown in the fat body resulted in an underdeveloped CNS and a
moderate organismal growth defect. Decrease in the CNS size can be caused by a variety of
factors, including death of neurons, glia, or NSCs, impaired NSC reactivation, or a disrup-
tion of NSC proliferation at later stages of larval development. I examined first instar larval
CNS when collagen IVvkg was knocked down in the fat body in order to distinguish among
these possibilities. Since shmiR knockdown of collagen IVvkg showed stronger phenotypes
than knockdown with RNAi, and that knockdown at 29 ºC showed stronger phenotypes than
at 25 ºC, all subsequent collagen IVvkg knockdown experiments were performed using the
shmiR strategy at 29 ºC. To further maximise knockdown efficiency, I used a fat body driver
combination of Cg-GAL4 and Lpp-GAL4 (two copies of fat body GAL4). In addition, I
decided to focus on collagen IVvkg instead of collagen IVcg25C for the analysis of Collagen
IV’s role in neural development. This is because the availability of collagen IVvkg shmiR
and protein trap constructs allowed for in-depth characterisation of Collagen IV.
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I confirmed that fat body secreted Collagen IVVkg is required for NSC reactivation.
Reactivation of quiescent NSCs starts with cell growth (enlargement), followed by mitosis.
When collagen IVvkg was knocked down in fat body using Cg-GAL4; Lpp-GAL4, NSCs
failed to enlarge at 24 hph, similar to under starved conditions (Figure 3.1.1). Phospho-
histone3 (PH3) marks mitosis, and showed no staining in VNC NSCs, indicating that no
NSCs divided in the absence of fat body derived Collagen IVVkg. However, the numbers of
NSCs in the VNC were normal compared to controls, which suggests that Collagen IVVkg
controls NSC reactivation without affecting their survival.
In third instar larval brains, some NSCs in collagen IVvkg knockdown larvae eventually
reactivated but CNS underdevelopment was permanent. At 72 hph, NSCs from fat body col-
lagen IVvkg knockdown larvae remained small, and the number of dividing NSCs remained
low (Figure 3.1.2). Because NSCs in the brain lobes and VNC were affected to similar de-
grees, I concentrated on the VNC for all subsequent analyses of Collagen IVVkg-dependent
NSC reactivation. This is because the proximity of NSCs to the VNC surface makes them
easier to quantify than their counterparts in the brain lobes.
To confirm the requirement of Collagen IVVkg for NSC reactivation, I examined a hypo-
morphic mutant of collagen IVvkg that survives past the time window of NSC reactivation.
The hypomorphic collagen IVvkgK197 line was generated by P-element insertion into the
intronic region of the collagen IVvkg locus (Yasothornsrikul et al. , 1997). As expected,
the hypomorphic collagen IVvkgK197 showed severely reduced brain size and impaired NSC
reactivation similar to fat body collagen IVvkg knockdown conditions (Figure 3.1.3).
Previous studies showed that glial cells in the CNS serve as a NSC niche. They play a
role in NSC reactivation by secreting local DIlps (Drosophila insulin-like peptides) (Chell
& Brand, 2010; Sousa-Nunes et al. , 2011). To assess if there is any glial contribution of
Collagen IV during NSC reactivation, I examined NSC enlargement and proliferation when
collagen IVvkg was knocked down in glial cells. NSC reactivation was unaffected (Figure
3.1.1). Therefore, these results suggest that Collagen IV from the fat body, but not from the
glial cells, is required for NSC reactivation. This is consistent with a previous study showing
that Collagen IVVkg in Drosophila is secreted centrally in the fat body and transported to
peripheral organs (Pastor-Pareja & Xu, 2011).
Next, I tested whether fat body secreted Collagen IV is sufficient for rescuing NSC
reactivation defects observed in the hypomorphic collagen IVvkgK197 mutants. Indeed, fat
body specific mis-expression of Collagen IVVkg protein in the mutant larvae could partially
rescue NSC enlargement and proliferation (Figure 3.1.3). Interestingly, Collagen IVVkg
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Fig. 3.1.1 Fat body-secreted Collagen IV is required for NSC reactivation. (A-C) Confocal im-
ages of NSC enlargement and proliferation under fed conditions (A), starved conditions (B), and fat
body-specific knockdown of collagen IVvkg (C, Cg-GAL4;Lpp-GAL4>UAS-collagen IVVkg shmiR).
CNS were dissected 24–30 hph. Dpn in red marks NSC nuclei and PH3 in green marks mitotic M
phase. Yellow arrows point to enlarged and dividing NSCs. (D) Quantification of NSC proliferation
(number of PH3 positive NSCs in VNC +/- sd) under fed conditions, starved conditions, fat body
knockdown of collagen IVvkg, glial knockdown of collagen IVvkg 24 hph (*P<0.05). (E-F) Quantifi-
cation of NSC number and enlargement of above mentioned conditions. All experiments here and
onwards that assess NSC reactivation defects at first instar stage were performed at 29 ºC
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Fig. 3.1.2 Loss of Collagen IVVkg has a permanent impact on larval neurogenesis. (A-C) NSC
proliferation in the brain lobes are severely impaired under fat body collagen IVvkg knockdown condi-
tions in third instar larvae. (D-F) Likewise, NSC proliferation in the VNC are also severely impaired.
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Fig. 3.1.3 Fat body secreted Collagen IVVkg can partially rescue NSC reactivation defects. (A-
B) Confocal images of NSC proliferation in CNS from hypomorphic collagen IVvkgK197 mutant larvae
(A) and in CNS from hypomorphic collagen IVvkgK197 mutant larvae in which collagen IVvkg was mis-
expressed in the fat body (B). Yellow arrows point to enlarged and dividing NSCs. (C) Quantification
of NSC proliferation in VNC from hypomorphic collagen IVvkgK197 mutant larvae and in CNS from
hypomorphic collagen IVvkgK197 mutant larvae in which Collagen IVVkg was mis-expressed in the fat
body (*P<0.05).
GAL4), could not rescue NSC reactivation defects in collagen IVvkgK197 mutants (data not
shown). In addition, I examined whether fat body Collagen IVVkg mis-expression under
starved conditions could induce ectopic NSC reactivation. I expressed either Collagen IVVkg
or Collagen IVCg25C alone, or the two together, in the fat body of starved larvae. I did not ob-
serve NSC reactivation under these circumstances, but fat body Collagen IV mis-expression
led to elongated VNC (Figure 3.1.4). This in part resulted from increased neuronal volume
as measured by the volume of Elav (a neuronal marker) staining using Volocity, but it re-
mains to be examined whether this was due to increased neuronal survival or other factors
(Figure 3.1.4).
Collagen IV is an important basement membrane component essential for maintaining
tissue integrity. Therefore, one may suspect that NSC reactivation phenotype observed in fat
body collagen IVvkg knockdown conditions may result from a disruption of fat body cells
and loss of fat body tissue. However, collagen IVvkg knockdown in the fat body did not
cause severe anatomical disruption of the fat body. Lipid droplets are still present, although
they tend to be smaller than under wildtype conditions (Figure 3.1.5). Similar to starved
conditions, fat body knockdown of collagen IVvkg resulted in smaller fat body cells, but did
not disrupt the integrity of fat body cells as shown by Phalloidin (a marker for F-actin) and
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Fig. 3.1.4 Fat body misexpression of Collagen IV in starved larvae increased neuronal volume
without causing ectopic NSC reactivation. (A-C) Confocal images of fed WT larvae, starved WT
larvae, and starved WT larvae in which Collagen IVVkg protein was misexpressed in the fat body.
Elav: neuronal marker. (D) Quantification CNS neuronal volume in starved WT larvae and starved
WT larvae in which Collagen IVVkg was misexpressed in the fat body.
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DAPI (a DNA marker) staining (Figure 3.1.5). I did not detect any difference in the shapes
of either the cells or nuclei under the two conditions.
Fed Starved












Fig. 3.1.5 Fat body collagen IVvkg knockdown did not disrupt fat body tissue structure. (A-
C) Membrane (Phalloidin) and DNA (DAPI) staining of fat body cells under fed (A), starved (B),
and fat body collagen IVvkg knockdown (C, Cg-GAL4; Lpp-GAL4> UAS-collagen IVvkg shmiR)
conditions. (A’-C’) DIC images of lipid droplets in fat body cells under fed (A’), starved (B’),
and fat body collagen IVvkg knockdown (C’, Cg-GAL4; Lpp-GAL4> UAS-collagen IVvkg shmiR)
conditions.
To verify that fat body Collagen IV expression is downstream of dietary amino acids
intake, I disrupted Slif-TOR signalling in the fat body, which has been shown to mediate
amino acid sensing in the fat body (Colombani et al. , 2003). The TSC complex serves as
a negative modulator of TOR signalling pathway and may function via direct interactions
with TOR or by blocking the access of TOR to their downstream target proteins (Abraham,
2002). In fat bodies expressing TSC1/2, Collagen IVVkg protein level was severely reduced
as shown by diminished Collagen IVVkg-GFP staining (Figure 3.1.6).
Taken together, these results show that fat body secreted Collagen IVVkg is downstream
of fat body amino acid sensing pathway, and it is necessary for NSC reactivation.
3.1.2 Collagen IV Could Travel From the Fat Body to the Brain and
Its CNS Deposition Is Developmentally Regulated
The key regulator of NSC reactivation, dIlp6, shows strong transcriptional upregulation in
the first 24 hph (Chell & Brand, 2010). I hypothesised that if Collagen IVVkg is indispens-
able for NSC reactivation, its deposition on the CNS surface may also increase during this
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Fig. 3.1.6 Fat body Collagen IVVkg expression is mediated by Slif-TOR nutrient sensing path-
way. (A-B) Collagen IVVkg-GFP and DNA (DAPI) staining in control fat body (A) and in fat body
expressing TSC1/2 (B, Cg-GAL4; Lpp-GAL4>UAS-TSC1/2).
critical time window. Indeed, brains from newly hatched larvae showed very low level of
Collagen IVVkg on their surface (Collagen IVVkg –GFP protein trap) (Figure 3.1.7). Colla-
gen IVVkg protein level on the CNS increased rapidly after larval hatching, and at 24 hph,
Collagen IVVkg formed a dense meshwork around the CNS (Figure 3.1.7). However, un-
der starved conditions, Collagen IVVkg deposition on the brain was dramatically reduced.
Therefore, the abundance of Collagen IVVkg on the brain surface also depends on dietary
amino acid intake.
Since fat body secretes Collagen IVVkg (Pastor-Pareja & Xu, 2011), I decided to test if
Collagen IVVkg directly travels to, and deposits on the CNS, or whether it requires the aid
of other modulators from the hemolymph (e.g. hemocytes) as suggested by a previous study
(Pastor-Pareja & Xu, 2011). To distinguish between these two possibilities, I performed
ex vivo tissue co-culture experiment of larval CNS and fat body explants to visualise the
deposition of Collagen IVVkg on the CNS (Figure 3.1.7). Wildtype CNS from newly hatched
larvae were co-cultured with fat body from third instar Collagen IVVkg-GFP larvae that were
fed a normal diet. Since the fat body tends to float on the surface of the culture medium
and larval CNS tends to sink, there was minimal physical contact between the two tissues
during the co-culture experiment. In addition, fat bodies were rinsed in PBS to minimise
the contamination with other hemolymph factors, in particular the hemocytes. Collagen











           Fat body 
collagen IVVkg knockdownControl





    -GFP







   VNC single sliceE’
Fig. 3.1.7 Collagen IV deposition on the CNS is developmentally regulated and it acts as a direct
humoral link between the fat body and the CNS. (A-C) Collagen IVVkg deposition on the CNS
surface (Collagen IVVkg-GFP VNC surface staining 3D reconstruction) just after larval hatching
(A), 24 hph under fed conditions (B), and 24 hph under starved conditions (C). (D-E) A explant
culture system was set up to investigate whether Collagen IVVkg from the fat body can travel to
and deposit on the CNS surface. CNS from just hatched wild type larvae (no endogenous Collagen
IVVkg-GFP expression) were co-cultured with fat body isolated from wandering third instar Collagen
IVVkg-GFP protein trap larvae in supplemented Schneider medium (D). Fat bodies were rinsed in
PBS to minimise the presence of other hemolymph factors in the culture. Anti-GFP staining on
wild type CNS were visualised 24 hours post culture. Both Collagen IVVkg-GFP VNC surface 3D
reconstruction (E) and single VNC slice (E’) show accumulation of GFP on the CNS surface. (F-
G) Anti-GFP 3D reconstruction of Collagen IVVkg-GFP VNC (F), and of VNC from a Collagen
IVVkg-GFP larvae in which Collagen IVVkg was knocked down in the fat body (G).
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Collagen IVVkg deposition onto the CNS surface can be direct, and it either does not require,
or requires minimal assistance of hemolymph factors.
Glial subtype TaDa transcriptional profiling showed that collagen IVvkg is also tran-
scribed by the perineurial glia during the time window of NSC reactivation (see Chapter 6,
Figure 6.2.9). In order to confirm that fat body makes the major contribution to Collagen
IVVkg proteins on the CNS surface, I examined Collagen IVVkg deposition in vivo. When
collagen IVvkg was knocked down in the fat body using shmiR in a Collagen IVVkg-GFP
protein trap larvae, I observed a dramatic reduction of Collagen IVVkg-GFP on the brain
surface. This experiment showed that the Collagen IVVkg on the CNS surface predomi-
nantly originates from the fat body. Moreover, this experiment validated that the shmiR
construct against collagen IVvkg is highly effective (Figure 3.1.7).
Earlier, I showed that fat body Collagen IVVkg expression is downstream of amino acid-
sensitive Slif-TOR signalling. Does impairment of fat body Slif-TOR signalling directly
affect the abundance of Collagen IVVkg protein on the CNS surface? Indeed, Collagen
IVVkg deposition on the CNS was substantially reduced when TSC1/2 was expressed in the











Fig. 3.1.8 CNS Collagen IV deposition is sensitive to Slif-TOR nutrient sensing pathway in the
fat body. (A-B) Anti-GFP VNC surface 3D reconstruction of Collagen IVVkg-GFP CNS (C) and
of Collagen IVVkg-GFP CNS from larvae mis-expressing TSC1/2 in the fat body (D, Cg-GAL4;
Lpp-GAL4>UAS-TSC1/2).
Taken together, Collagen IVVkg is required for NSC reactivation as collagen IVvkg knock-
down in the fat body led to impaired NSC enlargement and division. Furthermore, Collagen
IVVkg deposition on the CNS is strongly upregulated during the time window of NSC re-
activation. In vitro tissue co-culture experiment confirmed that Collagen IV acts as a direct
humoral link between the fat body and the brain.
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3.1.3 Collagen IV Deposition on the CNS Is Responsive to Nutritional
Fluctuation During Larval Life Beyond NSC Reactivation Con-
text
My data showed that the secretion and deposition of Collagen IV on the CNS surface are
tightly regulated during development and in response to nutrition. This raises the question
of whether Collagen IV secretion/deposition remains sensitive to nutritional inputs during
later larval development. For example, although Collagen IV deposition on the CNS after
larval hatching depends on the organism’s amino acid intake, it is not clear whether this
dependence is only relevant for the time window of NSC reactivation, or whether it holds
true during later stages of development past the reactivation time window. To address this
question, I first fed larvae for 24 hours on a normal diet so that the majority of NSCs started
to reactivate, and subsequently transferred them to sucrose solution. I wanted to examine
that once Collagen IV deposited on the brain surface after feeding, whether this process
could still respond to nutritional alterations, or whether Collagen IV continues to deposit
on the CNS irrespective of nutrition once the critical time window of NSC reactivation has
passed.
In larvae that were initially fed standard laboratory food, NSCs fully enlarged and Col-
lagen IVVkg coated the most of the brain’s surface area. However, there were still areas
that were visibly deficient in Collagen IVVkg coating, especially in the abdominal part of
the VNC. If larvae continued to feed, brain surface Collagen IVVkg deposition would have
continued to increase and Collagen IVVkg would have covered the entire VNC after another
approximately 12 hours. However, after larvae were transferred to starvation medium, no
further deposition was observed beyond the level already achieved during the first 24 hours
of feeding. This indicates that Collagen IVVkg deposition halted in response to starvation.
In the second experiment, I wanted to assess whether larvae that are starved for a pro-
longed period of time retain their ability to secrete Collagen IVVkg and reactivate their NSCs
in response to feeding. I first starved larvae for 72 hours immediately after larval hatching,
and then transferred them back to standard laboratory food. NSCs remained small and Col-
lagen IVVkg covered only a small portion of the CNS surface after 72 hours of starvation.
When larvae were transferred to standard laboratory food, I observed visible increase in
Collagen IVVkg deposition after 24 hours of re-feeding. After 48 hours of feeding, Collagen
IVVkg completely covered the CNS surface. NSCs also started to reactivate: after 48 hours
of feeding, NSCs fully enlarged. Therefore, prolonged starvation for as long as 3 days after
larval hatching did not impair the larvae’s ability to secreted/deposit Collagen IVVkg onto
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Fig. 3.1.9 Collagen IV deposition is responsive to nutritional fluctuation past the NSC reacti-
vation time window. (A-C) Collagen IVVkg deposition on the VNC (Collagen IVVkg-GFP protein
trap) in larvae fed a normal diet for 24 hours, and in larvae initially fed for 24 hours but suffered
prolonged starvation afterwards.
the CNS surface and reactivate their NSCs.
72h St 72h St+24h fed 72h St+48h fed
CollagenIVVkg-GFP
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Fig. 3.1.10 Prolonged starvation does not impair fat body’s ability to deposit Collagen IV on
the CNS. (A-C) Collagen IVVkg deposition on the VNC (Collagen IVVkg-GFP protein trap) in larvae
starved for 72 hours, and in larvae initially starved for 72 hours but fed a normal diet afterwards.
Taken together, I have shown that fat body secreted Collagen IV is necessary for NSC
reactivation. Collagen IV can travel directly from the fat body to deposit on the CNS surface,
both in vitro and in vivo. The deposition is highly sensitive to nutritional inputs both during
and beyond the time window of NSC reactivation.
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3.2 The ECM Protein, PerlecanTrol From BBB Glia, Is Re-
quired for NSC Reactivation
3.2.1 CNS Deposition of PerlecanTrol Is Nutrition-Dependent, and It
Follows Spatial Temporal Pattern as Collagen IVVkg
So far, I uncovered a novel role of fat body derived ECM protein, Collagen IV, in regulating
nutrient-sensitive NSC reactivation. This discovery led me to examine another ECM protein,
PerlecanTrol. Perlecantrol encodes a heparan sulfate proteoglycan (HSPG) and is highly
conserved in Drosophila and mammals (Park et al. , 2003; Voigt et al. , 2002). It is an
important component of the ECM that interacts with other ECM proteins, growth factors
and receptors, to regulate cellular signalling (Lin, 2004a). In perlecantrol null mutants,
NSC reactivation is severely impaired: NSCs enlarge, but never enter their first S phase
(Datta, 1995). Null mutations in hedgehog (hh) and branchless (bnl, an FGF homologue)
dominantly enhance the impairment in NSC proliferation in a sensitised perlecantrol mutant
background, suggesting that PerlecanTrol may regulate NSC reactivation by modulating Hh
and FGF signalling pathways (Park et al. , 2003). Since there is evidence that Collagen
IVVkg and PerlecanTrol can function antagonistically to maintain organ shape in Drosophila
(Pastor-Pareja & Xu, 2011), I investigated whether the two ECM proteins also interact in
the context of NSC reactivation.
I first characterised the temporal expression pattern of PerlecanTrol using a PerlecanTrol-
GFP protein trap line (Medioni & Noselli, 2005). I found that similar to Collagen IVVkg,
PerlecanTrol deposition on the CNS also increased significantly after larval hatching, dur-
ing the time window of NSC reactivation. By 30 hph, PerlecanTrol-GFP formed a dense
meshwork around the CNS surface (Figure 3.2.1). Interestingly, when larvae were deprived
of dietary amino acids, PerlecanTrol-GFP deposition was reduced, in a fashion similar to
Collagen IVVkg.
3.2.2 CNS PerlecanTrol Predominantly Derives From the Glial Cells
Prior to the present study, it is unclear where PerlecanTrol on the CNS originates from and
whether its expression is downstream of dietary amino acid intake (Britton & Edgar, 1998).
A previous study suggested that PerlecanTrol is produced in the fat body and deposits on
peripheral tissues (Pastor-Pareja & Xu, 2011). In support of this, PerlecanTrol has been
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Fig. 3.2.1 PerlecanTrol deposition on the CNS follows similar spatial-temporal pattern as Colla-
gen IVVkg. (A-C) Confocal images of PerlecanTrol deposition on the CNS surface (PerlecanTrol-GFP
protein trap CNS surface staining 3D reconstruction) just after larval hatching (A), 30 hph under fed
conditions (B), and 30 hph under starved condition (C).
cells are the source of CNS PerlecanTrol (Lindner et al. , 2007). Interestingly, the TaDa
transcriptional profiling in glia and fat body showed strong perlecantrol transcription in both
tissues during the time window of NSC reactivation (Table 3.2.1). Therefore, similar to the
DIlps, PerlecanTrol also exists as part of a systemic and a local pool.
To examine the origin of PerlecanTrol on the CNS, I knocked down the expression of
the PerlecanTrol-GFP protein trap by targeted RNAi against GFP (iGFPi) (Pastor-Pareja &
Xu, 2011) (Figure 3.2.2). Whereas iGFPi driven in the gut (Esg-GAL4) and imaginal discs
(Hh-GAL4) did not affect PerlecanTrol-GFP levels on the CNS surface (data not shown),
iGFPi in the glial cells (Repo-GAL4) resulted in a severe reduction, and iGFPi in the fat
body caused a moderate reduction (Figure 3.2.2). I also confirmed perlecantrol transcription
in the CNS using Q-PCR. perlecantrol transcription showed a strong peak immediately after
larval hatching, and sustained transcription throughout larval life (Figure 3.2.3).
Next, I assessed whether PerlecanTrol originating from the glial cells is essential for NSC
reactivation. When perlecantrol was knocked down in the fat body, NSCs enlarged and en-
tered mitosis as normal (wildtype number of PH3-positive NSCs; Figure 3.2.4). However,
when perlecantrol was knocked down in glial cells, NSC cell cycle re-entry was delayed
(Figure 3.2.4), although NSC enlargement was normal as was the number of NSCs. There-
fore, PerlecanTrol produced by glial cells is necessary for efficient reactivation of NSCs,

















Fig. 3.2.2 Investigation of the origin of CNS PerlecanTrol using iGFPi method. (A) A schematic
of iGFPi (in vivo GFP interference) method (Pastor-Pareja and Xu, 2011) for determining the source
of PerlecanTrol on CNS surface in first instar larvae. A GFP protein trap inserted into the PerlecanTrol
locus produces a functional and GFP-tagged PerlecanTrol. Tissue-specific contribution of CNS sur-
face PerlecanTrol can be assessed by knocking down GFP (UAS-GFP RNAi) under tissue-specific
GAL4 drivers and subsequently examining the reduction of GFP intensity on the CNS surface. (B-
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Fig. 3.2.3 Transcription of CNS perlecantrol in first and second instar larvae. Q-PCR analysis of
CNS perlecantrol transcripts level in wild type larvae under fed conditions. Q-PCR was performed
on RNA extracted from CNS of wild type (w1118) larvae at 0, 16, 24, 30,and 48 hph at 25 ºC. Values
are normalised to 0 hph condition. Error bar=sd, *P<0.05.
3.2.3 PerlecanTrol Is Required From the Perineurial Glia and Its Tran-
scription Is Controlled by Nutrition
NSCs are isolated from the hemolymph by the BBB, which is comprised of two glial cell
populations: the subperineurial glia (inner layer) and the perineurial glia (outer layer) (Fig-
ure 3.2.5) (Stork et al. , 2012). Septate junctions form between subperineurial glial cells
creating a physical barrier. The outermost perineurial glia are less well characterised, but
are hypothesised to mediate signalling from the hemolymph to the CNS due to their location
at the interface between the two (Stork et al. , 2008). The third population of glial cells, the
cortex glia, are located between NSCs, beneath the BBB. Cortex glia have a similar struc-
ture to mammalian astrocytes and may provide trophic support for the surrounding NSCs
(Freeman & Doherty, 2006b).
To identify which of these glial subtypes secretes PerlecanTrol, I first performed TaDa
transcriptional profiling (Southall et al. , 2013), of the different glial subtypes using subtype-
specific GAL4 drivers (see Chapter 8 for GAL4 drivers used). I found that perlecantrol is
transcribed in the perineurial glia during NSC reactivation, but not in the subperineurial or
cortex glia (Figure 3.2.6). In addition, expression of PerlecanTrol-GFP protein trap and
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Fig. 3.2.4 BBB glia-derived PerlecanTrol regulates NSC reactivation. (A-D) Confocal images of
NSC enlargement and proliferation under fed conditions (A), fat body knockdown of perlecantrol
(B, Cg-GAL4; Lpp-GAL4> UAS-perlecantrol shmiR), pan-glial knockdown of perlecantrol (C,
Repo-GAL4>UAS-perlecantrol shmiR), and perineurial glia knockdown (D, NP6293-GAL4>UAS-
perlecantrol shmiR) 24 hph. Dpn in red marks NSC nuclei and PH3 in green marks mitotic M phase.
Yellow arrows point to dividing NSCs. (E) Quantification of NSC proliferation (number of PH3 pos-
itive NSCs in VNC +/- sd) under above mentioned (A-D) conditions (P<0.05). (F-G) Quantification
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Fig. 3.2.5 PerlecanTrol-GFP protein trap reveals Perlecan expression by the perineurial glia.
(A) Cross-section schematic of VNC shows the NSCs and their glial niche, including the cortex glia,
subperineurial glia, perineurial glia, and the extracellular matrix. The Drosophila BBB consists of
perineurial and subperineurial glia. (B) XZ view of a confocal image of a single perineurial glia cell
expressing PerlecanTrol. PerlecanTrol-GFP is in green and the underlying subperineurial glia mem-
brane (Moody-GAL4>UAS-mCD8 RFP) is in red. Repo in blue marks glial nuclei. (C) XY view of
a confocal image of perineurial glia cells expressing PerlecanTrol, as visualised by PerlecanTrol-GFP
protein trap.
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Perlecan-expressing glial cells are on the CNS surface (Figure 3.2.5, see XY view) above
the subperineurial glia layer (Figure 3.2.5, see XZ view). Since perineurial glial cells are the
only cell type apical to the subperineurial glia, the identity of this population of PerlecanTrol-
expressing glial cells can be ascertained to be perineurial glia.
Furthermore, glial transcription of perlecantrol is dependent on nutrition: perlecantrol
transcription is down regulated in starved larvae in glial cells but not in fat body (Figure
3.2.7 and Table 3.2.1). Q-PCR analysis of brain extracts from fed and starved animals
confirmed the nutritional dependence of perlecantrol transcription (Figure 3.2.7). Next, I
knocked down perlecantrol specifically in perineurial glia. This resulted in a delay of cell
cycle re-entry without affecting NSC enlargement or survival (Figure 3.2.4). Taken together
our results show that, whereas both the fat body and glial cells secrete PerlecanTrol that can
be deposited on the CNS surface, perineurial glia-derived PerlecanTrol is responsible for












A. Schematic and GAL4 drivers
used for glial subtype Pol II TaDa
Fig. 3.2.6 Glial subytpe TaDa transcriptional profiling confirmed perineurial glial origin of
PerlecanTrol. (A) Glial subtype GAL4 drivers used for TaDa transcriptional profiling experiments.
(B) Pol II occupancy traces across perlecantrol locus in the three glial subtypes.
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Fig. 3.2.7 Transcription of perlecantrol is regulated by nutrition. (A) Pan-glial Pol II occupancy
traces across perlecantrol locus under fed and starved conditions. (B) Q-PCR experiment confirmed
the transcriptional regulation of perlecantrol by nutrition.
Table 3.2.1 Summary of Pol II binding intensity (Log2 scale) at Perlecan locus in glia and fat
body, under fed and starved conditions




3.3 Collagen IV Co-Localises With PerlecanTrol and Re-
cruits PerlecanTrol to the CNS Surface
3.3.1 ECM Proteins Interact With Both Populations of the BBB Glia
Previously, I showed that both Collagen IVVkg and PerlecanTrol are important for dietary
amino acid-dependent NSC reactivation, and they both deposit on the BBB. I decided to
further characterise their relationship with each other and their interaction with the glial
niche in order to gain insights into the mechanisms by which the ECM proteins regulate
NSC proliferation.
The BBB consists of two glial subtypes of perineurial glia and subperineurial glia.
Which glial subtype is responsible for transducing signals from the hemolymph to the in-
terior of the brain via interaction with ECM proteins? In order to observe ECM proteins’
deposition on the BBB, I took advantage of DeltaVision-OMX super resolution imaging
system (Applied Precision), which has a XY resolution of 120 nm and Z resolution of 300
nm (http://api.gehealthcare.com/api/deltavision-omx.asp).
The outermost layer of perineurial glia may seem a more feasible glial cell type for direct
ECM interaction. However, a closer investigation of the CNS surface structure during early
larval life revealed that subperineurial glia may also participate in ECM binding. From 0 to
24 hph (time window of NSC reactivation), perineurial glia undergoes rapid proliferation,
but their membranes are only able to partially cover the CNS by 24 hph, leaving patches of
the subperineurial glia apical surface directly exposed to the ECM and hemolymph during
the NSC reactivation time window (Figure 3.3.1). Perineurial glia completely seal the CNS
surface at about 40 hph. Interestingly, although perineurial glia proliferation was observed
in the first 24 hph under starvation conditions, the sealing would not occur if larvae were
starved (Figure 3.3.1). I hypothesise that the exposure of both perineurial glial and subper-
ineurial glial apical surface to ECM proteins may be functionally important for glial insulin
expression/secretion, which will be discussed in detail in Chapter 3.4.
OMX images showed that subperineurial glia are closely associated with the ECM layer
(Figure 3.3.2). Some parts of subperineurial glia’s apical membrane clearly abuts Collagen
IVVkg, whereas in other places considerable gaps were observed between the subperineurial
glia membrane and Collagen IVVkg (Figure 3.3.2). The gaps are most likely due to the
presence of perineurial glia situated in between ECM and the subperineurial glia. OMX
images of peirneurial glia membrane and Collagen IVVkg-GFP showed that Collagen IVVkg
















Fig. 3.3.1 Temporal pattern and nutritional dependence of perineurial glia proliferation. (A)
Limited CNS enwrapment of perineurial glia immediately after larval hatching. (B-C) Gradual in-
crease of CNS perineurial glia coverage if larvae were fed dietary amino acids. (B‘-C’) Impaired
CNS perineurial glia coverage if larvae were starved.
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staining was observed to cross the BBB, or to exist between the two glial layers (i.e. on
the basal side of the perineurial glia membrane). I observed the same patterns at the VNC
channels which are the invaginations formed by the apical surface of the BBB glia along the
midline of VNC.
Subperineurial glia 








Fig. 3.3.2 Localisation of Collagen IVVkg with respect to subperineurial glia. (A) DeltaVision-
OMX images (both XY and XZ view) of Collagen IVVkg (Collagen IVVkg –GFP protein trap) and
subperineurial glia membrane.
3.3.2 Collagen IVVkg and PerlecanTrol Co-Localise at the BBB
PerlecanTrol is produced locally by the perineurial glia and Collagen IVVkg is produced re-
motely by the fat body. How are they deposited with respect to each other on the BBB?
OMX image revealed close co-localisation of Collagen IVVkg and PerlecanTrol. Surpris-
ingly, the locally derived PerlecanTrol was deposited further apically (further away from the
CNS surface) than Collagen IVVkg, albeit following the same spatial patterns (Figure 3.3.4).
3.3.3 Collagen IV Recruits PerlecanTrol to the CNS Surface
Given the co-localisation between the two ECM proteins, I decided to examine whether
PerlecanTrol and Collagen IVVkg interact to regulate NSC reactivation. A previous study
showed that Collagen IVVkg recruits PerlecanTrol in the wing discs (Pastor-Pareja & Xu,
2011). In either a collagen IVvkgK197 hypomorphic mutant or fat body knockdown of col-
lagen IVvkg, the level of CNS PerlecanTrol protein was dramatically reduced (Figure 3.3.5).
Collagen IVVkg may be either required for the transcription of perlecantrol and/or the trans-
lation of the protein from the perineurial glia, or it may recruit PerlecanTrol protein to CNS
surface. Q-PCR analysis on perlecantrol with mRNA extracted from CNS under fat body
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Fig. 3.3.3 Localisation of Collagen IVVkg with respect to perineurial glia. (A) DeltaVision-OMX
images (both XY and XZ view) of Collagen IVVkg and perineurial glia membrane. (B) DeltaVision-
OMX images (both XY and XZ view) of Collagen IVVkg (Collagen IVVkg –GFP protein trap) and
perineurial glia membrane at the VNC channels.
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Fig. 3.3.4 PerlecanTrol and Collagen IVVkg closely co-localise at CNS surface. DeltaVision-OMX
super-resolution imaging shows the co-localisation of Collagen IVVkg (protein trap) and PerlecanTrol
(antibody staining) on the surface of VNC (A) and at the VNC channels (B).
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perlecantrol transcription, suggesting that it is more likely for Collagen IV to serve as a scaf-
fold upon which PerlecanTrol can deposit (Figure 3.3.5). Interestingly, the requirement of
Collagen IV for the deposition of PerlecanTrol is “one-sided”: Collagen IV deposition on
the CNS does not require PerlecanTrol, as CNS from PerlecanTrol null mutant larvae showed
similar level of Collagen IVCg25C protein on the CNS surface (Figure 3.3.6). In this exper-
iment, I only assessed Collagen IVCg25C protein level because the only available Collagen
IV antibody was produced against Collagen IVCg25C subunit. Since a functional Collagen
IV protein hetero-trimer consists of both Collagen IVCg25C and Collagen IVVkg subunits,
one can expect that the levels of Collagen IVCg25C serve as a reasonable read-out of the
abundance of functional Collagen IV trimers on the CNS surface.
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Fig. 3.3.5 PerlecanTrol CNS deposition, but not transcription, depends on The presence of Colla-
gen IVVkg. (A-D) Levels of PerlecanTrol deposition on the CNS surface (Anti-PerlecanTrol staining
3D reconstruction) in control (A), PerlecanTrol null (B), hypomorphic mutant collagen IVvkgK197 (C)
and fat body collagen IVvkg knockdown (D, Cg-GAL4; Lpp-GAL4> UAS-Vkg shimR) conditions
24 hph. (E) Q-PCR analysis of CNS perlecantrol transcripts under fed, starved, perlecantrol null, and
fat body collagen IVvkg knockdown conditions.
In summary, DeltaVision-OMX super resolution microscopy revealed that Collagen
IVVkg, PerlecanTrol, and the BBB glia are closely associated with one another. Furthermore,















Fig. 3.3.6 Loss of PerlecanTrol does not affect the deposition of Collagen IV on the CNS surface.
Snapshot of perlecantrol null VNC shows a complete loss of PerlecanTrol protein (B) but normal
deposition of Collagen IVCg25C on the CNS surface (A). Dlg, red; anti-CollagenCg25C, green; anti-
PerlecanTrol, green.
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IV is required to recruit PerlecanTrol to anchor at the CNS surface.
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3.4 Collagen IVVkg and PerlecanTrol Promote dILP6 Tran-
scription in the BBB Glia
3.4.1 BBB Glia Transcribes dIlp6 in Response to Dietary Amino Acids
NSCs reactivate in response to insulin signalling from the BBB glia, which act as a stem cell
niche (Chell & Brand, 2010; Sousa-Nunes et al. , 2011). PerlecanTrol and Collagen IVVkg
may stimulate NSC reactivation via the regulation of insulin secretion by the underlying
BBB glia (Chell & Brand, 2010). First, I confirmed that the BBB glia (subperineurial and
perineurial glia), but not the cortex glia, express dIlp6 during the time window of NSC re-
activation (glial subtype TaDa transcriptional profiling; Figure 3.4.1). TaDa transcriptional
profiling also verified the upregulation of dIlp6 transcription after feeding (Figure 3.4.1, Ta-
ble 3.4.1). I found no evidence for the involvement of other dIlps, including dIlp2, which
had been proposed to regulate NSC reactivation (Sousa-Nunes et al. , 2011): there is no
significant transcription of these dIlps 0–36 hph (Figure 3.4.1, Table 3.4.1).
Table 3.4.1 Summary Of pan-glial TaDa Pol II binding intensity (Log2 scale) across all 8 dIlp
loci under fed and starved conditions.
Gene symbol Log2 ratio_Fed FDR_Fed Log2 ratio_Starved FDR_Starved
dIlp1 -1.30 552.37 -0.17 28.68
dIlp2 -0.09 1.72 0.09 0.66
dIlp3 -1.30 918.76 -0.98 55002.07
dIlp4 -1.27 418.49 -0.40 326.59
dIlp5 -1.49 95.13 -0.05 1.25
dIlp6 1.59 0.00 1.09 2.03E-05
dIlp7 -0.13 1.68 -0.17 8.17
dIlp8 0.69 0.00 0.46 4.00
The transcription of dIlp6 in BBB glia but not cortex glia was confirmed with dIlp6
Fluorescence in situ hybridisation (FISH). Bright punctation of dIlp6 FISH signals were
observed on the CNS surface, co-localising with either subperineurial glia or perineurial
glia membrane (Figure 3.4.2).
These data indicate that the BBB glia but not cortex glia, serve as a nutrition-responsive
NSC niche during NSC reactivation. Indeed, disrupting vesicle trafficking using a dominant
negative Dynamin (ShiDN) in BBB glia, but not cortex glia, resulted in NSC reactivation























Fig. 3.4.1 Glial subtype transcription of dIlps according to TaDa transcriptional profiling. (A)
Pan-glial RNA Pol II occupancy across dIlp6 locus under fed and starved conditions. (B-C) RNA
Pol II occupancy across dIlp6 (C) and dIlp2 (D) loci in each glial subtype from DamID RNA Pol II
transcriptional profiling with glial subtype-specific GAL4 drivers. Perineurial glia driver: NP6293-
GAL4; subperineurial glia driver: moody-GAL4; cortex glia driver: NP2222-GAL4.
2.1 um deep 












Fig. 3.4.2 Fluorescence in situ hybridisation (FISH) confirmed the localisation of dIlp6 tran-
scripts in BBB glia. (A-C) XY view of dIlp6 FISH signals at the CNS surface (A), and deeper into
the CNS (B-C). (D-E) XZ view of dIlp6 FISH signals at the BBB.
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3.4.2 Collagen IVVkg and PerlecanTrol Regulate NSC Reactivation via
Glial Insulin Signalling
PerlecanTrol and Collagen IVVkg deposit at the apical surface of the BBB glia, which are
the source of local DIlp6. Thus, I hypothesised that the ECM proteins may regulate NSC
reactivation via insulin signalling from the underlying BBB glia. To test this, I extracted
mRNA from the brains of fed and starved larvae, perlecantrol null mutant larvae, and larvae
in which collagen IVvkg was knocked down in the fat body. Compared to controls, loss of
PerlecanTrol resulted in a mild but significant decrease in dIlp6 transcription, while loss of
Collagen IVVkg in the fat body resulted in a further decrease, giving a level similar to that
seen upon starvation (Figure 3.4.3).
Next, I examined whether forced expression of DIlp6 in glial cells could rescue NSC
reactivation in perlecantrol and collagen IVvkg mutant larvae. In perlecantrol null larvae,
NSCs can enlarge to a certain extent but fail to enter mitosis. Forced glial DIlp6 expression
was able to rescue NSC reactivation, driving NSCs into mitosis (> 50% of wildtype; Figure
3.4.4). collagen IVvkgK197 mutants could also be rescued, but to a lesser extent (Figure
3.4.4). Taken together, the data suggest that Collagen IVVkg and PerlecanTrol control NSC
reactivation through upregulation of dIlp6 transcription in the BBB glia. In addition, I could
partially rescue NSC reactivation in perlecantrol null or collagen IVvkgK197 hypomorphic
larvae by expressing a constitutively active form of Akt/PKB (a downstream effector of
insulin signalling) in the NSCs (data not shown).
3.4.3 Chapter Summary
In this chapter, I characterised fat body derived Collagen IVVkg and its role in regulating
nutrient-sensitive NSC reactivation. Collagen IVVkg travels from the fat body and deposits
on the brain surface. It recruits perineurial glia-derived PerlecanTrol to anchor at the BBB.
Glial subtype TaDa transcriptional profiling identified DIlp6 from the BBB glia as the main
reactivation signal from the glial niche. Furthermore, ECM binding on the BBB upregulates
dilp6 transcription from the BBB glia, leading to NSC reactivation.
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Fig. 3.4.3 Loss Of ECM proteins on the CNS surface impairs CNS dIlp6 transcription. Q-PCR
analysis of CNS dIlp6 performed on mRNA extracted from brains under fed conditions, starved
conditions, perlecantrol null, fat body collagen IVvkg knockdown (Cg-GAL4; Lpp-GAL4> UAS-
collagen IVvkg shimR) conditions. CNS were dissected 24 hph. Error bar=sd, *P<0.05.
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A B C D
Fig. 3.4.4 Both Collagen IVVkg and PerlecanTrol regulate NSC reactivation via glial insulin sig-
nalling. (A-D) Confocal images of NSC enlargement and proliferation in perlecantrol null CNS (A),
CNS with glial mis-expression of DIlp6 (Repo-GAL4> UAS-DIlp6) in perlecantrol null larvae (B),
hypomorphic mutant collagen IVvkgK197 CNS (C), and CNS with glial mis-expression of DIlp6 under
collagen IVvkg mutant background (D) 48 hph at 25 ºC. Dpn in red marks NSC nuclei and PH3 in
green marks mitotic M phase. The yellow arrows point to dividing NSCs. (E-F) Quantification of
NSC enlargement (E, VNC NSC diameter in µm +/- sd) and proliferation (F, number of PH3 positive
NSCs in VNC +/- sd) under above mentioned conditions *P<0.05.
Chapter 4
Exploring ECM-Receptor Interaction on
the CNS Surface and ECM Regulation of
Systemic Larval Growth
4.1 Glial Integrin Receptors Mediate ECM Binding to the
CNS Surface and NSC Reactivation
4.1.1 Glial βPS IntegrinMys and αPS2 Integrinif Are Required for Proper
CNS Development
Since the fat body is the main source of Collagen IV for the whole the organism (Pastor-
Pareja & Xu, 2011), collagen IVvkg knockdown in the fat body leads to systemic Collagen
IV deficiency. Other organs besides the CNS may require Collagen IV for their normal
functions, and some of these functions may be intertwined with CNS development. For
example, I observed Collagen IVVkg to coat the surface of the ring gland, which secretes
ecdysone that regulates larval growth including the CNS. Although fat body collagen IVvkg
knockdown using RNAi led to only a moderate systemic growth defect, knockdown using
shmiR led to severe growth retardation (see Appendix for RNAi lines used and Chapter 8 for
shmiR lines used), raising the possibility that NSC reactivation defects may be a secondary
consequence of global growth arrest. The difference is likely due to a higher knockdown
efficiency of the shmiR construct compared to RNAi. A recent study undertook a systematic
approach to compare the RNAi knockdown strategy, which uses a long double-stranded
hairpin RNA, with shmiR, which is modelled on an endogenous micro-RNA (Ni et al. ,
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2011). This study concluded that shmiR generally led to higher efficiency compared to
RNAi, consistent with my observation (Ni et al. , 2011).
Due to the concerns that systemic Collagen IV deficiency may cause secondary CNS
growth retardation, I sought to disrupt Collagen IVVkg binding on the CNS surface locally
without affecting Collagen IVVkg binding to other organs. To accomplish this, I first needed
to identify Collagen IV receptors on the CNS surface. Previous work on other organ systems
(e.g. wing discs) suggested that the βPS Integrin, Myospheroid (Mys), can act as a Collagen
IV receptor. However, ECM proteins can bind to different receptors depending on tissue
type and developmental context. For example, the mammalian Collagen IV is known to
bind to a variety of integrin receptors, including Integrin α1β1 and Integrin α10β1, as well
as DDR1 (Discoidin domain receptor family, member 1) (Leitinger & Hohenester, 2007).
Thus, even if βPS IntegrinMys also binds to Collagen IV at the CNS surface, it may not
be the only receptor. To search for all potential ECM receptors that mediate Collagen IV
binding at the BBB and regulate NSC reactivation, I used glial subtype TaDa transcriptional
profiling data to examine the expression of ECM protein receptors during the time window
of NSC reactivation. Using a Log2 ratio threshold of 0.58 and FDR rate cut-off of 0.01,
I found that many ECM receptors are transcribed by the glial cells. In particular, ECM
receptor transcription is most active in the two BBB glial subtypes compared to cortical
glia (Table 4.1.1). Next, I carried out an RNAi screen against all known Drosophila ECM
receptors using a pan glial driver (Repo-GAL4), assessing for brain size at third instar larval
stage. For candidates that led to CNS undergrowth when knocked down in glia, a secondary
screen was conducted to assess for NSC reactivation defects at first instar stage. Table 4.1.2
summarises the result of the RNAi/shmiR screens. RNAi and shmiR lines used for this
experiment are listed in Appendix.
When knocked down in all glia, αPS2 integrinif and βPS integrinmys exhibited NSC
reactivation defects (Table 4.1.2). Myospheroid (mys) encodes the only βPS Integrin in
Drosophila, whereas several αPS Integrins exist, including the αPS2 Integrin, encoded by
inflated (if ). Integrin receptors function by forming dimers between a βPS submit and
αPS submit. Given the similarity in their knockdown phenotypes, it appears that the αPS2
and βPS integrin complex is functionally important for CNS development. Since the two
integrins showed similar NSC reactivation phenotypes when knocked down in glia (normal
enlargement but reduced proliferation), I will present results regarding only βPS integrinmys
knockdown in the rest of the chapter.
Antibody staining was used to confirm βPS IntegrinMys expression at the CNS surface
in the first instar larvae (courtesy of N. Brown lab). Bright punctae of βPS IntegrinMys
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Table 4.1.1 Transcription of ECM protein receptors and matrix metalloproteinases in glial
subtypes based on glial TaDa transcriptional profiling.
Gene Symbol Gene Name Pan glia SPG PG CG
mew alphaPSi integrin y y n y
if alphaPS2 integrin y y y n
scb alphaPS3 integrin y y n n
alphaPS4 alphaPS4 integrin n y n n
alphaPS5 alphaPS5 integrin n n n n
mys betaPS integrin y y n n
betaInt_v betaV integrin n n n n
Dg dystroglycan n n n n
dally glypican5 y y n n
dlp dally-like(glypican 4) y y y n
sdc syndecan 1 y n n n
Table 4.1.2 An RNAi screen of all Drosophila ECM receptors for roles in CNS development.
Gene Symbol Gene name NSC reactivation defect when KD in glia
mew alphaPSi integrin N
if alphaPS2 integrin Y
scb alphaPS3 integrin N
alphaPS4 alphaPS4 integrin N
alphaPS5 alphaPS5 integrin N
mys betaPS integrin Y
betaInt_v betaV integrin N
Dg dystroglycan N
dally glypican5 N
dlp dally-like(glypican 4) N
sdc syndecan 1 N
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were observed throughout the CNS 24 hph, and they are particularly concentrated at the
CNS surface and channels, corresponding to the localisation of the BBB glia (Figure 4.1.1).
Punctated βPS IntegrinMys has been previously described at the surface of wing imaginal
discs (Brown et al. , 2002) and lamellocytes (Xavier & Williams, 2011). Interestingly, like
PerlecanTrol, glial expression of βPS IntegrinMys also depends on nutrition. I did not detect
any difference in CNS βPS IntegrinMys staining at 24 hph. However, at 48 hph, a higher
level of surface βPS IntegrinMys protein was observed in fed larvae as compared to starved
larvae (Figure 4.1.1).
βPS IntegrinMys 
             VNC cross section
Fed 48hphStarved 48hphFed 24hph
                     VNC 3D reconstruction
βPS IntegrinMys 
   
A B C
Fig. 4.1.1 βPS IntegrinMys localises to the BBB and its CNS protein level is nutrition dependent.
(A) A single cross section slice of VNC βPS IntegrinMys antibody staining. (B-C) βPS IntegrinMys
VNC 3D reconstruction in fed and starved larvae.
4.1.2 Super Resolution Microscopy Reveals Distinct βPS IntegrinMys
Organisation in the Two BBB Glial Subtypes
Glial subtype TaDa transcriptional profiling suggests that the subperineurial glia (SPG) tran-
scribe βPS integrinmys during the time window of NSC reactivation. Confocal microscopy
is unable to resolve whether βPS IntegrinMys protein is localised to the SPG or perineurial
glia (PG) membranes and how closely integrin receptors are associated with Collagen IV
and PerlecanTrol. Therefore, I took advantage of the DeltaVision OMX super resolution
imaging system to examine the co-localisation between integrin receptors, ECM proteins
and the BBB glial membranes. The OMX imaging system has a resolution of 120 nm in
XY direction and 300 nm in Z direction. The PG membrane is approximately 1000 nm
thick based on electron microscopy (Yager et al. , 2001). Although the thickness of SPGl
membrane has not been measured, one can expect it to be similar to that of PG because both
of the glial subtypes co-establish the BBB and exhibit a flattened morphology. The length
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of an individual integrin is approximately 10 nm (Comisar et al. , 2011), which cannot be
resolved by OMX imaging system. However, integrin complexes tend to organise in clusters
in biological systems, and the intermediate length of integrin clusters is approximately 50
to 500 nm (Comisar et al. , 2011). This means that although the smaller clusters cannot
be resolved, integrin clusters bigger than 120 nm can be resolved in XY direction and the
ones bigger than 300 nm can be resolved in the Z direction. Is OMX capable of resolving
the ECM layer (i.e. Collagen IV and Perlecan)? The thickness of ECM at the Drosophila
BBB has not been measured, but it is known that ECM layer at the surface of Drosophila
eye discs is approximately 400 nm thick (Schiller et al, 2013). Therefore, assuming that
ECM at the BBB has a comparable thickness, it can be resolved by OMX imaging in both
XY direction and Z direction.
βPS IntegrinMys has been shown to act as a Collagen IV receptor in Drosophila (Pastor-
Pareja & Xu, 2011), but it remains unclear whether it binds to PerlecanTrol. OMX images
reveal that βPS IntegrinMys is closely associated with both Collagen IVVkg and PerlecanTrol
(Figure 4.1.2). IntegrinMys punctae often partially overlap with Collagen IVVkg-GFP (yel-
low arrowheads), whereas they are mostly separated from PerlecanTrol. In a few instances,
IntegrinMys punctae partially overlap with PerlecanTrol. Whether the overlap between ECM
ligands and βPS IntegrinMys punctae indicates physical binding and whether their associ-
ations are functionally relevant await further investigation, such as biochemical assays of
protein interaction.
How is integrin localised with respect to the BBB glial membrane? OMX imaging re-
veals co-localisation between βPS IntegrinMys and membranes of both BBB glial subtypes
(Figure 4.1.3). βPS IntegrinMys punctae are often observed to overlap with the BBB glial
membrane, which is visualised by driving the expression of mCD8GFP under glial subtype-
specific GAL4 (see figure legends for GAL4 drivers used). This further supports the hy-
pothesis that both of the BBB glial subtypes can directly interact with the ECM. Initially, it
was puzzling that the TaDa glial subtype transcriptional profiling experiment showed βPS
IntegrinMys transcription in only SPG 0–24 hph, but βPS IntegrinMys protein was detected
in both PG and SPG at 24 hph. It is possible that βPS IntegrinMys is transcribed in PG prior
to larval hatching, and its protein is inserted into the PG membrane after embryogenesis.
Although βPS IntegrinMys proteins were found in both SPG and PG, the integrin pro-
tein complex exhibits different patterns of organisation in the two BBB glial subtypes. In
the SPG membrane (approximately 2–4 um from the brain surface), βPS IntegrinMys forms
hollow, ring-like structures that are 0.2–0.5 µm in diameter (Figure 4.1.4). The ring-like
structures completely disappear 4 µm deep from the surface below the SPG membrane
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Fig. 4.1.2 PerlecanTrol and Collagen IVVkg closely co-localise with integrin receptors. (A)
DeltaVision-OMX images (both XY and XZ view) of βPS IntegrinMys (antibody staining) and
PerlecanTrol (antibody staining). (B) DeltaVision-OMX images (both XY and XZ view) of βPS
IntegrinMys (antibody staining) and Collagen IVVkg (Collagen IVVkg –GFP protein trap).
(Figure 4.1.4). βPS IntegrinMys punctae also co-localise with the PG membrane (approxi-
mately 0–2 um from the brain surface), but the integrin staining pattern appears as solid dots
instead of ring-like structures. These ring-like structures are visible from approximately 2
µm basal from the PG layer into the SPG layer (Figure 4.1.4). Therefore, βPS IntegrinMys
is present in both PG and SPG membranes, but the ring-like structures are only in the SPG
membrane.
What are these βPS IntegrinMys ring structures? Since they are exclusively in the SPG
membrane, they may either mediate adhesion/communication between the two BBB glial
populations or ECM binding to the SPG surface where PG have not sealed on top. The
rings are not present right after larval hatching, and they can be observed in abundance at 24
hph (data not shown). The formation of IntegrinMys ring structures during the time window
when the majority of NSCs reactivate indicates that glial IntegrinMys complexes may play a
role in NSC reactivation. At 48 hph, the rings have enlarged in size, and sometimes bigger
rings appear to be the result of fusion between several smaller ones (Figure 4.1.5). Further
experiments are required to determine the functional significance of these SPG specific βPS
IntegrinMys ring structures.
IntegrinMys rings have not been described in the Drosophila CNS, but they are certainly
not unique to the BBB: they are also present in the basal membranes of Drosophila wing
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Fig. 4.1.3 Co-localisation of Collagen IVVkg and βPS IntegrinMys with subperineurial glia and
perineurial glia. (A) DeltaVision-OMX images (both XY and XZ view) of integrin (antibody stain-
ing) and perineurial glia membrane (NP6293-GAL4>UAS-mCD8RFP). (B) DeltaVision-OMX im-
ages (both XY and XZ view) of integrin and subperineurial glia membrane (moody-GAL4>UAS-
mCD8RFP).
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Fig. 4.1.4 Integrin rings co-localise with the subperineurial glia membrane but not perineurial
glial membrane. (A-A‘) DeltaVision-OMX images showed that integrin rings are localised to the
subperineurial glia membranes approximately 2–4 µm beneath the CNS surface (A, yellow arrows),
and were not observed at or below 4 µm beneath the CNS surface (A’). (B-B‘) DeltaVision-OMX
images showed that integrin rings are not localised to the perineurial glia membranes approximately
0–2 µm beneath the CNS surface (B, yellow arrows), but appeared at 2.5 µm beneath the CNS
surface at the level of subperineurial glia membrane (B’, yellow arrows).
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discs and are hypothesised to be the sites of focal adhesion (personal communication with
Benjamin Klapholz, Nicolas Brown lab). Preliminary investigation showed that the hollow
space between the rings contains F-Actin, as shown by co-staining with Phalloidin (Figure
4.1.5). In addition, integrin rings, but not dots, are closely associated with gap junctions
(Figure 4.1.6). Gap junctions are encoded by the connexin gene family in mammals (Seg-
retain & Falk, 2004) and the innexin gene family in Drosophila (Phelan, 2005). A recent
study identified Innexins from the Drosophila BBB as an important regulator of NSC re-
activation (Speder and Brand, 2014, in press): Innexins are required to translate metabolic
signals into synchronised calcium pulses and coordinated insulin secretion from the BBB
glia. Is the association between integrins and gap junctions observed with OMX imaging
functionally relevant? Interestingly, another recent study showed that the human α5β1 inte-
grin interacts directly with Connexin 43 and that this interaction is required for mechanical
stimulation-induced opening of the Connexin hemichannels in a human osteocytic cell line
(Nidhi Batra, 2012). Further work should address whether βPS IntegrinMys also interacts
with Innexins to regulate coordinated insulin secretion from Drosophila BBB glia.
    OMX: XY plane
βPS IntegrinMys 
   
PhalloidinMerge
0.5umA B C
Fig. 4.1.5 Integrin ring structures co-localise with F-actin. (A) Anti-βPS IntegrinMys and Phal-
loidin merged. (B) Anti-βPS IntegrinMys only. (C) Phalloidin only.
4.1.3 Glial βPS IntegrinMys Knockdown Impairs NSC Reactivation and
Glial Insulin Transcription
Is integrin required for ECM-mediated NSC reactivation? Q-PCR experiments showed
downregulation of dIlp6 transcripts in the CNS when βPS integrinmys was knocked down
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βPS IntegrinMys 




Fig. 4.1.6 Integrin ring structures are associated with gap junction. (A) Anti-βPS IntegrinMys
and anti-InnexinOgre merged. (A‘) Anti-InnexinOgre only. (A”) Anti-βPS IntegrinMys only.
in the glial cells, to level comparable to fat body collagen IVvkg knockdown (Figure 4.1.7).
Next, I checked if knockdown of βPS integrinmys recapitulates the NSC reactivation phe-
notype observed with fat body collagen IVvkg knockdown. CNS surface βPS IntegrinMys
levels were significantly reduced by pan-glial knockdown, validating the efficiency of the
RNAi construct (data not shown). Although NSCs were able to enlarge, fewer proliferating
NSCs were observed by 24 hph as compared to control (Figure 4.1.7).
βPS IntegrinMys is transcribed in SPG but its proteins can be detected in both SPG
and PG. Which population of integrins is important for NSC reactivation? To address this
question, I performed knockdown of βPS IntegrinMys in each glial subtype by expressing
an RNAi and shmiR construct simultaneously from the start of embryogenesis (UAS-βPS
integrinmys RNAi; UAS-βPS integrinmys shmiR). That way, I could maximise knockdown
efficiency during both embryonic and larval stages. Knockdown of βPS integrinmys in the
PG did not lead to NSC reactivation defects. NSCs enlarged and proliferated normally at
24 hph (Figure 4.1.8). On the other hand, knockdown of βPS integrinmys in SPG resulted
in impaired NSC reactivation. Although most NSCs enlarged, no NSC proliferation was
observed by 24 hph (Figure 4.1.8). In addition, βPS IntegrinMys antibody staining revealed
that the SPG knockdown resulted in a much stronger reduction of βPS IntegrinMys protein







Glial βPS integrinmys 



















ControlPan glial βPS 
IntegrinMys KD Pan glial βPS IntegrinMys KD




















Fig. 4.1.7 Glial integrin receptors mediate ECM dependent NSC reactivation. (A) Q-PCR anal-
ysis of CNS dIlp6 performed on mRNA extracted from brains under control condition (B, w1118X
UAS-βPS integrinmys RNAi; UAS-βPS integrinmys shmiR) and pan-glial βPS integrinmys KD con-
ditions (Repo-GAL4; UAS-DicerII X UAS-βPS integrinmys RNAi; UAS-βPS integrinmys shmiR).
CNS were dissected 24 hph. Error bar=sd, P<0.05. (B-C) Confocal images of NSC reactivation
under control condition and glial integrin knockdown condition. CNS were dissected 24 hph. Dpn in
red marks NSC nuclei and PH3 in green marks mitotic M phase. (D-E) Quantification of PH3 posi-
tive NSCs +/- sd and NSC diameters +/- sd in the VNC under control condition and glial knockdown
of βPS integrinmys 24 hph P<0.05.
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Fig. 4.1.8 Integrin receptors expressed by the subperineurial glia mediate ECM and nutrition-
dependent NSC reactivation. (A-B) Confocal images of NSC reactivation in controls (C, w1118X
UAS-βPS integrinmys RNAi; UAS-βPS integrinmys shmiR) and perineurial glial integrin knockdown
(D, NP6293-GAL4; UAS-DicerII X UAS-βPS integrinmys RNAi; UAS-βPS integrinmys shmiR). (C-
D) Confocal images of anti Dlg and anti βPS IntegrinMys staining at the BBB in controls (C, w1118X
UAS-βPS integrinmys RNAi; UAS-βPS integrinmys shmiR) and perineurial glial integrin knockdown
condition (D, NP6293-GAL4; UAS-DicerII X UAS-βPS integrinmys RNAi; UAS-βPS integrinmys
shmiR). (E) Quantification of PH3 positive NSCs +/- sd in the VNC in controls and perineurial glia
knockdown of βPS integrinmys 24 hph (P<0.05). (F-J) Confocal images of NSC reactivation (F-G),
anti dlg and anti-integrin staining at BBB (H-I) and quantification of the number of PH3 positive
NSCs (J) in controls and subperineurial glial knockdown of βPS integrinmys (Moody-GAL4>).
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4.1.4 Investigating the Roles of Integrin-Associated Proteins in Larval
Neurogenesis
Integrin-dependent adhesion and cellular signalling are mediated by a number of integrin
associated proteins. Paxillin (Pax), Talin (encoded by rhea in Drosophila), Focal adhesion
kinase (FAK) and integrin-linked kinase (Ilk) are among the most important proteins as-
sociated with integrin functions (Harburger & Calderwood, 2009). An increasing number
of recent studies suggest that integrin-dependent cellular processes are important for many
aspects of CNS growth and homeostasis in mammals (Mobley & McCarty, 2011; Wojcik-
Stanaszek et al. , 2011). To check the CNS expression patterns of these integrin-associated
proteins, I first examined Ilk-GFP and Pax-GFP protein trap expression. Ilk and Pax are
highly expressed in the BBB in first instar larvae, in a pattern similar to βPS IntegrinMys
(Figure 4.1.9).
Fig. 4.1.9 GFP protein trap expression patterns of integrin-associated proteins. VNC expression
pattern of Mys (A), Ilk (B) and Pax (C). Larval brains were dissected after 24 hph.
Next, I carried out an RNAi/shmiR knockdown experiment using a pan-glial driver, in
order to find out which of these integrin-associated proteins are required in glia during larval
CNS development. I assessed CNS size and shape at third instar stage and pupal lethality.
Since the null mutant of FAK is viable, it is highly unlikely that FAK is indispensable for
CNS growth. Thus I did not perform knockdown of FAK. For all the other candidates,
only talinrhea showed elongated VNC, brain size reduction, and pupal lethality similar to
the phenotypes observed with βPS integrinmys knockdown in the 3rd instar larvae (Table
4.1.3). TalinRhea was originally identified in Drosophila in a differential embryonic head
cDNA screen, and was found to be expressed in a subset of CNS neurons (Brody et al.
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, 2002). Consistent with my results, embryos deficient in talinrhea also showed similar
phenotypes to βPS integrinmys mutant, such as failure in germ band retraction and muscle
detachment (Brown et al. , 2002). Interestingly, no CNS-specific phenotype was detected in
talinrhea mutant embryos, as assayed by glial and neuronal markers (Brown et al. , 2002).
TalinRhea’s role in CNS development has not been assessed post-embryonically, and it is
possible that TalinRhea is required during larval, but not embryonic, neurogenesis. It is
slightly worrisome that only one out of three TalinRhea shmiR knockdown resulted in CNS
developmental phenotypes. To ascertain that the phenotype did not result from mere off-
target effects, I would like to verify the phenotype with additional RNAi lines.
If TalinRhea can be confirmed to play a role in larval CNS development, future experi-
ments need to investigate whether talinrhea knockdown also impairs NSC reactivation. If so,
I would like to investigate whether TalinRhea and βPS IntegrinMys function in the same path-
way to regulate NSC reactivation. To assess this question, I would examine glial knockdown
of both talinrhea and βPS integrinmys to see if this enhances CNS growth/NSC reactivation
defects in the knockdown of βPS integrinmys alone.
Table 4.1.3 An RNAi screen of integrin-associated proteins for roles in CNS development
Gene Symbol Gene name BL stock NO. 3rd instar CNS phenotype when KD Pupal lethality
rhea Talin 32999 shmiR NA NO
33913 shmiR elongated&smaller Yes
28950 dsRNAi NA NO
Pax Paxillin 42614 shmiR NA NO
28695 dsRNAi NA NO
Ilk Integrin linked kinase 35374 shmiR NA NO
In summary, I identified a role for βPS IntegrinMys and αPS2 IntegrinIf in mediat-
ing NSC reactivation. βPS integrinmys is transcribed in PG but βPS IntegrinMys protein
is present in both PG and SPG. The distinct ring-like integrin structures observed with
DeltaVision-OMX imaging are only present in the SPG membrane. Most importantly, inte-
grins in the SPG appear to be functionally important for NSC reactivation: knockdown of
βPS integrinmys in the SPG, but not in the PG, caused NSC reactivation defects. The identi-
fication of the integrin receptors allows me to impair nutrient-sensitive and ECM-mediated
NSC reactivation without causing a systemic growth defect in the whole larvae.
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4.2 ECM Protein Deficiencies Cause Systemic Growth De-
fect Potentially by Disrupting the Functions of IPCs
and Systemic Insulin Signalling
In both perlecantrol null mutant larvae and fat body collagen IVvkg knockdown larvae, overall
larval growth was significantly impaired. To a large extent, larval growth is coordinated by
circulating DIlps (Rulifson et al. , 2002). They are secreted into the hemolymph from
the IPCs (insulin-producing cells, pancreas equivalent) in the brain. As a starting point
to understand the systemic growth arrest phenotype of perlecantrol null and collagen IVvkg
knockdown larvae, we examined if there is a disruption of the IPCs and their DIlp secretion.
In wildtype larvae, IPCs are clustered symmetrically into two groups, one on either side
of the brain. The IPCs, marked with DIlp2 antibody, are situated right beneath the BBB
(Yellow arrows, Figure 4.2.1).
The clustering of IPCs may be important for coordinated systemic DIlp secretion, and
their close proximity to the BBB/ECM may also be functionally relevant. Indeed, in perlecantrol
null mutant larval brains, the IPCs lost their characteristic clustering, and instead formed two
or three smaller clusters on either side of the brain (yellow arrowheads, Figure 4.2.1). In
addition, the smaller clusters are no longer located close to the BBB and they have moved to-
wards the more interior parts of the brain. These phenotypes are unique to perlecantrol null
mutant larvae, and are not observed in fat body collagen IVvkg knockdown (Figure 4.2.1)
or glia perlecantrol knockdown condition (data not shown). Future work needs to address
how the loss of PerlecanTrol on the BBB leads to dissociation of the underlying clusters of
IPCs. Given the close proximity between the IPC clusters and the BBB, it is possible that
ECM-dependent signalling from the BBB glia is required for instructing proper formation
of IPC clusters during embryogenesis. It is also possible that ECM-dependent signalling is
essential for maintaining the structural integrity of the IPC clusters: the IPCs clusters may
have formed by default in the beginning, but an ECM deficiency may have led to IPCs’
dissociation from one another later on. In order to distinguish between these two possi-
bilities, I need to track IPC morphology throughout embryogenesis and early larval stage
in perlecantrol null animal. Furthermore, it would be interesting to investigate whether the
dissociation of IPCs impairs coordinated secretion of systemic DIlps from the IPCs.
What happens to DIlp secretion from IPCs in ECM-deficient larvae? The IPCs are
known to express a number of DIlps, including DIlp2 (Nässel et al. , 2013). The IPCs
project their axons into the larval endocrine gland and on the aorta, from which DIlp2 can
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Fig. 4.2.1 Loss of ECM proteins on the CNS surface disrupts the organisation of insulin pro-
ducing cells (IPCs) in the brain. Organisation of IPCs in control (W1118) larval brains (A), in
brains where collagen IVvkg was knocked down in the fat body (B), and in perlecantrol null larvae
(C). DIlp2 antibody marks the cell bodies of the IPCs; Repo marks glial nuclei, and Phalloidin (Pha)
marks cellular membranes.
be released into the circulating hemolymph (Ikeya et al. , 2002). In fed wildtype brains,
DIlp2 can be detected in both the IPC cell bodies and within their extensive axonal networks
(Figure 4.2.2, yellow arrows). Previous work showed that DIlp2 transcription remains un-
changed under starvation. However, DIlp2 is retained in the IPC cell body and as a result, its
secretion into the hemolymph is impaired (Ikeya et al. , 2002). Consistent with this observa-
tion, I also found a high level of DIlp2 antibody staining in the cell bodies of starved IPCs,
but DIlp2 staining was significantly reduced in axonal tracks compared to control condi-
tions. Similar to starvation, under both fat body collagen IVvkg knockdown and perlecantrol
null conditions, DIlp2 staining was strong in the IPC cell body but weak in the axons, indi-
cating that there may be cell body retention of DIlp2 and impaired DIlp2 secretion (Figure
4.2.2). Further work is required to address whether there is a causal relationship between
IPC DIlp2 retention and arrested larval growth in ECM deficient larvae.
Apart from regulating NSC reactivation, ECM proteins appear to play multifaceted roles
during larval development. I provided some preliminary evidence for their role in maintain-
ing proper CNS architecture and promoting neuronal survival. In addition, they are impor-
tant for systemic growth potentially by regulating the organisation and potentially secretory
functions of IPCs, which are located immediately beneath the ECM-covered BBB.
4.2.1 Chapter Summary
In this chapter, I briefly characterised the roles of integrin receptors in mediating ECM-
dependent NSC reactivation. I identified βPS IntegrinMys and αPS2 IntegrinIf as the ECM
receptors important for NSC reactivation. βPS IntegrinMys is expressed by both perineurial
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DIlp2 max intensity projection
A B C D
Fig. 4.2.2 Loss of ECM proteins on the CNS surface potentially impairs DIlp2 secretion from
the IPCs. Maximum projection of DIlp2 staining in the IPCs in fed control (W1118) larval brains
(A), in starved control larval brains (B), in brains where collagen IVvkg was knocked down in the fat
body (C), and in perlecantrol null larvae (D).
glia and subperineurial glia, but the distinct ring-like integrin structures are only present
in the subperineurial glia membrane. Most importantly, integrins in the subperineurial glia
appear to be functionally important for reactivation. The identification of the integrin re-
ceptors allowed me to impair ECM-dependent NSC reactivation without causing a systemic
growth defect in the whole animal.
In addition, I explored other roles of Collagen IV, PerlecanTrol and integrin receptors on
CNS development beyond the context of NSC reactivation. Loss of ECM ligands or integrin
receptors led to severe disruption in CNS organisation both internally and externally. ECM
deficiency also caused neuronal death and systemic growth retardation, which could be
caused by morphological abnormalities of the IPCs and impaired systemic insulin secretion.

Chapter 5
Nutrient Sensitive Fat Body Candidates
5.1 The Fat Body Proteins Hsc70–3 and CG13900 Are Re-
quired for CNS Development
5.1.1 Fat Body RNAi Screen Identified Hsc70–3 and CG13900 as Po-
tential Regulators of CNS Growth
An RNAi screen was carried out on genes encoding potentially secreted proteins that are up-
regulated under fed conditions. collagen IVvkg and collagen IVcg25C were among of the four
promising candidates whose knockdown in the fat body resulted in CNS underdevelopment
with mild systemic growth defect. The other two candidates were hsc70–3 and CG13900
(Figure 5.1.1).
Hsc70–3 is a highly conserved heat shock cognate protein. It is predicted to have ATPase
activity and has been shown to be involved in a variety of functions, including centrosome
duplication, RNA interference, sleep regulation, and response to heat (Cirelli, 2003; Dorner
et al. , 2006; Müller et al. , 2010). Hsc70–3 encodes a signal peptide in its protein sequence,
and a recent study on the characterisation of the hemolymph proteome detected Hsc70–3
protein in the third instar Drosophila larval hemolymph (Handke et al. , 2013). Interest-
ingly, Hsc70–3 protein levels in the hemolymph were upregulated under fed conditions as
compared to starved conditions, although the difference did not reach a statistically signifi-
cant level. In addition, the mammalian Hsc70 protein was found to be secreted in a variety
of cells (Evdokimovskaya et al. , 2013; Vega et al. , 2008). Given Hsc70–3’s role in pro-
tein folding, Hsc70–3 is more likely to serve as a post-translational regulator of other fat
body-derived growth signals (e.g. Collagen IV), instead of acting as a direct fat body signal
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itself.
CG13900 is the Drosophila ortholog of the mammalian splicing factor 3b subunit (SF3b).
It is highly conserved in chordates: the Drosophila and human orthologs share approxi-
mately 75% amino acid conservation. Apart from its role in alternative splicing, the mam-
malian SF3b is also involved in damaged DNA binding, mitotic spindle organization, mRNA
splicing and neurogenesis (Herold et al. , 2008; Mount, 2000; Neumüller et al. , 2011). Re-
cently, the mammalian SF3b has been identified as the target of potent anti-tumour chemi-
cals pladienolide and FR901464 and SF3b-regulated alternative splicing has emerged as an
important regulator of tumour growth (Webb et al. , 2013). 15% of the most downregulated
genes in patients with SF3b1 mutations have a role in mitochondrial function (Papaem-
manuil et al. , 2011). The identities and functions of genes alternatively spliced by SF3b
are just beginning to be understood (Bonnal et al. , 2012). Although CG13900 is predicted
by SecretomeP program to be secreted via a non-classical pathway, its secretion seems un-
likely given its function. In addition, CG13900 protein was not detected in third instar
Drosophila larval proteome (Handke et al. , 2013). It is possible that CG13900 acts as a
post-transcriptional regulator of other fat body derived growth signals that are destined for
secretion.
5.1.2 CNS Development and NSC Morphology Are Impaired by Knock-
down of Fat Body hsc70–3 and CG13900
When CG13900 or hsc70–3 were knocked down in the fat body, CNS size was severely
reduced, but unlike glial perlecantrol or fat body collagen IV knockdown, the CNS retained
its normal shape.
However, in both knockdown conditions, NSCs in the ventral nerve cord showed ab-
normal elongated slit-like morphology (Figure 5.1.2, yellow arrows), which was rarely ob-
served in controls. NSCs and their nuclei are normally rounded in shape (Figure 5.1.2, white
arrows). Interestingly, the abnormal NSC morphology phenotype was only observed in the
ventral nerve cord but not in the brain lobes, despite the brain lobes showing a reduction in
size compared to control brains (Figure 5.1.2).
In addition to Collagen IV, Hsc70–3 and CG13900 play an important role in nutrient-
sensitive CNS growth based on a functional RNAi screen. Both proteins are unlikely to
serve as direct growth-promoting signals, but they may be important post-transcriptional and
post-translational regulators of other fat body proteins via alternative splicing and promoting
proper protein folding. They are poorly characterised in Drosophila, and more experiments
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Fig. 5.1.1 Fat body knockdown of hsc70–3 and CG13900 led to CNS underdevelopment without
causing significant systemic growth defects. (A) Whole third instar images of control larvae (Lpp-
GAL4>UAS-mCD8GFP), fat body hsc70–3 knockdown (Lpp-GAL4>UAS-hsc70–3 RNAi) and fat
body CG13900 knockdown (Lpp-GAL4>UAS-CG13900 RNAi). (B-D) Whole brain images (anti-
Dlg) of control larvae, fat body hsc70–3 knockdown and fat body CG13900 knockdown.
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Fig. 5.1.2 Impaired NSC proliferation and abnormal NSC morphology in fat body hsc70–3
and CG13900 knockdown Conditions. (A-C) Single plane of VNC images of control larvae (Lpp-
GAL4>UAS-mCD8GFP), fat body hsc70–3 knockdown larvae (Lpp-GAL4>UAS-hsc70–3 RNAi)
and fat body CG13900 knockdown larvae (Lpp-GAL4>UAS-CG13900 RNAi). White arrow points
to a normally shaped NSC. Yellow arrows point to slit-like NSC nuclei morphology. (A‘-C’) Max-
imum intensity projection brain lobe images of control larvae, fat body hsc70–3 knockdown larvae
and fat body CG13900 knockdown larvae. Dpn marks NSC nuclei and PH3 marks mitotic M phase.
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are required to elucidate their functions in the context of CNS development.
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5.2 Investigating the Role of CG13900 in NSC Reactiva-
tion
5.2.1 CG13900 Transcription Is Nutrient-Sensitive in Multiple Tissues
CG13900 transcription is highly upregulated under fed conditions in the fat body (Figure
5.2.1). To determine the expression of CG13900 in the brain, I examined CG13900 expres-
sion in glia of fed vs. starved animals (in collaboration with Pauline Speder and Jessie Van
Buggenum, Brand lab). I also examined CG13900 expression in NSCs based on a NSC
TaDa transcriptional profiling experiment performed by Seth Cheetham (Brand lab). It was
somewhat surprising that CG13900 is transcribed in both glia and NSCs, in addition to fat
body (Log2 ratio>=0.58 and FDR<=0.01, Figure 5.2.2). Furthermore, CG13900 transcrip-
tion is highly upregulated in glia under fed conditions, and moderately upregulated in VNC
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Fig. 5.2.1 RNA Pol II occupancy across CG13900 locus under fed and starved conditions in fat
body. The traces were obtained from fat body TaDa transcriptional profiling (Lpp-GAL4>UAS-Lt2-
Dam-Pol II). The experiment was performed 0–24 hph, under fed and starved conditions.
The upregulation of CG13900 under fed conditions in all three tissues led to the hy-
pothesis that CG13900 may be a global nutrient-responsive gene. In support of this idea,
Zinke et al performed microarray using whole larvae extracts and identified CG13900 as
one of the 19 genes that are transcriptionally down-regulated under both complete starva-
tion and sugar-only-diet in comparison to larvae fed a normal diet at 48 hph (Zinke et al. ,
2002). CG13900-regulated alternative splicing events and other functions may be nutrient
dependent as well.
Glial subtype transcriptional profiling showed that CG13900 is only transcribed in sub-














A.  Pan glia POL II DamID
B.  Subperineurial glia POL II DamID
C.  NSC POL II DamID
Fed
Starved
Fig. 5.2.2 RNA Pol II occupancy across CG13900 locus under fed and starved conditions
in glia and NSCs. Traces A were obtained from pan-glia TaDa transcriptional profiling (Repo-
GAL4>UAS-Lt2-Dam-Pol II) under fed and starved conditions 12–36 hph. Trace B was obtained
with subperineurial glia TaDa transcriptional profiling (Moody-GAL4>UAS-Lt2-Dam-Pol II) under
fed conditions 0–24hph (in collaboration with Pauline Speder and Jessie Van Buggenum, Brand lab).
Traces C were obtained from NSC TaDa transcriptional profiling (Insc-GAL4>UAS-Lt2-Dam-POL
II) under fed and starved conditions 12–36 hph in the VNC (courtesy of Seth Cheetham, Brand lab).
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The subperineurial glia are an essential component of the NSC niche: they are the source of
DIlp6 and abut the NSCs. Interestingly, the mammalian homologue of CG13900, SF3b3, is
enriched in the mouse BBB, suggesting SF3b-mediated alternative splicing may be impor-
tant for both invertebrate and vertebrate CNS development (Daneman et al. , 2010).
5.2.2 CG13900 May Act as a General Regulator of Growth and Prolif-
eration
CG13900 is transcribed in a variety of tissues, including the fat body, glia and NSCs. I
wanted to determine if CG13900 is required for NSC reactivation, and if so from which
tissue(s). CG13900 knockdown in the fat body impaired NSC reactivation at 24 hph (Figure
5.2.3). NSCs showed significantly reduced proliferation. In addition to affecting NSC pro-
liferation, CG13900 is also important for maintaining proper fat body architecture. Knock-
down of CG13900 resulted in shrinkage as well as a change in the texture of fat body tissue
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Fig. 5.2.3 Fat body derived CG13900 is required for NSC reactivation. (A-B) Confocal images
of NSC enlargement and proliferation under control condition and fat body-specific knockdown of
CG13900. CNS were dissected 24–30 hph. Dpn in red marks NSC nuclei and PH3 in green marks
mitotic M phase. (C) Quantification of NSC proliferation (number of PH3 positive NSCs in VNC
+/- sd) under above-mentioned conditions *P<0.05.
Interestingly, CG13900 knockdown in subperineurial glia also impaired NSC reactiva-
tion (Figure 5.2.4). Similar to the fat body knockdown, NSCs enlarged but failed to enter





     
    S
PG





      SPG CG13900 








35  Number of PH3 





Fig. 5.2.4 Subperineurial glia derived CG13900 is required for NSC reactivation. (A-B) Con-
focal images of NSC enlargement and proliferation under control condition and subperineurial glia-
specific knockdown of CG13900. CNS were dissected 24–30 hph. Dpn in red marks NSC nuclei
and PH3 in green marks mitotic M phase. (C) Quantification of NSC proliferation (number of PH3
positive NSCs in VNC +/- sd) under above-mentioned conditions *P<0.05.
Since CG13900 is transcribed by the reactivating NSCs, CG13900 may be required cell
autonomously for NSC reactivation. A previous study (Neumüller et al. , 2011) showed that
knockdown of CG13900 with a NSC GAL4 driver (Insc-GAL4) results in larval lethality
and NSC under-proliferation at third instar stage. This study, which performed genome-
wide RNAi analysis, identified regulators of alternative splicing as a major enriched gene
cluster affecting NSC asymmetric cell division and self-renewal in a cell autonomous man-
ner (Neumüller et al. , 2011). It remains to be tested whether and how CG13900-mediated
alternative splicing affects NSC reactivation. Recently, a number of studies began to inves-
tigate the role of alternative splicing in mammalian brain development. The splicing factor
TRA2B has been shown to be expressed in murine cortical neural progenitors, and its dele-
tion in neural progenitors results in death and disorganisation of the cortical plate. (Roberts
et al. , 2014).
Splicing factor 3B subunit 3, a protein in humans that is encoded by the SF3B3 gene,
has been shown to perform a variety of roles. Although little attention was paid to the
Drosophila ortholog, SF3B3’s role in mammalian alternative splicing has been well char-
acterised. Splicing factor 3b forms the U2 small nuclear ribonucleoproteins complex (Us
snRNP) together with splicing factor 3a and a 12S RNA unit (Will, 2002). In addition,
splicing factor 3b is part of the minor U12-type spliceosome (Biplab K Das, 1999). U12-
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type introns represent less than 1% of all introns in human, but many of the genes have
essential functions. Only a small number of Drosophila genes are predicted to be spliced
by the U12 minor spliceosome. To investigate if CG13900’s involvement in U12 splicing
is important for its function in the fat body, I conducted a functional RNAi screen on genes
predicted to contain U12-type introns. None of these knockdowns resulted in phenotypes
comparable to what was observed with CG13900 knockdown. Therefore, the fat body genes
important for regulating NSC reactivation are mostly likely spliced via the U2 spliceosome.
Splicing factor 3B Subunit 3 has also been identified as part of the STAGA (SPT3-
TAF(II)31-GCN5L acetylase) transcription co-activator-HAT (histone acetyltransferase) com-
plex, and the TFTC (TATA-binding-protein-free TAF(II)-containing complex) (Martinez
et al. , 2001). Therefore, CG13900/SF3B3 may be involved in a diverse array of other
functions such as transcription, DNA repair, and chromatin modification.
Another notable function of CG13900 is its potential role as a snoRNA (small nuclear
RNA) host gene. CG13900 encodes 9 snoRNAs in its intron region, including Psi18S–110,
Me28S-C788b, Me28S-C788a, Me28S-G3113b, Me28S-G3113b, Me5.8S-G74, Me28S-
A771, Psi28S–3308, and Psi18S–1086. Despite the common assumption that snoRNAs
only have cellular housekeeping functions, in the past few years, studies using diverse strate-
gies have con- verged in implicating snoRNAs in the control of cell fate and oncogenesis in
mammals, as reviewed in (Williams & Farzaneh, 2012). In addition, the CG13900 locus en-
codes a long non-coding RNA, CR45184 (Figure 5.2.5)(http://flybase.org/cgi-bin/gbrowse/
dmel/?Search=1;name=FBgn0035162). Long non-coding RNA also recently emerged as
important regulators during mammalian neural development and pathogenesis, as reviewed
in (Brian S Clark, 2014). Can snoRNAs and CR45184 contribute to the observed phe-
notypes of CG13900 knockdown? The RNAi construct maps to exon 7 of the CG13900
transcript as well as exon 1 of CR45184. Therefore, further investigation is required to
determine whether knockdown of CG13900 or CR45184 led to impaired NSC reactivation.




In this chapter, I briefly explored the role of two other fat body proteins, Hsc70–3 and
CG13900, in CNS development. They are both upregulated in the fat body under fed con-
ditions and are predicted to be secreted. Fat body knockdown of CG13900 or Hsc70–3 led
to NSC reactivation defects and abnormal NSC morphology. Interestingly, CG13900 is also
required in glia and NSCs for NSC reactivation/proliferation.
Due to the complex nature of the CG13900 locus, further work is required to elucidate
which one(s) of its potential roles are relevant in the context of Drosophila NSC regulation,
and in which tissue(s). Since pre-mRNA splicing occurs in close proximity with the tem-
plate DNA, and concurrently with transcription (Jiménez-García & Spector, 1993; Zhang
et al. , 1994), the TaDa technique (Southall et al. , 2013) may be a useful tool to assess
binding sites of CG13900 and alternative splicing events mediated by it in a tissue specific
manner. TaDa technique has never been adopted to study splicing factors, so it might be im-
portant to first test the technique with a known Drosophila splicing factor whose regulatory




Transcriptional Responses to Changes in
Systemic Energy Metabolism
6.1 Response of Glial Subtypes to Changes in Metabolism
The main effort of my PhD project was to study how nutrient-sensitive fat body signals
regulate NSC reactivation and CNS development. After the discovery that ECM proteins’
binding to their receptors on the glial surface induces glial dIlp6 transcription, I wanted to
know what signal molecules interact with ECM proteins at the BBB and operate upstream
of Dilp6 production. In mammals, ECM ligands and their receptors participate in a wide ar-
ray of signalling pathways, including FGFs, HGF (Hepatocyte growth factor), VEGF, BMP
(Bone morphogenetic protein), TGF-beta (Transforming growth factor beta), EGF (Epider-
mal growth factor receptor), PDGF (Platelet-derived growth factor) and IL–3 (Interleukin
3), as reviewed in (Brizzi et al. , 2012). In Drosophila, ECM proteins’ are also known to
regulate a few signalling pathways, including BMP (Bunt et al. , 2010; Sawala et al. , 2012;
Wang & Su, 2011), FGF (Park et al. , 2003) and Hedgehog (Barrett et al. , 2008). I decided
to take a systematic approach to examine glial cells’ transcriptional responses to starvation
in order to identify downstream effectors of signalling pathways mediated by the ECM.
In a collaboration with three other colleagues in the Brand lab (Pauline Speder, Jessie
Van Buggenum and Jorge Buendia-Buendia), we analysed the glial transcriptional response
to changes in nutritional intake using the glial subtype RNA Polymerase II (Pol II) Targeted
DamID (TaDa) transcriptional profiling data (Southall et al. , 2013). In this collabora-
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tive project, Pauline Speder, Jessie Van Buggenum and myself performed brain dissection,
DNA sample preparation and microarray. Jorge Buendia-Buendia and myself performed
data analysis. We expected that our data would yield insights regarding the specific glial
signalling pathways mediated by ECM proteins at the BBB-hemolymph interface. The
analysis would also help to address a number of other outstanding questions, such as which
glial subtypes are most sensitive to systemic nutritional fluctuations and how do glial cells
sense such fluctuations. Furthermore, while DIlp6 is a key glial signal to induce NSC re-
activation, DIlp6 alone is unable to fully rescue the NSC reactivation defect under starved
conditions (Chell & Brand, 2010). Glial expression of DIlp6 in starved larvae led to full
rescue of NSC enlargement but only partial rescue of proliferation. This means that other
signals, perhaps in parallel with DIlp6, are responsible for modulating the scale and/or tim-
ing of NSC reactivation and are yet to be identified. It is possible that some of these signals
may be secreted from the glial cells and our analysis of the glial transcriptome could lead to
the identification of these signals.
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6.2 CNS Glial Cells’ Transcriptional Response to Starva-
tion
6.2.1 Pan-Glial TaDa Transcriptional Profiling Reveals Significant Changes
in Glial Transcriptional Profiles in Response to Starvation
As discussed in previous chapters, quiescent NSCs reactivate when larvae are fed a normal
diet containing essential amino acids after larval hatching, but remain quiescent when larvae
are starved. The reactivating NSCs are surrounded by glial cell (Figure 6.2.1), which secrete
mitogenic DIlp6 in response to feeding. Therefore, it was hypothesised that the CNS glia
serve as a nutrient sensitive NSC niche (Chell & Brand, 2010). As a starting point to
investigate the glial cells’ transcriptional response to amino acid starvation, I performed
transcriptional profiling experiment in the glial cells under fed and starved conditions in
collaboration with Pauline Speder and Jessie Van Buggenum. Taking advantage of the Pol
II TaDa technique (Southall et al. , 2013), we were able to map Pol II binding across the
entire Drosophila genome in all the CNS glial cells from 12 hph to 36 hph, a time window
closely coinciding with NSC reactivation (Figure 6.2.2). We used Repo-GAL4 as the CNS
glial driver, which has a highly specific expression pattern in all glial cells except for midline
glia (Figure 6.2.3). Importantly, Repo-GAL4 shows comparable driver strengths in CNS of
both fed and starved larvae, which should allow for comparable expression of Pol II-Dam
fusion protein and DNA methylation under the two experimental conditions (Figure 6.2.1
and Figure 6.2.3).
A threshold of Log2 ratio>=0.58 and FDR <= 0.01 was used to determine significantly
transcribed genes. Genome-wide transcription patterns differ substantially between fed and
starved conditions (Figure 6.2.4). There appears to be global transcriptional downregulation
in the glial cells under starvation: starting with comparable amounts of genomic DNA,
starved glial cells contain significantly lower level of Pol II bound sequences compared to
glial cells from fed larvae (Figure 6.2.5). 4823 genes are transcribed in the glial cells under
fed conditions, whereas only 2517 genes are transcribed under starved conditions. This
difference cannot be explained by a change in the number of glial cells (quantified with
glial nuclei staining) or overall expression levels of Repo-GAL4 (quantified using UAS-
MyrRFP), as neither of them changed significantly between the two experimental conditions
(Figure 6.2.3). A significant proportion of genes are transcribed in both fed and starved
conditions (2318 in total), which are probably essential for glial development and function
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Fig. 6.2.1 Reactivating NSCs are surrounded by glial processes. Confocal images of NSCs
(marked by Dpn in green) surrounded by glial processes (Repo-GAL4>UAS-MyrRFP) in CNS from
fed and starved larvae. NSCs enlarge and enter mitosis under fed conditions. Under starved condi-
tions, NSC nuclei do not enlarge. White arrow points to an enlarged NSC. Yellow arrow heads point
to BBB glia and cortex glia that are associated with NSCs.
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Fig. 6.2.2 Schematic of glial Pol II TaDa transcriptional profiling in fed and starved first instar
larvae, 12 hph to 36 hph. A schematic of workflow for pan-glial transcriptional profiling, which
was performed between 12–36 hph, a time window closely associated with NSC reactivation. Repo-
GAL4 was used as a pan-glial driver. 220–250 CNS from fed larvae, and 250–300 CNS from starved
larvae were dissected. Tubulin-GAL80ts was used to allow temporal expression of GAL4.
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ratio>=0.58, FDR<=0.01), I found that 2094 genes were upregulated under fed conditions
as compared to starved conditions, whereas only 37 genes are upregulated under starved
conditions. The symbols of differentially transcribed genes, their Log2 ratios and FDR can
be found in my thesis’ data deposition folder (see Chapter 8). I found that genes known to
be upregulated under fed conditions in glial cells, such as dIlp6 (Chell & Brand, 2010) and
perlecantrol, are represented in our data. The top 40 most highly upregulated genes under
fed conditions are summarised in Appendix.
Very little is known about glial genes transcriptionally upregulated under starved condi-
tions. However, among the only 37 genes upregulated under starved conditions, 2 encode
proteins with known functions associated with the glial cells. CG6398 encodes a membrane-
associated protein which is predicted to be a Drosophila homolog of Claudin based on se-
quence similarities (http://www.ebi.ac.uk/interpro/). Claudins are a family of proteins that
are the most important components of tight junctions, where they establish a barrier that
controls the flow of molecules between cells of an epithelium (Furuse, 1998). CG6398
has been shown to play a role in establishing glial septate junction (Drosophila equivalent
of tight junction) at the Drosophila BBB (Stork et al. , 2008). jeb (jelly belly) encodes a
transmembrane tyrosine receptor kinase which is expressed in glial cells surrounding NSCs
(Cheng et al. , 2011). Interestingly, jeb plays a role in brain sparing (i.e. privileged brain
growth) during starvation in late larval stages (Cheng et al. , 2011). Jeb binds to its Alk
(anaplastic lymphoma kinase) receptors on the surface of NSCs, and activates PI3K sig-
nalling to promote proliferation of NSCs when larvae are deprived of nutrition. Many other
glial genes upregulated in starved conditions have been shown to be involved in CNS func-
tion and development based on Gene Ontology. Gene symbols and GO biological functions
of all 37 genes upregulated under starved conditions are summarised in the Appendix.
I hypothesised that glial niche factors important for NSC activation are likely to be
transcriptionally upregulated under fed conditions. Therefore, I decided to focus on these
genes. First of all, I analysed enriched GO biological processes via DAVID (Database
for Annotation, Visualisation and Integrated Discovery) (Huang et al. , 2009). Using a
fold enrichment cutoff of 1, p value cutoff of 0.05, and GO level of 3, I found that 117
biological processes are enriched among the glial genes transcriptionally upregulated under
fed conditions (Figure 6.2.6). After grouping these terms into broad categories, I found
that three categories are most highly represented compared to others, including metabolic
processes, organismal development, and morphogenesis.
GO terms associated with the category “metabolic processes” are highly diverse and
encompass not only amino acid/protein metabolism, but also cofactor, lipid, sugar and nu-
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F. Average intensity of 
   Repo-GAL4>MyrRFP
Fig. 6.2.3 Repo-GAL4 driver strength and numbers of glial cells in fed and starved first instar
CNS. (A-B) Maximum Z-projection of confocal images showing all glial nuclei (anti-Repo in green)
in CNS from fed and starved larvae. (C) Quantification of Repo-positive nuclei under fed and starved
conditions. No significant difference was detected between the two conditions. (D-E) Single plane of
confocal images showing membrane RFP (Myr-RFP) driven by Repo-GAL4 under fed and starved.























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 6.2.4 Pan-glial TaDa Pol II transcriptional profiles under fed and starved conditions. Heat
maps are generated from pan-glial TaDa transcriptional profiling experiments under fed and starved






























Number of genes transcribed in glia
Fig. 6.2.5 Global glial transcriptional down-regulation in starved larvae. (A) Agarose gel of total
genomic DNA extracted from larval CNS under fed and starved conditions. (B) Agarose gel of PCR-
amplified methylated DNA sequences under fed and starved conditions. (C) Venn diagram showing
numbers of transcribed genes in glial cells under fed and starved conditions. Log2 ratio>=0.58 and
FDR<=0.01.
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Fig. 6.2.6 GO biological processes enriched in genes upregulated under fed conditions. 128
highly significantly enriched biological processes (P value<=0.05, GO_BP level=3) were identified
among glial genes upregulated under fed conditions, using Gene Ontology algorithms. Each hor-
izontal bar represents a specific GO term. All enriched GO terms were clustered into 17 broader
functional categories, shown in the graph.
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Table 6.2.1 Gene Ontology (GO) terms associated with metabolic processes enriched in glial
genes upregulated under fed conditions
GO terms related to metabolic processes Fold change
sulfur metabolic process 2.07
lipid catabolic process 2.01
carbohydrate biosynthetic process 1.99
cell redox homeostasis 1.84
cellular lipid metabolic process 1.71
organic acid metabolic process 1.68
monosaccharide metabolic process 1.65
cofactor metabolic process 1.64
homeostatic process 1.63
cellular ketone metabolic process 1.63
generation of precursor metabolites and energy 1.54
cellular carbohydrate metabolic process 1.49
lipid metabolic process 1.45
cellular amino acid and derivative metabolic process 1.40
regulation of metabolic process 1.12
regulation of macromolecule metabolic process 1.13
macromolecule biosynthetic process 1.17
cellular macromolecule metabolic process 1.19
cellular biosynthetic process 1.21
nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process 1.22
cellular nitrogen compound metabolic process 1.24
cellular catabolic process 1.29
phosphorus metabolic process 1.30
heterocycle metabolic process 1.33
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cleotide metabolic processes (Table 6.2.1). In addition, other processes that one would
expect to be associated with glial cells are also represented in the GO biological processes
enrichment analysis, such as “nervous system regulation”, “stem cell regulation”, “stress
response”, and “endocytosis/exocytosis”. I next sought to examine which pathways are en-
riched among genes upregulated under fed conditions using KEGG (Kyoto Encyclopedia of
Genes and Genomes) algorithm via DAIVD (Huang et al. , 2009). Using a fold enrichment
cutoff of 1, and KEGG p value cutoff of 0.1, I found that 8 pathways are enriched in the
glial cells under fed conditions (Table 6.2.2). The majority of these pathways are related to
amino acid and fatty acids metabolism. Under fed conditions, larvae were provided with a
well-rounded diet containing protein, lipid and sugar, whereas larvae under starved condi-
tions were fed only sugar. Therefore, the upregulation of pathways involved in amino acid
and lipid metabolism under fed conditions is perhaps unsurprising.
In conclusion, pan-glial Pol II TaDa transcriptional profiling experiments showed that
CNS glial cells exhibit profound transcriptional changes in response to feeding as com-
pared to starvation. GO and KEGG analyses highlighted metabolic pathways expected to
be upregulated under fed conditions, validating the transcriptome data for further analyses.
Table 6.2.2 KEGG pathways enriched in glial genes upregulated under fed conditions
KEGG pathway terms Fold Enrichment
Fatty acid elongation in mitochondria 3.55
beta-Alanine metabolism 2.35
Propanoate metabolism 2.27
Cysteine and methionine metabolism 2.23
Fatty acid metabolism 2.15
Valine, leucine and isoleucine degradation 2.10
Ribosome 2.09
Citrate cycle (TCA cycle) 1.69
6.2.2 Pan-Glial TaDa Transcriptional Profiling Across Different Time
Windows Shows Temporal Shifts in Glial Starvation Response
I also performed a similar experiment at an earlier developmental time window together with
Pauline Speder. This time window should capture glial transcription before NSC reaction
and during the early phase of NSC reactivation, from 4 hours before hatching (hbh) to 16
hph (Figure 6.2.7). This experiment was also performed for brains from both starved and
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fed larvae. Combining the two experiments, I was able to explore the glial transcriptional
response to systemic metabolic changes over time.
    Glial TaDa transcriptional profiling
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Fig. 6.2.7 Schematics of glial Pol II TaDa transcriptional profiling in fed and starved first instar
larvae 4 hbh to 16 hph. A schematic of workflow for pan-glial transcriptional profiling, which was
performed between 4 hbh and 16 hph, a time window closely associated with NSC reactivation.
Repo-GAL4 was used as a pan-glial driver.
During the 4 hbh to 16 hph time window, glial cells’ transcriptional response to feeding
is far less dramatic compared to the slightly later time window at 12–36 hph. A global tran-
scriptional profile heat map was generated with log2 ratio of fed over starved conditions for
all genes that pass an FDR threshold of 0.01, across the two time windows analysed (Figure
6.2.8). More genes showed transcriptional upregulation under fed vs. starved conditions
during the later time window. For example, both dIlp6 and perlecantrol transcription was
unchanged between fed and starved conditions during the earlier time window, but were
significantly upregulated during the later time window. This is consistent with a a previous
study showing that CNS dIlp6 transcript level exhibited only moderate increase (approx-
imately 0.5 fold) at 12 hph, but increased nearly 8 fold at 24 hph under fed condition,
compared to 0 hph (Chell & Brand, 2010).
Using a medium stringency level cut off (log2 ratio>=0.58 or>=1.5 fold change, FDR<=0.01),
only 92 genes are upregulated under fed conditions between 4 hbh and 16 hph, in contrast
to 2094 genes that are upregulated under fed conditions between 12 hph and 36 hph. Pro-
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Fig. 6.2.8 Transcriptional responses to starvation in CNS glial over time. Heat maps are gener-
ated from pan-glial TaDa transcriptional profiling experiments under fed and starved conditions over
two time windows (4hbh–16hph, 12hph–36hph). Log2 ratio between fed and starved conditions for
all genes with FDR<=0.01 were calculated and plotted across two time windows.
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teins encoded by these 92 genes form a dense interaction network according to known and
predicted protein interactions, based on STRING functional protein association network
analysis (Franceschini et al. , 2013; von Mering et al. , 2005). Enriched clusters of inter-
action include “translation”,“RNA processing”,“fatty acid biosynthesis”,“citric acid cycle”
and “extracellular matrix proteins” (Figure 6.2.9). Interestingly, the “extracellular matrix
proteins” cluster includes both Collagen IVCg25C and Collagen IVVkg, which have previ-
ously been shown to travel from the fat body and deposit on the CNS surface. Although
glial TaDa transcriptional profiling indicates that glial cells may be capable of expressing
their own Collagen IV protein locally, I confirmed that the majority of Collagen IV protein
on the CNS surface originate from the fat body and that only fat body derived Collagen IV
is required for NSC reactivation (see Chapter 3 for details).
RNA processing





        protein
Fig. 6.2.9 Known and predicted interactions between the products of 92 genes upregulated in
the glia under fed conditions. Analysis was performed using STRING with a medium confidence
score of 0.4 and all interaction methods available. Clusters representing selected pathways and pro-
cesses are highlighted. Single nodes are not displayed
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6.3 Components of the Glial Niche Show Distinct Tran-
scriptional Signatures
6.3.1 CG, PG and SPG Undergo Extensive Transcriptional Activities
During the Time Window of NSC Reactivation
The glial niche associated with NSCs consists of three major glial subtypes: subperineurial
glia (SPG), perineurial glia (PG), and cortex glia (CG). Studies so far have not reached a con-
sensus regarding the relative contributions of glial subtypes to NSC reactivation. Whereas
Chell and Brand suggest that the “surface glia” (PG and/or SPG) are the most important
components of the glial niche (Chell & Brand, 2010), another study argues for a prominent
role of the cortex glia (Sousa-Nunes et al. , 2011). Due to the technical difficulty of isolating
individual glial subtypes, it has not been feasible to systematically assess the contribution
of individual glial subtype to NSC reactivation. Taking advantage of the availability of glial
subtype specific GAL4 drivers and the TaDa technique (Southall et al. , 2013), we un-
dertook the first systematic approach to examine the transcriptomes of each glial subtype
during the critical time window of NSC reactivation (Figure 6.3.1).
The TaDa transcriptional profiling experiment revealed extensive transcriptional activi-
ties and distinct transcriptional signatures among the three glial niche components (Figure
6.3.2). SPG showed the highest level of transcriptional activity. Using a medium stringency
level of Log2 ratio>=0.58 and FDR<=0.01, I found 2997, 1214 and 848 genes are tran-
scribed in SPG, PG and CG, respectively during the first 24 hours post larval hatching. The
transcriptomes and enriched pathways in the three glial subtypes showed extensive overlaps
(Figure 6.3.3). Interestingly, among the 308 genes transcribed in all glial subtypes, KEGG
pathways related to “glycolysis/gluconeogenesis” are enriched, indicating that carbohydrate
metabolism/homeostasis is a shared and essential function of CNS glial cells (Figure 6.3.3).
The role of glial carbohydrate metabolism as energy conduits for neurons and NSCs are con-
served in flies and mammals. For example, astrocytes in the mammalian BBB localise glu-
cose transporters at their endfeet, which project into the surrounding brain capillaries to take
up glucose from the circulation. The astrocytes store glucose in the form of glycogen and
release glucose to fuel neuronal activities when needed. For a review of mammalian glial
niche’s role in carbohydrate metabolism of the CNS, see (Freeman & Doherty, 2006a). In
Drosophila, the main energy supply of the brain is provided by trehalose in the hemolymph
(Wyatt & KALE, 1957). Trehalose is a disaccharide, which is taken up and broken down to
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Fig. 6.3.1 Schematics of glial subtype TaDa transcriptional profiling. Glial subtype transcrip-
tional profiling was performed between 0–24 hph, a time window closely associated with NSC reac-
tivation. Glial subtype specific GAL4 drivers used: NP6293-GAL4 for PG, Moody-GAL4 for SPG,
and NP2222-GAL4 for CG.
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neurons (personal communication with Stefanie Limmer, Christian Klambt lab, University
of Munster).
The two BBB glia, SPG and PG, shared “oxidative phosphorylation” and “pentose phos-
phate pathway” as enriched pathways in addition to the two mentioned earlier. Interest-
ingly, the two BBB glia showed distinct enrichment in different amino acid metabolism:
whereas metabolism of the non-essential alanine, glutamate and aspartate are enriched in
PG, metabolism of three essential amino acids, valine, leucine and isoleucine, are enriched
in SPG. This may indicate cooperation or “division of labor” between the two BBB glial
cell types in the complex process of amino acid/protein metabolism.
Interestingly, lipid metabolism pathways are enriched in both BBB glial subtypes. It
should be noted that sphingolipid metabolism is highly enriched only in the PG. Sph-
ingolipid is a class of lipid known to participate in cellular signalling, such as MAPK
(Mitogen-activated protein kinase) and JNK (c-Jun N-terminal kinases) signalling, as well
as play a role in nutrient response. For a review of sphingolipids in flies, see (Kraut,
2011). Recent studies revealed a novel role of sphingolipid in regulating exocytosis (Dar-
ios et al. , 2009), which is particularly relevant to the function of the glial niche. CNS
glia is known to secrete factors important for NSC reactivation, such as DIlp6, PerlecanTrol
and Anachronism. Therefore, exocytosis plays an essential part in the glial regulation of
CNS development. Exocytosis occurs when vesicles loaded with secretory particles such as
neurotransmitters fuse with the plasma membrane, causing release of their content. Neu-
ronal exocytosis requires three SNARE (soluble-N-ethylmaleimide sensitive factor attach-
ment protein receptor) proteins: synaptobrevin–2 (also known as VAMP–2) on the synaptic
vesicle, and syntaxin–1 with SNAP–25 (Synaptosomal-associated protein 25) on the plasma
membrane (Jahn & Scheller, 2006). The formation of SNARE complex by the three pro-
teins is an essential step toward membrane fusion and exocytosis. Sphingosine allows for the
release of synaptobrevin from its phospholipid anchorage so that SNARE complex can be
formed together with syntaxin/SNAP–25. It would be interesting to investigate whether sph-
ingolipids play similar roles to facilitate exocytosis from the perineurial glia, and whether
sphingolipid-mediated secretion/signalling are important for NSC reactivation.
The Drosophila CNS glial cells were considered to perform the function of a NSC niche
mainly based on the prominent roles of several glial factors, including DIlp6, Anachronism,
and PerlecanTrol. However, the precise sources of these key glial factors (i.e. which glial
subtype do they come from) were previously unknown or ambiguous. For example, whereas
one study showed that DIlp6 is secreted by “surface glia” (PG and/or SPG) (Chell & Brand,
2010), another argued that DIlp6 is expressed by the cortex glia (Sousa-Nunes et al. , 2011).
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Fig. 6.3.2 Glial subtypes exhibit distinct transcriptional signatures. Heat maps are generated
with Log2 ratios of all genes from glial subtype TaDa transcriptional profiling experiments in three
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Fig. 6.3.3 Overlaps of transcribed genes and enriched pathways in the glial subtypes. (A) Venn
diagram shows the numbers of genes transcribed in and shared between three glial subtype. (B) Venn
diagram shows biological pathways enriched in and share between three glial subtypes.
Whereas Ebens et al showed that anachronism proteins are associated with the cortex glia
(Ebens et al. , 1993), a more recent study suggests that NSCs transcribe anachronism, which
is suppressed by a microRNA to enable proper NSC proliferation (Weng & Cohen, 2012).
Our glial transcriptome analysis was able to trace these factors to their subtype origin: SPG
and PG both transcribe dIlp6, PG transcribes perlecantrol, and CG transcribes anachronism
(Figure 6.3.4). dIlp6 has 3 transcription start sites which result in 4 mRNA isoforms that
encode proteins with the same amino acid sequences. Based on Pol II binding patterns,
transcription of dIlp6 initiates at different sites in the two BBB glia subtypes (Figure 6.3.4).
In CG, an abrupt peak of Pol II binding coincides with a transcription start site in the mid-
dle of the dIlp6 locus, suggesting Pol II pausing. As discussed previously, perlecantrol is
transcribed exclusively in the perineurial glia. In addition, the current study revealed many
other glial subtype-specific factors that potentially contribute to the development of the CNS
and NSC proliferation/differentiation. 73 genes, most of which are transcribed specifically
in the SPG, have been implicated in neurogenesis according to analysis of GO biological
processes (see Appendix).
Our data suggest that many glial genes are conserved between flies and human. Some
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Fig. 6.3.4 Pol II binding at ana, trol and dIlp6 loci in three glial subtypes. Three known regulators
of NSC reactivation, ana, trol and dIlp6 are transcribed by different glial subtypes during the time
window of NSC reactivation. ana is transcribed by CG only, trol is transcribed by PG only, and dIlp6
is transcribed by SPG and PG.
CNS pathologies, from Alzheimer’s to neuroblastoma (Table 6.3.1). In mammalian CNS,
glial cells greatly outnumber neurons, and the majority of malignant brain tumours are de-
rived from glial cells or their progenitors, as reviewed in (Jessen, 2004). Although many
neurodegenerative diseases were initially thought to be neuronal pathologies, increasing ev-
idence points to the contributions of glial cells (Dong et al. , 2010; Nagele et al. , 2004;
Shie et al. , 2009). For example, astrocytes contribute to the development of amyloid plaque
in Alzheimer’s (Nagele et al. , 2004). Due to technical and ethical constraints, it is often
difficult to study the functions of genes involved in human CNS pathogenesis and to dis-
sect their functions in human glial cells. The identification of these conserved genes means
that Drosophila can serve as a useful model system to study human CNS diseases. With
its powerful genetics, Drosophila could advance our mechanistic understanding of glial bi-
ology, which could help to elucidate how different types of glial cells participate in the
pathogenesis of the brain, such as during ageing and tumour formation.
6.3.2 Analysis of Global Transcriptional Profiles Revealed Closer Clus-
tering Between the Two BBB Glial Cell Types
Both SPG and PG are located at the surface of the CNS and have been proposed to form the
Drosophila BBB (Stork et al. , 2008). However, efforts investigating the Drosophila BBB
function has focused predominantly on the SPG, to an almost total exclusion of PG. Key
functions such as septate junction (equivalent to mammalian tight junction) formation and
clearance of toxic agents are associated with the SPG (DeSalvo et al. , 2011), but virtually
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nothing is known about the function of PG. The hypothesis that PG forms the BBB was
purely based on the localisation of PG rather than any molecular evidence. I hypothesised
that if indeed PG and SPG form the BBB, their molecular functions may be intertwined,
and thus their transcriptional profiles may show greater similarity with each other than with
the CG. Indeed, I have shown earlier that a significant number of genes are co-expressed in
PG and SPG (Figure 6.3.3). Next, I decided to investigate the relationship of the three glial
subtypes’ transcription profiles in a more quantitative manner. A scatterplot matrix of Log2
ratios of all Drosophila genes was created for all available pairs of glial transcriptomes
(CG vs. PG, CG vs. SPG, PG vs. SPG, CG vs. pan-glia, PG vs. pan-glia, and SPG
vs. pan-glia). Correlations between all pairs of expression profiles are visualised in Figure
6.3.5 and summarised in Table 6.3.2. Colours indicate the degrees of correlation, with red
representing the strongest correlation and yellow representing the weakest (Figure 6.3.5).
The clustering diagram on the left-hand side of Figure 6.3.5 was again computed based
on correlations between each pair of transcriptional profiles. The correlation coefficient
is highest between SPG and pan-glia, followed by SPG and PG, whereas the correlation
coefficients between SPG and CG or PG and CG are low in comparison. This suggests that





















Fig. 6.3.5 Matrix and clustering of global Pol II binding profile scatterplots for pan-glial and
glial subtype transcriptomes. A scatterplot matrix of Log2 ratios of all Drosophila genes were
created for all available pairs of glial transcriptomes (CG and PG, CG and SPG, PG and SPG, CG
and pan-glia, PG and pan-glia, and SPG and pan-glia). Colours indicate the strength of association
(decreasing level of association from red to yellow to blue).
Table 6.3.2 Correlation table of Pol II binding profiles in individual glia subtype
LogRatio_SPG LogRatio_PG LogRatio_CG LogRatio_Pan-glia
LogRatio_SPG 1 0.73 0.47 0.81
LogRatio_PG 0.73 1 0.68 0.82
LogRatio_CG 0.47 0.68 1 0.62
LogRatio_panglia 0.81 0.82 0.62 1
Using an alternative approach, Jorge Buendia-Buendia investigated gene expression
clustering by comparing the on/off states of transcription for all genes which pass a FDR
threshold of 0.01, among three glial subtypes. Again, we found closer clustering between
PG and SPG (data not shown).
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6.3.3 TheDrosophilaBBB Glial Transcriptional Profiles Share Remark-
able Similarity With the Mammalian BBB
Although recent years have seen exciting advances in the investigation of the mammalian
BBB, our understanding of the BBB remains rudimentary. BBB has been implicated in a va-
riety of CNS diseases, including multiple sclerosis, stroke, and cancer, as reviewed in (Stork
et al. , 2008). However, pathogenic mechanisms of these diseases still remain elusive. In ad-
dition, scientists and clinicians have long been frustrated by the obstacle that the BBB poses
to pharmacologic intervention of the brain. Previously, several parallels have been drawn
between the Drosophila and mammalian BBB. Do Drosophila and mammalian BBBs share
conserved functions on a larger scale? Can the Drosophila BBB help to advance our under-
standing of basic mechanisms governing mammalian BBB development and homeostasis?
Comparing the published mammalian BBB transcriptome (Daneman et al. , 2010) with
our BBB glial transcriptome (PG + SPG), we were able to compare invertebrate and verte-
brate BBB gene expression, biological functions and signalling pathway enrichment, on a
genome-wide scale.
A mouse BBB transcriptome of both adult and post-natal animals has recently been
published (Daneman et al. , 2010). I decided to first compare our BBB glial transcrip-
tional profiling with post-natal mouse BBB. The mouse BBB consist of pericytes, astrocytic
end-feet, and endothelial cells. In the Daneman et al study, both post-natal pericytes and
endothelial cells are marked by Tie2GFP, which were FACS sorted into one combined cat-
egory (Daneman et al did not publish the post-natal astrocyte transcriptome). Ideally, it
would be interesting to compare the SPG transcriptome with the endothelial cell transcrip-
tome, because the septate junction-forming Drosophila SPG are proposed to be the func-
tional equivalent of the tight junction-forming mammalian endothelial cells. Likewise, the
PG, which form a loosely fenestrated network around the brain, show morphological sim-
ilarities to the pericytes and/or astrocytes. However, since Daneman et al did not separate
post-natal endothelial cells from pericytes when performing their transcriptome analysis, I
decided to compare their merged BBB transcriptome (containing both endothelial cells and
pericytes) with our BBB transcriptome (containing both SPG and PG).
In order to compare the Drosophila and mammalian transcriptional data, I first identi-
fied known or predicted mammalian orthologs of the Drosophila genes of interest through
the online DRSC Integrative Ortholog Prediction Tool (Drosophila RNAi Screening Center)
website (http://www.flyrnai.org/diopt) (Hu et al. , 2011). This tool integrates all existing
approaches to facilitate identification of vertebrate othologs of Drosophila genes. All pre-
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diction settings were left to default, except that the “exclude low score” filter was selected.
The converted Drosophila-to-mouse ortholog gene list was then compared to the mouse
BBB transcriptome. Approximately half of genes transcribed by larval Drosophila PG and
SPG are also transcribed by the post-natal mouse BBB (Table 6.3.3).
In addition to serving as a physical barrier between the brain and the blood/hemolymph,
the BBB in both vertebrates and flies plays an active role in the clearance of foreign and
toxic substances, therefore serving as a chemical barrier and detoxification centre for the
brain, as reviewed in (Stork et al. , 2008). The conserved BBB genes show enriched KEGG
pathways related to these roles, such as “drug metabolism” and “metabolism of xenobiotics
by cytochrome P450” (Table 6.3.4). Genes and their molecular functions associated with
drug metabolism are shown in Table 6.3.5. In addition, several metabolic pathways related
to both essential and non-essential amino acids, lipids and aerobic respiration as previously
observed to be enriched in genes transcribed by PG and SPG, are also enriched in the con-
served gene list.
Interestingly, our analysis highlighted an enrichment of “retinol metabolism” among
conserved BBB genes. This finding is consistent with a recent discovery that retinoic acid is
secreted from the NSCs (radial glial cells) to induce BBB formation in the mouse fetal brain,
and expression of retinoid acid as well as its receptors are highly enriched in human fetal
BBB, although their mechanism of action are unclear (Mizee et al. , 2013). The current
study provides the first indication that retinol-signalling may be a conserved pathway that
regulates BBB development and homeostasis in invertebrates and vertebrates. Genes and
their molecular functions associated with retinol metabolism are shown in Table 6.3.6.
Next, I identified and clustered enriched biological processes among the conserved gene
list using Gene Ontology. GO terms associated with metabolism, developmental processes
and morphogenesis are most prevalent, but processes related to “transport and exo/endo-
cytosis”, “regulation of growth” and “cell/tissue size”, and “cell cycle” are also highly en-
riched (Figure 6.3.6). Interestingly, “amino acid transport” was found under the “transport
and exo/endo-cytosis” cluster. If toxic molecules cannot penetrate the brain, then nutrients
and metabolites have similar difficulty in passing the BBB to reach and nourish cells within
the brain (DeSalvo et al. , 2011). Recent years have seen growing interest in understanding
the transport and delivery of nutrients such as amino acids in mammalian brain. Several spe-
cific amino acid transporters have been identified in mammalian CNS, but little is known
about BBB-dependent nutrient homeostasis in Drosophila (Freeman et al. , 2003; Stork
et al. , 2008). Therefore, our study identified potential players of amino acid transport in
the BBB and provided a starting point to investigate how the Drosophila BBB regulates
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CNS amino acid metabolism, which will allow for more meaningful cross-comparison with
the vertebrate BBB. Another point of interest about BBB mediated amino acid transport
is its potential role during NSC reactivation. Existing evidence suggests that fat body is
the key systemic amino acid sensor in Drosophila (Britton & Edgar, 1998; Sousa-Nunes
et al. , 2011). In response to dietary amino acids, it secretes circulating factors to instruct
the BBB glia to produce DIlps, which in turn reactivates the NSCs. However, it cannot
be ruled out that the BBB glia possess intrinsic amino acid sensing capacity, which sig-
nals directly upstream of TOR and DIlp production in parallel or independently of fat body
factors. In support of this idea, a recent study showed that when the amino acid-sensitive
PI3K/TOR signalling components were disrupted in CNS glia, NSCs fail to reactivate ef-
ficiently even though fat body signals were undisturbed (Sousa-Nunes et al. , 2011). The
current glial transcriptome analysis provides evidence for the existence of a diverse array
of conserved amino acid transporters/sensors in the BBB. Some of these transporters, such
as the proton-assisted amino acid transporter family (Slc36/path), have been shown to play
dual transporter and sensor functions, directly impinging on downstream TOR signalling, as
reviewed in (Reynolds et al. , 2007). Genes and their molecular functions associated with
amino acid transport/sensing are shown in Table 6.3.7.
Thus, the GO analysis not only confirmed known biological processes of the BBB, such
as metabolism, response to external stimulus/stress response, and cellular junction forma-
tion, but also highlighted potential novel processes worthy of further investigation such as
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Fig. 6.3.6 Clustered GO biological processes among conserved BBB genes. 126 significantly
enriched biological processes (P value<=0.05, GO_BP level=3) were identified among genes tran-
scribed in both Drosophila and mammalian BBB, using Gene Ontology algorithms. These were
clustered into 19 broader functional categories, shown in the graph.
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Table 6.3.1 Glial subtype specific genes whose human orthologs play roles in human CNS dis-
eases
Fly gene symbol Glial subtype Human gene symbol Nervous system diseases
mRpL10 SPG MRPL10 Alzheimer’s disease (cognitive decline)
Got2 SPG GOT1 Aspartate aminotransferase
Bem46 SPG ABHD13 Attention deficit hyperactivity disorder and conduct disorder
gkt SPG TDP1
Spinocerebellar ataxia, autosomal recessive
with axonal neuropathy
Wdr82 SPG WDR82 Bipolar disorder
fy SPG FUZ Neural tube defects
Npc1a SPG NPC1 Niemann-Pick disease, type C1
Myo31DF SPG MYO1D Hypertension risk in short sleep duration
Tap42 SPG IGBP1 Agenesis of Corpus callosum, with mental retardation
cenG1A SPG AGAP1 Schizophrenia
VhaSFD SPG ATP6V1H Bipolar disorder (mood-incongruent)
fbp SPG FBP1 Fructose-1,6-bidphosphatase deficiency
Arpc2 SPG ARPC2 Inflammatory bowel disease
Acon SPG ACO2 Infantile cerebellar-retinal degeneration
Uba1 SPG UBA1 Spinal muscular atrophy, X-linked 2, infantile
park CG PARK2 Disc degeneration (lumbar)
toy CG PAX6 Coloboma of optic nerve
hoe1 CG OCA2 Parkinson’s disease (age of onset)
esg CG SNAI2 Waardenburg syndrome, type 2D
dac CG DACH1 Obsessive-compulsive disorder




btl CG FGFR1 Jackson-Weiss syndrome
Eaat2 CG SLC1A2 Essential tremor
salm CG SALL1 Townes-Brocks syndrome
Blimp-1 CG PRDM1 Crohn’s disease
Csas CG CMAS Entorhinal cortical thickness
peb CG RREB1 Multiple sclerosis
Sp1 CG SP8 Bipolar disorder
SoxN CG SOX2 Microphthalmia, syndromic 3
Cg25C PG COL4A5 Alport syndrome
Dh44-R2 PG CRHR1 Intracranial volume
Sema-5c PG SEMA5A Autism
htl PG FGFR3 Crouzon syndrome with acanthosis nigricans
Dys PG DMD Response to antidepressant treatment
trol PG HSPG2 Schwartz-Jampel syndrome, type 1
dnc PG PDE4D Neuroticism
Spred PG SPRED2 Inflammatory bowel disease
lin-28 PG LIN28B Neuroblastoma
LpR1 PG VLDLR Alzheimer’s disease (age of onset)
Syb PG VAMP3 Periodontal microbiota
Dys PG NPAS4 Bipolar disorder
Slc45-1 PG SLC45A2 Oculocutaneous albinism, type IV
Ac78C PG ADCY8 Total ventricular volume
plx PG TBC1D1 Crohn’s disease
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Table 6.3.3 Overlap between Drosophila and mouse BBB gene expression
Glial Subtype NO. of transcribed genes NO. of transcribed genes Percentage of transcribed genes
whose orthologs are whose orthologs are
transcribed in mouse BBB transcribed in mouse BBB
SPG 2914 1413 48
PG 1184 562 47
Table 6.3.4 KEGG pathways enriched in BBB genes expressed in both Drosophila and mouse
Kegg pathway terms Fold Enrichment
Cysteine and methionine metabolism 2.83
beta-Alanine metabolism 2.65
Propanoate metabolism 2.62
Valine, leucine and isoleucine degradation 2.48




Pentose and glucuronate interconversions 1.89
Drug metabolism 1.81
Metabolism of xenobiotics by cytochrome P450 1.77
Citrate cycle (TCA cycle) 1.71
Table 6.3.5 Conserved BBB genes involved in drug metabolism
Fly gene symbol Mouse gene symbol Molecular function Prediction derived from
Cyp9f2 Cyp3a59 electron carrier activity Homologene, Inparanoid, orthoMCL
GlcAT-S B3gat1
galactosylgalactosylxylosylprotein
3-beta-glucuronosyltransferase activity Compara, OrthoDB
Ugt86Dd Ugt2b37 glucuronosyltransferase activity Inparanoid, Isobase
CG15661 Ugt2b38 glucuronosyltransferase activity Inparanoid, Phylome
CG4302 Ugt2b36 glucuronosyltransferase activity
Homologene, Inparanoid, OMA,
orthoMCL, Phylome
Ugt36Bc Ugt3a2 glucuronosyltransferase activity Compara
Ugt86Di Ugt2a3 glucuronosyltransferase activity Inparanoid, Isobase
Ugt35a Ugt8a glucuronosyltransferase activity Compara, Inparanoid, orthoMCL
GstD1 Gstt2 glutathione transferase activity Compara, OrthoDB
gfzf Gsto2 glutathione transferase activity Isobase
GstE1 Gstt2 glutathione transferase activity Compara, OrthoDB, orthoMCL
GstE6 Gstt3 glutathione transferase activity Compara, orthoMCL
GstE7 Gstt3 glutathione transferase activity Compara, orthoMCL
GstE9 Gstt2 glutathione transferase activity Compara, OrthoDB, orthoMCL
GstE3 Gstt2 glutathione transferase activity Compara, OrthoDB, orthoMCL
GstE2 Gstt3 glutathione transferase activity Compara, orthoMCL
Fmo-1 Gm4847 monooxygenase activity Inparanoid, orthoMCL, RoundUp
Adhr Hpgd





oxidoreductase activity, acting on the aldehyde or
oxo group of donors, NAD or NADP as acceptor Compara, OrthoDB, RoundUp, Treefam
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Table 6.3.6 Conserved BBB genes involved in retinol metabolism
Fly gene symbol Mouse gene symbol Molecular function Prediction derived from
mdy Dgat1 diacylglycerol O-acyltransferase activity
Compara, Homologene, Inparanoid,
Isobase, OMA, OrthoDB, orthoMCL,
Phylome, RoundUp, Treefam





3-beta-glucuronosyltransferase activity Compara, OrthoDB
Adhr Hpgd alcohol dehydrogenase (NAD) activity
Compara, OrthoDB, orthoMCL,
Phylome, Treefam
Ugt35a Ugt2b35 glucuronosyltransferase activity Inparanoid, OMA, orthoMCL
Cyp9f2 Cyp3a11 electron carrier activity
Inparanoid, Isobase, orthoMCL,
Phylome, RoundUp
Ugt86Dd Ugt1a6b glucuronosyltransferase activity Inparanoid, OMA




oxidoreductase activity, acting on




Ugt36Bc Ugt1a6b glucuronosyltransferase activity OMA
Ugt86Di Ugt8a glucuronosyltransferase activity Compara, Inparanoid, OMA
Table 6.3.7 Conserved BBB genes involved in amino acid transport




Compara, Homologene, Inparanoid, Isobase,
OrthoDB, orthoMCL, Phylome, RoundUp, Treefam
CG7888 Slc36a1
amino acid transmembrane




Compara, Homologene, Inparanoid, Isobase, OMA,
OrthoDB, orthoMCL, Phylome, RoundUp, Treefam
CD98hc Slc3a2 cation binding Compara, Isobase, Phylome, Treefam
path Slc36a3
amino acid transmembrane
transporter activity Compara, Phylome
mnd Slc7a10
amino acid transmembrane
transporter activity Isobase, orthoMCL
Ncc69 Slc12a3 sodium:chloride symporter activity
Inparanoid, OrthoDB, orthoMCL, Phylome,
RoundUp, Treefam




Compara, Homologene, Inparanoid, Isobase,
OrthoDB, orthoMCL, Phylome, RoundUp, Treefam
JhI-21 Slc7a10
amino acid transmembrane
transporter activity Compara, orthoMCL, Phylome
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6.4 BBB Glia Constitute a Nutrition-Sensitive NSC Niche
6.4.1 Analysis of Glial Subtype Transcriptional Profiles Under Differ-
ent Nutrient Conditions
In order to interrogate each glial subtype’s response to nutrition and advance our understand-
ing of each subtype’s role during NSC reactivation, Jorge Beundia-Buendia and I analysed
glial subtype transcriptional profiles in conjunction with pan-glial transcriptional profiles
under fed and starved conditions. This comprehensive analysis combining the two experi-
ments allowed me to identify glial subtype-specific genes that are differentially transcribed
under different nutritional conditions.
First, I wanted to compare the three glial subtypes’ sensitivity to amino acid starvation.
Among all genes upregulated under fed conditions, 1055 genes are SPG specific, 354 genes
are transcribed in both SPG and PG, 79 are PG specific, whereas only 43 are CG specific
(Figure 6.4.1). Based on numbers of genes affected by nutritional states, the BBB glial
subtypes, especially SPG, appear to be the most sensitive to dietary amino acid deprivation,










Fig. 6.4.1 SPG and PG contain higher numbers of nutrient-responsive genes than CG. A mod-
ified Venn Diagram showing numbers of genes upregulated under fed conditions in individual glial
subtypes.
However, nutrient-sensitive gene numbers may be biased, because the SPG Pol II TaDa
transcriptome contained higher number of total transcribed genes compared to other glial
subtypes whereas CG contained the lowest number of total transcribed genes to start with.
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In order to address such bias, I interrogated proportions of genes that are differentially ex-
pressed under different nutrient conditions, within each glial subtype. I hypothesised that
if the SPG is indeed the most nutrient-sensitive glial subtype, a greater percentage of SPG
genes would be differentially transcribed under different nutrient conditions as compared to
other glial subtypes. Indeed, this is true when analyses were performed on total genes tran-
scribed in each glial subtype (Figure 6.4.2 and Table 6.4.1), and on genes that are specific
to each glial subtype (Figure 6.4.3 and Table 6.4.2). Proportions of genes upregulated under
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Fig. 6.4.2 BBB glial subtypes, especially SPG, transcribe higher proportions of nutrient-
responsive genes than CG. The spine plots show the proportions of genes upregulated under fed
conditions, genes upregulated under starved conditions, and genes unchanged under different nu-
trient conditions, among all transcribed genes within each glial subtype. Area of spine plots are
proportional to total number of genes in different glial subtypes.
Table 6.4.1 Percentage of nutrient-responsive genes expressed by glial subtypes
Glial subtype Total expressed genes(%) Up in fed (%) Up in starved(%) No change(%)
SPG 100 55.33 0.10 44.56
PG 100 50.74 1.07 48.18
CG 100 32.42 2.00 65.56
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Fig. 6.4.3 BBB glial subtypes, especially SPG, contain higher proportions of nutrient-responsive
subtype-specific genes than CG. The spine plots show the proportions of genes upregulated under
fed conditions, genes upregulated under starved conditions, and genes unchanged under different
nutrient conditions, among genes that are specific to each glial subtype. Area of spine plots are
proportional to total number of genes in different glial subtypes.
Table 6.4.2 Percentage of nutrient-responsive genes specific to glial subtypes
Glial subtype Total specific genes (%) Up in fed (%) Up in starved (%) No change (%)
SPG 100 54.92 0 45.07
PG 100 40.21 1.08 58.69
CG 100 12.25 1.47 86.27
6.4.2 Disruption of Vesicle Trafficking in BBB Glia Impairs NSC Re-
activation
SPG is most sensitive to nutritional fluctuation, and is also one of the sources of a key
NSC reactivation signal, DIlp6. Thus, I hypothesised that SPG is the most important glial
subtypes contributing to nutrition-dependent NSC reactivation. To test this hypothesis, I
sought to disrupt vesicle trafficking in individual glial subtypes using a dominant negative
Dynamin (ShiDN ), and assessed the outcome of NSC reactivation. Indeed, disrupting vesi-
cle trafficking in SPG resulted in the strongest NSC reactivation defects, followed by PG
and CG (Figure 6.4.4). At 24 hph, NSCs enlarged and started to proliferate in control larvae
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and in larvae where a ShiDN was expressed in the cortex glia. When ShiDN was expressed
by the subperineurial glia, NSCs failed to enlarge. When ShiDN was expressed by the per-
ineurial glia, NSCs enlarged but showed impaired proliferation. Quantifications of NSC
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Fig. 6.4.4 Disruption of vesicle trafficking in BBB glia impairs NSC reactivation. Glial traffick-
ing was disrupted by expressing dominant negative Dynamin (UAS-ShiDN;UAS-ShiDN) in different
subtypes of glial cells after larval latching. GAL80ts was used to suppress GAL4 expression during
embryogenesis. NSC enlargement and reactivation was assessed 24 hours post hatching with Dlg,
Dpn, and PH3 staining. (A-A‘) In control larvae (w1118 X UAS-ShiDN;UAS-ShiDN), NSCs en-
larged (A) and started to proliferate (A’) by 24 hph. (B-B’) Disruption of cortical glia did not impair
NSC enlargement, and only mildly affected proliferation. See Figure 6.4.5 for quantification. (C-
C’) Disruption of subperineurial glia vesicle trafficking led to complete impairment of reactivation.
NSCs were unable to enlarge and no proliferation was observed. (D) Disruption of perineurial glia
led to moderate impairment of both enlargement and proliferation. See Figure 6.4.5 for quantifica-
tion.
6.4.3 Exploration of Signalling Pathways in BBB Glia Regulating NSC
Reactivation
A simplified model for NSC reactivation states that upon receipt of fat body signals, the
BBB glia secrete DIlps, which in turn drives the NSCs into mitosis. However, little is
known about the upstream regulators of DIlp6 production from the BBB. In addition, mis-
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Fig. 6.4.5 Quantification Of NSC reactivation defects when vesicle trafficking was disrupted in
glial subtypes. (A) NSC enlargement in the VNC was assessed by measuring the longest diameter
of Dpn positive cells using Dlg to determine cell membrane boundaries. NSC enlargement was
examined at 24 hph. Brains from control (w1118 X UAS-ShiDN; UAS-ShiDN) progeny were used
as controls. Students’ t test was conducted between control and experimental condition for each
GAL4 driver at each time point. n=6. * P<0.05. (B) NSC proliferation in the VNC was assessed
by measuring the number of PH3 positive and Dpn positive cells at 24 hph. Students’ t test was
conducted between control and experimental condition for each GAL4 driver at each time point. *
P<0.05.
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expression of DIlp6 alone was able to rescue NSC enlargement completely, but was not able
to rescue NSC proliferation to the full extent (Chell & Brand, 2010). Thus, it is probable
that other signalling pathways in the BBB glia may act in parallel with DIlp6 to instruct NSC
reactivation. To identify these unknown pathways upstream of, or in parallel with, DIlp6, I
searched for enriched signalling pathways among SPG specific genes that are upregulated
under fed conditions using KEGG algorithm via DAIVD (Huang et al. , 2009). Using a
medium stringency level, fold enrichment cutoff of 1, and p value cutoff of 0.1, I found
that 6 pathways are enriched in the dataset (Table 6.4.3). TGF-beta pathway is the only
enriched signalling pathway, with 7 components enriched in the SPG under fed conditions
(Table 6.4.4). Interestingly, another report demonstrated a role for TGF-beta signalling in
controlling NSC proliferation during a later stage of larval neurogenesis in Drosophila (Zhu
et al. , 2008). Zhu et al showed the involvement of glial cells in this process, as Activin,
a TGF-beta ligand, was expressed in the glia. However, the authors did not investigate the
contribution of glial subtypes or delved into further mechanistic details.
Ongoing experiments aim to address whether and how TGF-beta signalling mediate
nutrition-dependent NSC reactivation, and most importantly, whether ECM proteins regu-
late NSC reactivation via TGF-beta signalling pathway. Existing evidence suggests that Col-
lagen IV may act as a co-receptor to recruit signalling ligands. The most well-characterised
signalling pathway mediated by Collagen IV in Drosophila is BMP signalling (Bunt et al.
, 2010; Sawala et al. , 2012; Tian & Jiang, 2014; Wang et al. , 2008), which belongs to
the TGF-beta superfamily signalling pathway. Although the interaction between Collagen
IV and TGF-beta ligands in Drosophila (including Activin-beta, Dawdle, Myoglianin and
Maverick) has not been investigated, Collagen IV was shown to bind to TGF-beta1 ligands
in vertebrates (Paralkar et al. , 1991). Since the BBB glia transcribe multiple TGF-beta
ligands and downstream effectors during the time window of NSC reactivation (data not
shown), I hypothesise that an autocrine/paracrine TGF-beta signalling may mediate NSC
reactivation via ECM-ligand interaction at the CNS surface.
6.4.4 Chapter Summary
In collaboration with Pauline Speder, Jessie Van Buggenum and Jorge Buendia-Buendia
(Andrea Brand lab), I performed a systematic analysis of the glial niche’ responses to star-
vation, during two sequential time windows. I showed that CNS glia are highly responsive
to nutrient-deprivation after approximately 12 hph, with each glial subtype exhibiting dis-
tinct transcriptional signatures. Glial subtype transcriptome analyses reveal that the BBB
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glia’s transcriptional activity is most sensitive to changes in nutritional intake, and many
genes involved in neurogenesis and multiple metabolic/signalling pathways are upregulated
upon feeding. These analyses may serve as a starting point for identifying signalling path-
ways acting in parallel with or upstream of glial dIlp6 transcription. They may also aid in
elucidating the molecular mechanisms underlying ECM binding to the CNS and its role in
glial insulin production.
Many glial genes are conserved between flies and human. Some glial subtype-specific
genes have human orthologs which have been implicated in human CNS pathologies. In
addition, a comparison between mammalian and Drosophila BBB transcriptomes revealed
high degree of overlap. Therefore, with its powerful genetics, Drosophila can serve as a
useful model system to study glial contribution to human CNS development, homeostasis,
and diseases. In particular, further mechanistic investigation of these genes may help to elu-
cidate how different types of glial cells, especially BBB glia, participate in the pathogenesis
of the brain, such as during ageing and tumour formation. Some novel/important BBB glial
functions highlighted in our analysis that await further investigation include sphingolipid
signalling, retinoid acid signalling, amino acids sensing, and TGF-beta signalling. In par-
ticular, TGF-beta signalling may hold the key to understanding how ECM proteins regulate
NSC reactivation at the BBB.
Table 6.4.3 KEGG pathways enriched in SPG-specific genes upregulated under fed conditions
KEGG Pathway Terms Fold Enrichment
Glyoxylate and dicarboxylate metabolism 4.28
Valine, leucine and isoleucine degradation 3.53
Propanoate metabolism 3.03
Citrate cycle (TCA cycle) 2.65
TGF-beta signaling pathway 2.57
Ubiquitin mediated proteolysis 1.95
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Table 6.4.4 SPG specific genes involved in TGF-beta signalling pathway
Gene Symbol Gene Name










7.1 Summary of Main Findings
Nutrient intake affects the development and homeostasis of the brain in both vertebrates and
invertebrates. The fat body acts as a systemic metabolic sensor and coordinates organismal
growth with nutrient availability. Using an unbiased approach of fat body transcriptional
profiling, I identified genes upregulated in the fat body under fed conditions as compared
to starved conditions. I focused on Collagen IV, which is secreted from the fat body and
released into the hemolymph where it regulates NSCs’ exit from quiescence. Collagen IV is
deposited onto the CNS surface and this in turn is required for the proper deposition of BBB
glia derived PerlecanTrol. Furthermore, both Collagen IV and PerlecanTrol are critically
required for NSC reactivation at least in part via integrin receptors and the induction of
insulin signalling from the BBB glia. I showed that ECM components are key factors that
mediate inter-organ communication in the context of NSC reactivation. A schematic of the
ECM and insulin signalling mediated fat body-glia-NSC reactivation relay is summarised in
Figure 7.1.1. In addition to ECM proteins’ roles in NSC reactivation, I also briefly explored
their functions in other aspects of larval development, including their role in systemic larval
growth and insulin secretion from the IPCs.
In parallel to the investigation of fat body signals, I also took part in a collaborative
effort to systematically investigate the glial niche’s response to nutritional fluctuation based
on glial TaDa transcriptional profiling experiments. The aim of this analysis was to iden-
tify candidate signalling pathways that are active in the glial niche and are mediated by
ECM proteins at the brain surface. Bioinformatics and in vivo analyses revealed BBB glia
as a nutrient-sensitive NSC niche, and highlighted important niche factors and signalling
pathways, such as BMP/TGF-beta signalling, in mediating glia’s nutrient response.
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Fig. 7.1.1 ECM proteins and insulin-signalling dependent fat body-glia relay regulates NSC
reactivation. (A) A relay model of amino acid dependent NSC reactivation via fat body secreted
Collagen IV and glial insulin signalling. Upon sensing dietary amino acids and activation of Slif-
TOR amino acid sensing pathway, the fat body secretes Collagen IV, which travels to and coats the
CNS surface. (B) Collagen IV recruits perineurial glia-derived PerlecanTrol, a known requirement
for NSC reactivation, to the BBB and the vicinity of NSCs. Upon binding to integrin receptors on
glial cells, the two ECM proteins induces glial insulin/IGF signalling from the BBB glia, which in
turn triggers NSC reactivation. See text for more details.
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7.2 ECM Is Important for Neurogenesis and NSC Behaviour
Many ECM components are highly conserved between vertebrates and Drosophila (Kaza-
nis, 2011). A flurry of recent vertebrate studies has uncovered the crucial functions of
ECM proteins in the development and homeostasis of the CNS. In particular, ECM proteins
control NSC proliferation, differentiation, and migration (Ariza et al. , 2010; Kazanis &
ffrench Constant, 2011; Kazanis et al. , 2010; Schlaepfer et al. , 2000; Schneller et al. ,
1997). Notably, the NSC microenvironment in the neurogenic subependymal zone of adult
mammalian brain is associated with distinct ECM signatures in its quiescent and reacti-
vated state, respectively (Kazanis et al. , 2010). ECM proteins including laminins and their
integrin receptors are implicated in regulating NSCs’ transition from quiescence to reac-
tivation (Kazanis et al. , 2010). Whereas the mammalian studies revealed a requirement
of ECM proteins for a variety of NSC behaviours, the current study aimed at investigating
the mechanisms and signalling pathways mediated by ECM during neurogenesis. Impor-
tantly, I uncovered a novel involvement of insulin signalling downstream of Collagen IV
and Perlecan binding at the BBB.
Both Collagen IV and Perlecan may have conserved roles in vertebrate and invertebrate
neurogenesis. A transcriptome analysis of neurogenic regions of human and mouse fetal
neocortex suggests that ECM proteins may be involved in neuronal progenitor self-renewal
(Simone A Fietz, 2012). In this study, transcripts of perlecan were highly enriched in the
germinal zones consisting of neuronal progenitors compared to the cortical plates consisting
of mature neurons. collagen IVvkg transcripts were exclusively present in the germinal zone
and absent from the cortical plate.
In flies and mammals alike, ECM proteins are important for early CNS development, in-
cluding NSC proliferation. CNS PerlecanTrol expression can be detected in both Drosophila
and mammals. Loss of PerlecanTrol led to microcephaly in mouse, as well as impaired CNS
development in flies. However, although collagen IV expression was detected in the CNS,
the consequences of Collagen IV-deficiency during CNS development have not been de-
scribed in mammalian systems before. It remains unclear whether mammalian Collagen
IV is also required for PerlecanTrol deposition. It should be noted that the source of CNS
Collagen IV may be different in mammals and flies: the current study and work of others
(Pastor-Pareja & Xu, 2011) showed that Collagen IV at the Drosophila BBB originates ex-
clusively from the fat body. I did not detect local Collagen IV expression in the Drosophila
CNS based on glial TaDa transcriptional profiling. However, the mammalian fetal brain is
capable of producing its own Collagen IV locally (Simone A Fietz, 2012).
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Although PerlecanTrol deposition on the CNS surface is downstream of Collagen IV de-
position, I believe that Collagen IV’s role in NSC reactivation only in part functions through
PerlecanTrol. This is because deprivation of Collagen IVVkg led to much stronger phenotypes
compared to deprivation of PerlecanTrol: whereas loss of PerlecanTrol only resulted in mod-
erate (app. 30%) reduction of CNS dIlp6 transcription and impaired proliferation without
affecting NSC enlargement, fat body knockdown of Collagen IVVkg resulted in a striking
60% reduction of dIlp6 transcription (similar to starvation conditions). Both NSC enlarge-
ment and proliferation were abolished. Therefore, levels of dIlp6 transcripts in the CNS
appear to correlate with various degrees of NSC reactivation. It is possible that a lower
threshold of DIlp6 level is required for NSC enlargement, but CNS DIlp6 needs to reach a
higher level to drive NSCs into mitosis.
7.3 Collagen IV Plays a Fat Body Specific Role in Regulat-
ing Amino Acid Dependent NSC Reactivation, Poten-
tially via BMP/TGF-Beta Signalling
Prior to the present study, very little was known about the identity and mechanism of fat
body factors involved in NSC reactivation. This is in part due to technical constraints, as the
fat body in the first instar larvae is difficult to isolate in its entirety. With TaDa transcriptional
profiling, I eliminated the need for dissection, and was able to map the transcriptome of first
instar larval fat body in vivo.
Collagen IV is a main component of basement membrane and it has recently been shown
to play key signalling roles in both human and in flies (Bunt et al. , 2010; Kaido et al. ,
2004; Sawala et al. , 2012). Although previous studies showed that hemocytes are required
for Collagen IV diffusion during embryogenesis (Bunt et al. , 2010), I found that Collagen
IVVkg can travel to the larval CNS surface without or with minimal aid of hemolymph fac-
tors, at least in vitro. How does Collagen IV on the brain surface regulate CNS development?
Existing evidence suggests that Collagen IV may act as a co-receptor to recruit signalling
ligands. Whereas little is known about Collagen IV’s participation in cellular signalling in
mammalian systems, studies in Drosophila started to uncover Collagen IV’s involvement
in BMP signalling both in vivo and in vitro. Wang et al first demonstrated that interaction
between Dpp and Collagen IVVkg is essential for correct signalling in the Drosophila ger-
marium and early embryo. This study suggests that Dpp secreted from the germline stem
cell niche binds to Collagen IVVkg, which restricts the spreading of extracellular Dpp from
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the source. In collagen IVVkg mutant germaria, less Dpp would be bound, resulting in an in-
creased Dpp signalling range and increased germline stem cell number (Wang et al. , 2008).
The formation of a BMP morphogen gradient in Drosophila embryos requires transport of
a heterodimer of the BMPs Dpp and Scw in protein shuttling complexes. Recently, Sawala
et al provided mechanistic insights that Collagen IV facilitates such gradient formation by
physically binding to Dpp: Collagen IV functions as a scaffold to promote the assembly
of the shuttling complexes in a multistep process to restrict the range of BMP signalling in
embryos (Sawala et al. , 2012). This study also attempted to map the binding sites of BMP
ligands on Collagen IV and identified Dpp as the only BMP ligand that physically binds
to Collagen IV. In addition, Collagen IV-dependent BMP signalling has been shown to be
important in other developmental contexts such as renal tubule morphogenesis (Bunt et al.
, 2010) and midgut stem cell proliferation (Tian & Jiang, 2014). In the latter, Dpp and Gbb,
two BMP ligands, are produced by enterocytes and act in a paracrine fashion to promote
intestinal stem cell (ISC) self-renewal in the niche (Tian & Jiang, 2014). In vertebrates,
Collagen IV has also been found to bind BMP4 and has been suggested to potentiate sig-
nalling in cultured cells (Wang et al. , 2008). Collagen IV was also shown to be able to bind
to TGF-beta1 ligands in an osteoblast cell line (Paralkar et al. , 1991). These results suggest
that Collagen IV can affect BMP/TGF-beta signalling during vertebrate development.
Could BMP/TGF-beta signalling play a role at the NSC niche to regulate NSC reactiva-
tion, similar to what has been previously reported for the ISC niche (Tian & Jiang, 2014)?
Encouragingly, bioinformatic analysis identified TGF-beta signalling as the only nutrient-
sensitive signalling pathway enriched in BBB glia. Ongoing experiments are underway to
test a potential role for autocrine/paracrine BMP/TGF-beta signalling at the BBB upstream
of insulin production by the glial cells. Glial transcriptional profiling shows that a number of
BMP/TGF-beta ligands, including Dpp, Daw and Myo, are transcribed in BBB glia during
the time window of NSC reactivation (data not shown). When a Dpp-GFP fusion protein
is expressed by the glial cells, GFP is detected exclusively at the apical surface of the BBB
and co-localises with the ECM. Furthermore, perturbing glial BMP/TGF-beta signalling by
over-expression of ligands or expression of constitutively-active receptors (Tkv and Babo),
led to abnormal NSC reactivation (data not shown).
It remains to be tested whether BMP/TGF-beta signalling is disrupted when the BBB
is deprived of ECM, and whether glial insulin transcription/secretion is impaired upon dis-
ruption of BMP/TGF-beta signalling at the BBB. Interestingly, a few recent studies in both
vertebrates and flies showed evidence of cross-talk between BMP/TGF-beta and insulin sig-
nalling pathways. Lin et al showed that TGF-beta/Smad3 signalling regulates insulin gene
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transcription in pancreatic beta-cells, and Smad3 occupies the promoter region of the insulin
gene (Lin et al. , 2009). Furthermore, expression profiling of the Drosophila larval CNS
showed dIlp2 as one of the 101 down-regulated genes in wit (wishful thinking, shared BMP/
TGF-beta Type II receptor) mutants (Kim & Marqués, 2010). dIlp6 transcripts were not af-
fected in wit mutants. However, this study examined late third instar larvae. It remains to be
examined whether dIlp6 is transcriptionally regulated by wit and BMP/TGF-beta signalling
during the first instar stage.
7.4 Perlecan Participates in a Diverse Array of Signalling
Pathways
In vertebrates, Perlecan has been well characterised in the growth and morphogenesis of the
skeleton and vascular system, and it is involved in FGF, PDGF, and VEGF signalling (Mel-
rose et al. , 2008; Segev et al. , 2004; Whitelock et al. , 2008). Recent studies also revealed
its participation in BMP signalling (DeCarlo et al. , 2012), and TGF-beta signalling by
interacting with the prodomains of TGF-beta ligands (Sengle et al. , 2011). Its involvement
in a diverse array of signalling pathways could be at least partly responsible for its essential
roles in many aspects of brain functions. For example, Perlecan is required for mammalian
neurogenesis (Girós et al. , 2007), promotes regeneration from ischemic stroke (Roberts
et al. , 2012), and protects the brain from βamyloid fibre-induced neurotoxicity (Parham
et al. , 2013).
In Drosophila, early studies on PerlecanTrol focused on its role on NSC reactivation.
Null mutations in hedgehog (hh) and branchless (bnl, an FGF homologue) dominantly en-
hance the impairment in NSC proliferation in a sensitised perlecantrol mutant background,
suggesting that PerlecanTrol may modulate Hh and FGF signalling activities (Park et al. ,
2003). A recent study supported PerlecanTrol’s role in Hh signalling in a different context.
perlecantrol mutant lymph glands showed disrupted architecture and premature stem cell
differentiation, and overexpression of hh in PerlecanTrol mutants was able to rescue the pre-
mature differentiation phenotype (Grigorian et al. , 2013). Another study revealed a novel
role of PerlecanTrol in Wnt signalling. At the Drosophila neuromuscular junction (NMJ),
Wnt/Wingless (Wg) regulates the formation of both pre- and postsynaptic structures. Muta-
tion in perlecantrol resulted in diverse postsynaptic defects and overproduction of synaptic
boutons at the NMJ. The postsynaptic defects of perlecantrol mutants could be rescued by the
postsynaptic activation of the Wnt pathway (Kamimura et al. , 2013). Whether PerlecanTrol
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is also involved in BMP/TGF-beta signalling in Drosophila, and especially in the context of
NSC reactivation, awaits further investigation.
7.5 Collagen IV and Perlecan Regulate NSC Reactivation
at Least in Part via Integrin Receptors
ECM proteins can either mediate signalling and NSC reactivation indirectly by sequestering
ligands close to the BBB, or they may act as direct signals to induce insulin secretion via
binding to their integrin receptors, or by a combination of both. The present study provided
evidence that the integrin receptors, including βPS IntegrinMys and αPS2 IntegrinIf, at the
BBB are at least in part responsible for the role of Collagen IV and PerlecanTrol in NSC
reactivation.
In vertebrates, integrins can be bound by many ECM ligands, including Collagen IV and
Perlecan. In vitro biochemical assays confirmed human Collagen IV-Integrin binding. Pu-
rified α1β1 and α2β1 integrin complexes can directly bind Collagen IV, with α1β1 show-
ing higher binding affinity, as reviewed in (Tuckwell & Humphries, 1996). However, in
Drosophila, only a small number of ECM proteins have been confirmed as integrin ligands,
which includes two laminins (Henchcliffe et al. , 1993; Martin, 1999), tiggrin (Fogerty
et al. , 1994), thrombospondin (Subramanian et al. , 2007) and tenectin (Fraichard et al.
, 2010). Other ECM proteins, such as Collagen IV (Le Parco et al. , 1986) and tenascin
(Graner et al. , 1998) and Perlecan (Friedrich et al. , 2000) are important in Drosophila but
they have not been confirmed to be integrin ligands with biochemical assays. OMX images
in my study showed close association and partial co-localisation between Collagen IVVkg
and βPS IntegrinMys. In addition, a number of recent in vivo studies in different develop-
mental contexts support the idea that Collagen IV can exert its functions via its association
with integrin receptors.
Vanderploeg et al showed that the accumulation of integrins (βPS1 IntegrinMys and
αPS3 IntegrinScb) is required for the migration of cardioblasts and the establishment of the
luminal domain during the formation of Drosophila heart (Vanderploeg et al. , 2012). In an
effort to search for factors acting in the same or in a converging pathway with integrin during
this process, Vanderploeg et al explored genetic interaction between αPS3 integrinscb and
other genes, including genes encoding various ECM ligand proteins. Whereas heterozygous
mutant αPS3 integrinscb embryos were not affected in their cardioblast migration, homozy-
gous mutant αPS3 integrinscb embryos exhibited dramatic defects in this process. Embryos
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simultaneously heterozygous for αPS3 integrinscb and collagen IVvkg showed similar phe-
notypes to αPS3 integrinscb homozygous mutants. This indicates that αPS3 IntegrinScb and
Collagen IVVkg regulate heart formation in the same or in a converging pathway, raising
the possibility that the ECM ligand-receptor interaction may account for the convergence of
their functions (Vanderploeg et al. , 2012).
Haigo and Bilder showed that Drosophila oocytes undergo stereotypical rotation when
transforming from a sphere to an ellipsoid shape during oogenesis (Haigo & Bilder, 2011).
Follicle epithelia mutant for either integrin or Collagen IVVkg showed nearly identical phe-
notypes: eggs fail to rotate and elongate which resulted in round shapes. These results again
point to the possibility that the interaction between integrin receptors and Collagen IV at
follicle epithelia promotes egg rotation.
Finally, a study by Pastor-Pareja and Xu provides good in vivo evidence for Collagen
IVVkg binding to integrin receptors. They created wing discs clones of cells mutant for
βPS1 integrinmys in the genetic background of a Collagen IVVkg-GFP protein trap (Pastor-
Pareja & Xu, 2011). Loss of βPS1 IntegrinMys led to “scars” in the wing disc basement
membrane, where Collagen IVVkg-GFP was absent. This shows that integrins are involved
in the capture of Collagen IV from hemolymph.
Collagen IV-integrin receptor interactions alone are likely to be necessary but not suffi-
cient for NSC reactivation: misexpression of Collagen IVVkg and Collagen IVCg25C in the
fat body under starved conditions could not rescue NSC reactivation. On the other hand,
it is difficult to assess the extent to which functional Collagen IV proteins were produced
under the misexpression condition. This is because components involved in Collagen IV se-
cretion, such as the chaperone protein SPARC (Martinek et al. , 2008; Pastor-Pareja & Xu,
2011), and components required for the assembly of Collagen IV trimers, such as Prolyl–
4-Hydroxylase (PH4alphaNE3) (Abrams & Andrew, 2002) were simultaneously downreg-
ulated transcriptionally in the fat body during starvation according to the fat body TaDa
transcriptional profiling (data not shown). In addition, glial transcription of perlecantrol
and the βPS integrinmys receptor is also downregulated under starvation conditions (data
not shown). Thus, even if abundant functional Collagen IV protein were over-expressed
in the fat body, it could not deposit on the CNS. In order to fully recapitulate the condi-
tions under fed conditions, it would require the co-misexpression of Collagen IV, SPARC,
PH4alphaNE3 from the fat body, as well as PerlecanTrol and βPS IntegrinMys from glia.
This experiment is technically difficult and therefore has not been performed.
A recent study showed the requirement for integrin-dependent adhesion and signalling
in stem cell proliferation and homeostasis of another Drosophila stem cell niche, the ISC
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niche of the midgut (Lin et al. , 2013). Integrin-mediated cell adhesion facilitates ISC an-
chorage to the basement membrane. Specifically, the αPS1 IntegrinMew, αPS3 IntegrinScb
and βPSMys are expressed by ISCs and are required for their maintenance: integrin mutant
ISCs are less proliferative, and genetic interaction studies suggest that Ilk (integrin-linked
kinase)-dependent integrin signalling is required for ISC proliferation in response to vari-
ous proliferative signals. Whereas this study did not identify ECM ligands, it shows that
integrin-mediated signalling may be a conserved mechanism of regulating cell proliferation
in different stem cell niches.
OMX images in my study showed that PerlecanTrol is also closely associated with βPS
IntegrinMys. Similar to Collagen IV, Perlecan’s interaction with integrin receptors are better
characterised in mammals compared to Drosophila. Perlecan protein has five domains, and
its domain V consists of an array of three laminin G-type (LG) modules and four epidermal
growth factor-like (EG) modules. The LG and EG modules have been shown to bind to
βPS Integrin receptors both in vivo and in vitro in mammalian systems (Bix et al. , 2006,
2004; Brown et al. , 1997). Interestingly, a recent study showed that Perlecan-Integrin
interaction can protect neuronal cells from neurotoxicity caused by amyloid fibres during
the pathogenesis of Alzheimer’s disease (Wright et al. , 2012). The amino acid sequence
of Perlecan domain V is highly conserved between Drosophila and mammals, including
the LG and EG repeats (Friedrich et al. , 2000). Therefore, Drosophila PerlecanTrol is
also capable of binding to integrin receptors, but their physical interaction awaits precise
biochemical assays (Friedrich et al. , 2000). A recent study provided the first and only in
vivo evidence of Drosophila PerlecanTrol’s interaction with integrin receptors. PerlecanTrol
plays a cell-autonomous role in anchoring intestinal stem cells (ISCs) to their niche and
is required for ISC proliferation (You et al. , 2014). Whereas ISC anchorage does not
depend on integrins, PerlecanTrol-mediated ISC proliferation is partially dependent on βPS
IntegrinMys. Ectopic expression of βPS IntegrinMys in PerlecanTrol null mutant ISC clones
can partially rescue ISC proliferation defects observed in PerlecanTrol null ISCs (You et al.
, 2014).
7.6 Matrix-Integrin Interaction Controls Insulin Signalling
in Vivo
The present study presents an interesting parallel between invertebrate and mammalian reg-
ulation of insulin signalling by ECM proteins. RT-PCR analyses showed that in the absence
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of Collagen IVVkg and PerlecanTrol on the CNS surface, glial dIlp6 transcription is downreg-
ulated. Forced expression of DIlp6 can partially drive NSC reactivation in the collagen IVvkg
and perlecantrol mutant. Therefore, whereas Collagen IV and PerlecanTrol act antagonisti-
cally in the process of maintaining organ shape (stretching vs. constricting) (Pastor-Pareja
& Xu, 2011), they function cooperatively upstream of insulin signalling during the regula-
tion of NSC reactivation.
Strikingly, glial knockdown of the ECM receptor, βPS integrinmys, resulted in nearly
50% decrease of CNS dIlp6 transcript level, on a par with fat body-specific collagen IVvkg
knockdown or starvation. However, knocking down βPS integrinmys using a either PG spe-
cific or SPG specific GAL4 driver was not able to recapitulate the phenotype. It is possible
that the pan-glia driver, Repo-GAL4, may have stronger expression and earlier onset of ex-
pression in the BBB glia than the subtype specific drivers themselves. In addition, βPS
IntegrinMys-mediated dIlp6 transcription may occur in both perineurial glia and subper-
ineurial glia (both glial subtypes express βPS integrinmys and dIlp6). Therefore, there may
be some degree of functional redundancy and compensation between the two glial subtypes
with regards to their regulation of insulin signalling. Therefore, one may need to knockdown
integrin receptors in both glial populations simultaneously in order to efficiently block dIlp6
transcription in the BBB.
ECM-mediated insulin signalling from the Drosophila BBB is consistent with studies
showing that key ECM components such as Collagen IV can directly regulate glucose-
dependent insulin secretion in human pancreatic beta cells (Kaido et al. , 2004; Weber et al.
, 2008). However, whereas the mammalian evidence comes from isolated pancreatic tissue
in culture, the present study provided the first in vivo evidence of ECM regulation of insulin
transcription. Although it is very likely that Collagen IV and PerlecanTrol regulate glial
insulin signalling indirectly by harnessing other signalling molecules at the BBB, decreased
dIlp6 transcription and impaired NSC reactivation under glial integrin knockdown condition
suggest that binding of ECM proteins to their receptors itself is at least partially responsible
for the transcription of glial insulin. Indeed, integrins are known as critical regulators of β
cell survival and function. They have been shown to protect against cell death and promote
glucose-induced insulin expression and secretion in both rodent and human islet cells in
vitro (Krishnamurthy et al. , 2008; Rondas et al. , 2012). A recent study also provided
convincing in vivo evidence that conditional knockout of βPS1 integrin in pancreatic islet
cells led to impaired glucose tolerance in mice, with a significant decrease in pancreatic
insulin content (Riopel et al. , 2011).
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7.7 Alteration in Nutrition and Systemic Metabolism Se-
lectively Affect Relevant ECM Protein Expression
The present study identified key nutrient-sensitive ECM components in invertebrates. The
expression of collagen IVvkg and collagen IVcg25C depend on the availability of dietary
amino acids. Dietary amino acids not only regulate glial perlecantrol transcriptionally, they
also regulate PerlecanTrol protein deposition on the CNS via Collagen IV. To our initial sur-
prise, Q-PCR reveals peak CNS transcription of perlecantrol just after larval hatching before
the larvae are even exposed to food. This is followed by rapid PerlecanTrol protein deposi-
tion, which can be observed a few hours after larval hatching. The high level of perlecantrol
transcription immediately after larval hatching perhaps allows for fast and immediate CNS
deposition of PerlecanTrol protein in response to nutrient-availability. In this way, the animal
can coordinate its ECM deposition with the fastest proliferative phase of the NSCs in the
first 24 hours of larval life. Later on, glial perlecantrol transcription becomes sensitive to
nutrition starting from approximately 12 hph, as suggested by pan-glial transcriptional pro-
filing under fed and starved conditions in two time windows (4hbh–16hph vs. 12–36hph).
Similar to what I observed in Drosophila larvae, alterations in nutritional status can
affect the production and deposition of ECM proteins in mammals as well (Alcantara et al.
, 2011; Farhadian et al. , 2012; Groos et al. , 2003; Guerra et al. , 2009; Higami et al. ,
2006). This may lead to systemic physiological responses such as autophagy and organ
remodelling. In particular, Higami et al showed that dietary restriction in mice led to down
regulation of a number of ECM proteins, including Collagen IV, in the white adipose tissue
(Higami et al. , 2006). Although future research is needed to address the physiological
significance of this down-regulation, this study indicates that the regulation of Collagen
IV in vertebrate and invertebrate fat tissue by nutrition may be conserved. It remains to be
tested whether Collagen IV or other mammalian ECM proteins have tissue non-autonomous
functions, and whether insulin signalling plays a role downstream of Collagen IV deficiency
when altering nutritional state in mammalian systems.
7.8 Dissecting the Interaction Between Systemic Signals
and Local Niche in Regulating NSC Behaviour
Using the powerful genetic tools of Drosophila, we are starting to dissect the mechanisms of
how NSCs are regulated by their systemic environment and local niche, as well as how the
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two interact. In Drosophila, the fat body serves as a systemic energy sensor to coordinate
organismal growth with food availability. Another fat body-secreted factor, Unpaired2, was
shown to regulate body growth in response to dietary lipid and sugar in adult flies (Rajan
& Perrimon, 2012). It acts by binding to its receptor on the surface of GABAergic neurons
which in turn synapse on the insulin producing cells in the brain (Rajan & Perrimon, 2012).
I wondered whether Collagen IV could interact with Unpaired2 in regulating NSC reacti-
vation, but I did not observe Unpaired2 transcription in the first instar larval fat body in
our transcriptome data (data not shown). In addition, Unpaired2 receptor dome is not tran-
scribed by either SPG or PG during the time window of NSC reactivation based on TaDa
transcriptional profiling (data not shown). Disrupting Unpaired2 signalling in the BBB glia
by expressing an RNAi construct against dome had no effect on CNS development (data not
shown). As a systemic energy sensor throughout fly life, the fat body is likely to produce
multiple factors in response to different nutritional inputs such as sugar, lipids, and amino
acids, and at different developmental stages.
How are systemic signals transduced to NSCs, which do not have access to the hemolymph
(blood equivalent)? CNS glial cells secrete local insulin to reactivate NSCs under feeding
conditions (Chell & Brand, 2010; Sousa-Nunes et al. , 2011) upon ECM binding. There-
fore, the present study confirmed the BBB’s role as a NSC niche, and illustrated one po-
tential mechanism through which systemic fat body signals can be relayed to NSCs via the
glial niche. The novel discovery that PerlecanTrol is expressed exclusively by perineurial
glia highlights the essential role of the BBB in modulating the ECM environment of the
CNS during neurogenesis. The source of CNS DIlp6 was a matter of contention among
previous studies. One study showed that “surface glia” are responsible for producing DIlp6
based on expression pattern of a promoter fusion dIlp6-GAL4 (Chell & Brand, 2010). An-
other study suggested that the cortex glia may be the source based on the expression pattern
of another enhancer trapped Ilp6-GAL4 lines (Sousa-Nunes et al. , 2011), where GAL4
insertion is upstream of dIlp6 gene but within the coding region of another gene, phl. Our
TaDa transcriptional profiling confirmed Chell and Brand’s observation that the BBB glia
transcribe dIlp6 during the time window of NSC reactivation. This makes sense anatomi-
cally, as the BBB is situated at the interface between the hemolymph and the NSCs: both
fat body secreted Collagen IV and glial derived PerlecanTrol deposit on the BBB, and the
reactivating NSCs are located below. Signalling through the BBB glia would therefore be
the most efficient way for systemic regulation of NSC behaviour.
Therefore, the BBB is not just a physical barrier separating neuronal tissues from the
systemic environment. The present study provided convincing evidence that the BBB is in
157
fact an active regulator of neurogenesis by modulating the ECM environment and secreting
neurogenic factors such as DIlp6 and PerlecanTrol to promote NSC reactivation. Future stud-
ies should strive to further characterise the interaction between the systemic regulation and
the local NSC niche, in particular, how ECM molecules induce insulin signalling from the
BBB glia. Interestingly, a recent study identified Betatrophin, a novel peptide hormone se-
creted by the mammalian liver and adipose tissue, in controlling glucose-dependent insulin
secretion from the pancreatic beta cells in vivo (Yi et al. , 2013). This suggests that the
systemic regulatory function of the invertebrate fat body or vertebrate liver/adipose tissue
on insulin production may be conserved.
7.9 BBB: a Nutrient Sensitive NSC Niche
Since the discovery that astrocytes induce neurogenesis from adult NSCs, it has been pro-
posed that glial cells act as a NSC niche (Song et al. , 2002). In the past ten years, little
has been understood about the mechanistic details of glial cells’ actions as well as upstream
regulators of the glial niche factors, partly due to the difficulty in manipulating mammalian
glial cells in vivo. The powerful genetic tools of Drosophila make it an attractive system to
help elucidate these intriguing questions. The Drosophila glial cells, especially the flat and
thin BBB glial subtypes, are difficult to isolate due to their position and morphology. This
is part of the reason why individual glial subtype’s roles have not been investigated system-
atically (i.e. with RNA seq or microarray). Taking advantage of the TaDa transcriptional
profiling transcriptional profiling technique, we were able to map glial subtype transcrip-
tional profiles in vivo in intact glial cells without isolation and cell sorting, during early
larval stages. Combining glial subtype transcriptional profiles with pan-glial transcriptional
profiles under fed and starved conditions from a similar time window, we helped to elu-
cidate signalling networks governing early glial development, glial subtypes’ response to
nutrition, and discover novel glial signalling pathways mediating nutrition-sensitive NSC
reactivation.
The present study highlighted that although DIlp6 is the key factor regulating NSC reac-
tivation, other glial factors may act to fine tune nutrient-dependent NSC reactivation. Glial
subtype transcriptome analyses reveal that the BBB glia’s transcriptional activity is highly
sensitive to changes in nutritional intake, and many genes involved in neurogenesis and
multiple metabolic/signalling pathways are upregulated upon feeding. These analyses may
serve as a starting point to identify signalling pathways acting in parallel with or upstream
of glial dIlp6 transcription. Furthermore, they may aid in elucidating the molecular mecha-
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nisms underlying ECM binding to the CNS and its role in glial insulin production.
Of particular interest is the BMP/TGF-beta signalling pathway, which shows upregu-
lation in the BBB upon feeding. Many of the components in this pathway, including lig-
ands, receptors, and downstream effectors, are enriched in the BBB glia. Collagen IV has
been shown to play an important role in BMP signalling in other developmental contexts
in Drosophila. It remains to be examined whether PerlecanTrol also plays a role in BMP
signalling in Drosophila. Encouragingly, closely related heperan sulphate proteoglycans
such as Dally and Dlp have established roles in BMP signalling in vertebrates (Yan & Lin,
2009). A recent study showed that Perlecan can augment BMP–2 activity during osteogen-
esis in a human cell line (DeCarlo et al. , 2012). Current efforts aim to investigate whether
both Collagen IV and Perlecan regulate BMP/TGF-beta signalling, and whether glial BMP/
TGF-beta signalling regulates NSC reactivation upstream of insulin signalling.
Chapter 8
Experimental Procedures
8.1 Statement of Collaboration
Chapter 6 was carried out in collaboration with Pauline Speder, a postdoc in the Brand lab,
Jessie Van Buggenum, a Master’s student in the Brand lab, and Jorge Buendia-Buendia,
another Master’s student in the Brand lab. Pauline Speder and I dissected brains for pan-
glial TaDa transcriptional profiling under fed and starved conditions. I dissected samples
for glial subtype TaDa transcriptional profiling together with Pauline Speder and Jessie Van
Buggenum: I was in charge of dissection and microarray for perineurial glia TaDa transcrip-
tional profiling, whereas Pauline Speder and Jessie Van Buggenum were in charge of pan
glia, subperineurial glia, and cortex glia samples. Data analysis of chapter 6 was performed
in collaboration with Jorge Buendia-Buendia, where Jorge generated all heat map figures
and I generated all the rest of the figures.
8.2 Fly Husbandry and Strains
Flies were raised at 25 °C on standard Drosophila cornmeal-molasses-agar medium vials
or bottles. For temperature shift experiments using temperature sensitive GAL80 (tub-
GAL80ts), flies were kept at 18 °C, the permissive temperature for GAL80ts, and transferred
to 29 °C to inactivate GAL80ts. In addition, all knockdown experiments were performed at
29 °C.
The following fly strains were used: w1118 and OrR were used as wild-type controls;
the fat body drivers cg-GAL4 (H Asha, 2003) and lpp-GAL4 (Brankatschk & Eaton,
2010); pan-glial driver repo-GAL4 (Sepp, 2001); perineurial glia driver NP6293-GAL4
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(DGRC, Kyoto); subperineurial glia driver moody-GAL4 (gift from Takeshi Awasaki); cor-
tex glia driver NP2222-GAL4 and NP0577-GAL4(DGRC, Kyoto); gut driver esg-GAL4
(DGRC); imaginal discs driver hh-GAL4 (Tanimoto et al. , 2000); NSC driver ase-GAL4
(Zhu et al. , 2006); Collagen IVVkg-GFP (Morin et al. , 2001); hypomorphic Collagen
IVVkg K1672 (gift from Hilary Ashe); hypomorphic Collagen IVVkg k197 (gift from Hilary
Ashe); UAS-Collagen IVVkg; UAS-Collagen IVCg25C ; PerlecanTrol-GFP (gift from Stephan
Noselli); PerlecanTrol null (Voigt et al. , 2002); UAS-PerlecanTrol ShmiR (Bloomington
38298); UAS-CollagenVkg ShmiR (Bloomington 50895); UAS-dIlp6 (Ikeya et al. , 2002);
UAS-Tsc1/2 (Tapon et al. , 2001); UAS-Mys RNAi (VDRC 103704); UAS-Mys shmiR
(BL33642); UAS-Slifanti (Colombani et al. , 2003); Mdr65-GAL4 (Arnim Jenett, 2012);
βPS IntegrinMys-GFP (gift of Nick Brown); Ilk-GFP (gift of Nick Brown); Pax-GFP (gift
of Nick Brown); UAS-DicerII (Dietzl et al. , 2007); UAS-Tubulin-GAL80ts (McGuire
et al. , 2003); UAS-LT2-Dam (Southall et al. , 2013); UAS-LT2-Dam-PolII (Southall et al.
, 2013); Worniu-GAL4 (gift from Tony Southall, Brand lab); Insc-GAL4; UAS-Syntaxin5
RNAi (VDRC 3859); FB-GAL4 (gift of Maria Southall); ppl-GAL4 (gift of Pierre Leopold);
UAS-shiDN; UAS-shiDN (Bloomington ). RNAi lines used in the screen of secreted fat
body factors were obtained from VDRC, Vienna, Austria. When available, lines from the
KK library were used. In cases where KK lines were unavailable, flies from the GD library
were used. Screens of glial ECM receptors, βPS IntegrinMys associated proteins, as well
as glial receptors for major signalling pathways involved in neurogenesis were conducted
using ShmiR and RNAi lines in the TRiP stock, which are available from the Bloomington
Stock Centre. All TRiP and VDRC lines used for screens are listed in Appendix 1.
8.3 Larval Culture
Embryos were laid on a fresh apple juice plate prior to larval hatching. Larvae that hatched
within a 30 min window were transferred to fresh yeast plates, and this was called 0 hour
post hatching (hph) (referred to as “fed” condition). To deprive larvae of dietary amino
acids, larvae were transferred to a solution of 20% sucrose in PBS after hatching instead
of fresh yeast (referred to as “starved” condition). Sucrose solution was sterile filtered and
kept at 4 ºC prior to use.
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8.4 Larval Brain and Fat Body Explant Co-Culture
CNS from just hatched larvae (0 hph) and fat bodies from crawling 3rd instar larvae were
dissected for tissue co-culture experiments. Prior to dissection, larvae were washed with
70% ethanol followed by two rinses with sterile water. Fat body and CNS dissections were
performed in the culture medium using sterile tools. Culture medium consists of Schnei-
der’s medium (Gibco) supplemented with 10% fetal calf serum (Sigma), 2 mM L-glutamine
(Gibco) and Pen/Strep 1X (Gibco). The dissected CNS and fat bodies were rinsed in cul-
ture medium to minimise contamination of the explant culture by hemolymph factors. These
were transferred to Nunclon 4-well dishes containing fresh culture medium, and then placed
in a humidified chamber at 25 °C. Hydrogen peroxide was added to the space between the
wells to oxygenise the tissue.
8.5 Generation of UAS-CollagenVkg and UAS-CollagenCg25C
transgenic flies
8.5.1 Primer Design
Primers were designed by submitting the sequence of the gene of interest (5’ to 3’) to
the OligoCalc online tool (http://www.basic.northwestern.edu/biotools/oligocalc.html), us-
ing algorithms designed by Kibbe et al (Kibbe, 2007). Primer selection criteria included:
primer length between 20 and 25 bp; primers ending with G or C; salt adjusted melting
temperature difference between forward and reverse primer of a given gene smaller than 3
ºC. All other parameters were left at default settings.





*Note: these were the primer sequences sufficient for amplifying the genes of interest. Addi-
tional sequences were added to the primers in order to create final primer sequences suitable
for carrying out Gibson Assembly reactions (see “Cloning with Gibson Assembly” section,
below).
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8.5.2 PCR Amplification of CollagenVkg and CollagenCg25C Transcripts
Full length CollagenVkg and CollagenCg25C transcripts were PCR amplified from an embry-
onic genomic cDNA library generated by Boris Egger (Brand lab). The optimal annealing
temperature was determined to be 65 ºC for both CollagenVkg and CollagenCg25C.
The PCR reaction mix was prepared using the following recipe:
cDNA template (85ng/µl) 1µl
5X High Fidelity Buffer (New England Biolabs) 10µl
10 mM dNTP mix 1.5µl
10 µM forward primer 1µl
10 µM reverse primer 1µl
dd H2O 35µl
Phusion Polymerase (New England Biolabs) 0.5µl
PCR reaction mix total volume: 50µl
The following PCR programme was used to amplify CollagenVkg and CollagenCg25C:
98 ºC 2 min (denaturation of the template)
30 cycles start:
98 ºC 20 sec (denaturation)
65 ºC 20 sec (annealing)





To check the quality of PCR amplified DNA, 1 to 2 µl of DNA was used for analysis by
agarose gel electrophoresis. A 1% agrose gel was made by adding 0.5 g agarose (Invitrogen)
to 50 ml 1X Tris/Borate/EDTA (TBE) buffer. DNA was visualised by adding Ethidium Bro-
mide (100ng/ml, Sigma-Aldrich) to the gel mix before it set. DNA was mixed with ddH2O
and 5X DNA loading buffer (Bioline) to achieve a final concentration of 1X prior to loading.
A Gel Doc 2000 machine (BioRad) was used to image the gel and DNA fragment sizes were
determined by comparing to a 200bp–10kb DNA ladder (HyperLadder I, Bioline).
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8.5.4 DNA Purification and Quantification
If a single band was detected with agarose gel electrophoresis, PCR products were sub-
sequently purified using Qiaquick PCR Purification kit (Qiagen) using the manufacturer’s
protocol. If multiple bands were present, the desired band was isolated using agarose gel
electrophoresis. The band was excised with a razor blade and purified with Qiaquick Gel
Extraction kit (Qiagen).
8.5.5 Cloning with Gibson Assembly
Gibson Assembly was used to sub-clone CollagenVkg and CollagenCg25C sequences into
the pUAST vector. This method can simultaneously join several DNA fragments based on
sequence identity. It requires that the DNA fragments contain 20–40 bp overlap with adja-
cent DNA fragments. These DNA fragments are mixed with a master solution containing
three enzymes: exonuclease, DNA polymerase, and DNA ligase. The exonuclease digests
DNA from the 5’ end, leaving single-stranded overhang regions on adjacent DNA fragments
which anneal to one another. The DNA polymerase subsequently fills in any gaps. In the
final steps, DNA ligase covalently joins the DNA of adjacent segments to remove nicks in
the DNA (Gibson, 2011; Gibson et al. , 2009). The Gibson assembly protocol used in this
study was modified by Elizabeth Caygill (Brand lab).
The pUAST vector containing an attB site was created by Tony Southall (Brand lab).
The attB site allows for targeted insertion of the desired construct into defined attP docking
sites in the embryo’s germline during the generation of transgenic flies. The vector con-
tained multiple restriction sites. NotI and XbaI were used to linearise the vector. The final
primer sequences used for amplification of CollagenVkg and CollagenCg25C cDNA contain
a 5’ 30bp that overlap with the linearised vector at the insertion site as well as a Cavener/
Kozak consensus sequence to facilitate the translation initiation (Cavener, 1987):
CollagenCg25C Forward:
GGGAATTGGGAATTCGTTAACAGATCTGCAATCAAAAATGTTGCCCTTCTGGAAGCGGCTG
Italic: overlapping sequence with vector sequence downstream of NOT I cutting site
Bold: Kozak consensus sequence
CollagenCg25C Reverse:
ACAGAAGTAAGGTTCCTTCACAAAGATCCTCTAGGGGGCGGTGGTGTCC




Italic: overlapping sequence with vector sequence downstream of NOT I cutting site
Bold: Kozak consensus sequence
CollagenVkg Reverse:
ACAGAAGTAAGGTTCCTTCACAAAGATCCTCTACGAGGAGTTCTTCATGCACACC
Italic: overlapping sequence with vector sequence upstream of Xba I cutting site
Approximately 100 ng of the linearised vector backbone and equimolar amounts of PCR
purified CollagenCg25C or CollagenVkg cDNA sequences were added to thawed 15 µl Gib-
son master mix. The solution was topped up to 20 µl with ddH2O. The Gibson assembly
reaction was carried out at 50 ºC for 1 hour, and immediately placed on ice. Diagnostic
agarose gel electrophoresis was conducted to check successful assembly before transforma-
tion.
Gibson assembly master mix (optimised for 20 to 150 bp sequence homology overlaps)
contained:
5X ISO Buffer (see recipe below) 320 µl
10 U/µl T5 exonuclease (Epicentre) 0.64 µl
2 U/µl Phusion polymerase (New England Biolabs) 20 µl
40 U/µl Taq ligase (New England Biolabs) 160 µl
add dH20 up to 1.2 ml
5X ISO buffer contained:
1 M Tris-HCl pH 7.5 3 ml
2 M MgCl2 150 µl
100 mM dNTP mix (25 mM each: dGTP, dCTP, dATP, dTTP) 240 µl
1 M DTT 300 µl
PEG–8000 1.5g
100 mM NAD 300 µl
add dH20 up to 6ml
8.5.6 Transformation of E.Coli
5 µl of the Gibson Assembly reaction was added to 100 µl of DH5a competent E.Coli and
incubated for 10 min on ice. The mixture was heat shocked for 45 seconds at 42 ºC. After
adding 200 µl LB, the mixture was incubated at 37 ºC for 30 min, with vigorous shaking.
The mixture was spread onto agar plates containing ampicillin (50 µl per plate), which were
incubated overnight at 37ºC.
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8.5.7 DNA Plasmid Preparation and Sequencing
Individual bacteria colonies were picked and cultured in 2 ml LB medium containing ampi-
cillin antibiotic at 37 ºC overnight. Plasmid DNA was isolated using QIAprep Miniprep Kit
(Qiagen) according to the manufacturer’s protocol. A Thermo Scientific NanoDrop 1000
was used to determine DNA concentration.
Plasmid DNA was sequenced by Cogenics (Beckman Coulter Genomics). Primer se-
quences used for sequencing are listed below. MacVector software was used to analyse the
sequencing results.
AttB primer (used for both Collagen IVCg25C and Collagen IVVkg sequencing):
CGATTCATTAATGCAGCTGGC
























Site specific attP-attB mediated transgenesis was accomplished using a protocol from Tony
Southall (Brand lab). In short, purified attB plasmid (100 ng/µl) and helper integrase plas-
mid (400 ng/µl) were injected into embryos carrying either attP2 or attP154 docking sites to
ensure that the insertion of the transgenes occurred at the same genomic loci on the third or
the second chromosome. Micro-injection was performed by Melanie Cranston (Brand lab)
and John Overton (Nick Brown lab). Hatched adults from micro-injected embryos were
individually crossed to w1118 flies, and the progeny were examined for eye colour. Flies
with non-white eye colour were crossed to balancer flies to establish balanced stocks.
8.6 Dam ID Transcriptional Profiling
The Targeted Dam ID (DNA adenine methyltransferase identification), or “TaDa”, protocol
was designed by Tony Southall (Southall et al. , 2013), modified from van Steensel et
al. and Choksi et al (Choksi et al. , 2006; van Steensel et al. , 2001). This technique
involves tagging a DNA or chromatin binding protein with the E. coli Dam (DNA adenine
methyltransferase). Wherever the Dam fusion protein binds the genome, surrounding DNA
sequences are methylated at the A nucleotide of GATC (Figure 8.5.1).
Fig. 8.6.1 Schematic of TaDa technique mechanism. TaDa involves tagging the E. coli Dam (DNA
adenine methyltransferase) with a DNA or chromatin binding protein. I used Dam fused with RNA
PolII (RNA Polymerase II) subunit for transcriptional profiling. Wherever the Dam-POLII fusion
protein binds the genome, surrounding DNA sequences are methylated.
The methylated sequences can be digested with DpnI, PCR amplified, and hybridised
to Roche Nimblegen whole genome tiling arrays to determine DNA binding sites. In the
present study, I used the TaDa system to express the Dam-RNA POLII fusion protein
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in a tissue-specific manner utilising the GAL4/UAS system (Brand & Perrimon, 1993).
UAS-Dam was used as a control to account for background methylation by the Dam pro-
tein. Temporal control was achieved with a temperature sensitive GAL80, tubulin-GAL80ts
(McGuire et al. , 2003). A schematic of the fat body specific POLII TaDa experiment was
shown in Figure 9.6.2.
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Fig. 8.6.2 Schematic of fat body TaDa transcriptional profiling under fed and starved condi-
tions. A fat body specific GAL4 driver (Lpp-GAL4) drives Dam-POL II fusion protein expression in
the fat body. In combination with tubulin-GAL80ts, temporal control of Dam-POL II fusion protein
expression can be achieved, so that one can obtain transcriptional profiles during the time window of
interest (18 ºC: GAL4 off, 29 ºC: GAL4 on).
8.6.1 Larval CNS Dissection
For glial TaDa experiments, larval CNS were dissected in 1XPBS and kept on ice. Dis-
section time was limited to less than 1 hour to keep the tissue fresh. The tissue was snap
frozen in dry ice and stored at –80 °C. 220–250 CNS from fed larvae, and 250–300 CNS
from starved larvae were used for each condition. In total, 880–1000 brains from fed larvae
and 1000–1200 brains from starved larvae were used for each glial TaDa transcriptional
profiling experiment.
For fat body TaDa experiments, whole larvae were collected and immediately washed 3
times in 1XPBS containing 100 mM EDTA (PH=8). The larvae were snap frozen and stored
at –80 °C. 100–120 fed larvae, and 120–150 starved larvae were used for each condition.
In total, 400–480 fed larvae, and 480–600 starved larvae were used for each fat body TaDa
experiment. It was essential that whole larvae homogenisation was carried out in 100 mM
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EDTA in PBS because the EDTA prevented DNAase in the larval gut from shearing the
genomic DNA non-specifically.
8.6.2 Genomic DNA Extraction
Genomic DNA was extracted from larval CNS using DNeasy Blood and Tissue kit (Qi-
agen). Larval brains were thawed from –80 °C and washed with 1XPBS. Samples were
homogenised with a sterile pestle. 20 µl DNase free RNase A (12.5 µg/µl, ROCHE) was
used to degrade RNA and the samples incubated at room temperature for 20 min. Cells were
lysed and proteins were digested by adding 20 µl of proteinase K and 200 µl of buffer AL
(DNeasy kit, Qiagen).
Samples were mixed by pipetting up and down gently approximately 50 times. After a
quick centrifuge, samples were incubated at 70 °C for 10 min for protease K digestion. DNA
was purified according to manufacturer’s protocol (Qiagen), and eluted in 2 X 200 µl of AE
buffer sequentially (e1=elution1, e2=elution2). Eluted genomic DNA was analysed on an
agarose gel by electrophoresis to examine the quality and quantity of genomic DNA. The
samples should be a single band on the gel with low mobility. In the case of genomic DNA
shearing, a smear pattern would appear in the agarose gel and those samples were discarded.
The concentration of genomic DNA was measured with a Thermo Scientific NanoDrop
1000. Elution 1 and elution 2 were combined together to proceed to DNA precipitation.
8.6.3 DNA Precipitation
Approximately 100 µl of ddH2O were added to the total eluted gDNA (e1+e2) to make a
total of 500 µl. To precipitate the genomic DNA, 1 ml of 100% ethanol, 50 µl of 3M sodium
acetate, and 1 µl of molecular grade glycogen were added. The mixture was incubated at
–20 °C for at least 30 min. Genomic DNA was precipitated by centrifugation (16100 x g) at
4 °C for 30 min. The supernatant was removed and the pellets were washed with 500 µl of
70% ethanol and centrifuged again for 10 minute at 4 °C (16100 x g). Ethanol was removed
and the DNA was air-dried for approximately 5 min. Care was taken so that DNA was not
over-dried.
8.6.4 DpnI Digestion
The air-dried DNA pellets were digested with 50 µl DpnI enzyme (New England Biolabs)
in reaction buffer at 37 °C overnight. DpnI was used to cut methylated GATC sequences,
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allowing the isolation of sequences that have been methylated by Dam methyltransferase.
DpnI reaction mix was made up with the following recipe.
DpnI (New England Biolabs): 1.5 µl
10X Buffer4 (New England Biolabs): 5 µl
ddH2O: 43.5 µl
To prevent non-specific DNA shearing, the enzyme solution was added to the pellets
gently without mixing. The next morning, another 5 U, or 1.5 µl of DpnI was added into
the samples, gently mixed with pipet tips, and incubated at 37 °C for one hour to complete
the digestion. DpnI enzyme purchased within 6 months was used to ensure maximal enzyme
activity.
8.6.5 Adaptor Ligation
DpnI digest was inactivated by incubating the sample at 80 °C for 20 min. Digested samples
were purified using a PCR purification kit (Qiagen). Samples were eluted with 30 µl of
ddH2O. In order to provide primer sequences for PCR amplification of methylated DNA
later on, a double stranded oligonucleotide adaptor was ligated to each of the blunt ends of
DNA fragments digested by DpnI. 15 µl of purified DpnI digested genomic DNA was mixed
with 5 µl of ligation solution (containing 2 µl of ligation buffer (ROCHE, Rapid Ligation
Kit), 1 µl of T4 DNA ligase (ROCHE), 0.8 µl of double strand adaptor oligonucleotide (50
uM) and 1.2 µl ddH2O). The ligation mixtures were incubated at 16 °C for 2 hours. The
double stranded adaptor was made by annealing two oligonucleotides (AdRt and AdRb).




The ligation mixture was incubated for 10 min at 65 °C to inactivate the T4 DNA ligase.
Genomic DNA fragments containing unmethylated GATC sites were digested with DpnII,
so that these fragments would not be amplified by PCR. DpnII reaction mix was added to
the ligation reaction and incubated at 37 °C for one hour or overnight.
DpnII reaction mix was made with the following recipe.
10X DpnII buffer (New England Biolabs): 8 µl
DpnII (New England Biolabs): 1 µl
ddH2O: 51 µl
170
8.6.7 PCR Amplification of Methylated DNA Fragments
PCR was used to amplify methylated DNA fragments with the adaptors on both ends.
PCR reaction mix was made up with:
DpnII digested DNA: 20 µl
10 X PCR reaction buffer (Clontech): 8 µl
50 µM AdR PCR primer: 1.25 µl
50 X dNTP mix (Clontech): 1.6 µl
50 X Advantage DNA polymerase mix (Clontech): 1.0 µl
48.15 µl: ddH2O
PCR reaction total volume: 80 µl
3 µl of PCR product was analysed on agarose gel. A smear pattern was observed if
methylated DNA fragments were successfully amplified. For successful sample, PCR prod-
ucts were purified using the QIAquick PCR purification kit (Qiagen). 30 µl of ddH2O was
used for elution and the concentration was measured with a Thermo scientific NanoDrop
ND–1000 spectrophotometer.
8.6.8 Genome-Wide Tiling Microarray
Purified DNA samples were analysed by microarray at the FlyChip facility at the Depart-
ment of Genetics, University of Cambridge. Samples were hybridised to Drosophila whole-
genome tiling arrays. The tiling arrays contain 385,000 probes with each probe representing
an average 60 bp of the genomic DNA spaced every 300 bp to cover the entire Drosophila
euchromatic genome (ROCHE Nimblegen). Microarray data were visualised using Nim-
bleScan software. Full details of labelling and hybridisation can be found online: http://
www.flychip.org.uk/protocols/chip/NimblegenBioPrime.php. 3 replicates were performed
for fat body TaDa transcriptional profiling experiments (fed vs. starved), 2 replicates were
performed for pan-glial transcriptional profiling TaDa experiments (fed vs. starved), and 3
replicates were performed for glial subtype TaDa transcriptional profiling. Each experiment
contained one dye swap replicate.
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8.7 Clarification Regarding Fat Body TaDa Transcriptional
Profiling and RNAi Screen
I carried out a functional RNAi screen after I completed two replicates of fat body TaDa
Transcriptional Profiling, which yielded 150 genes up in fed conditions. The number of
upregulated genes decreased to only 83 after I performed three replicates of fat body TaDa
transcriptional profiling. Since all the 83 genes are nested within the original 150 gene list,
and my main concern was to avoid false negatives, I reported the screen results based on
the original 2 replicate screen. The top candidates, including Collagen IV, CG13900 and
Hsc70–3 were retained in the new gene list after analysis of 3 replicates.
8.7.1 Bioinformatics Analysis
An algorithm with false discovery rate (FDR) analysis was developed by Tony Southall
(Brand lab) to identify significant Dam-POLII binding sites (Southall et al. , 2013). Firstly,
log2 ratio files were generated (Dam-Pol II over Dam-only) and median normalised (Nim-
bleScan software) for each replicate. Using Drosophila genome annotation release 5.47, the
mean ratio change across each annotated transcript was calculated. To assign a FDR value,
the frequency of transcripts with a mean ratio over specific values (from 0.1 to 0.75 log2
increase) were calculated within a randomised data set (for each chromosome arm) using
10 iterations and 1,000 sampling events. This was repeated for a range of gene sizes (250
to 2,500 bp). These data were used to model FDR values relative to the Dam-Pol II enrich-
ment across a transcript and gene sizes, enabling extrapolation of FDR values for larger ratio
changes and larger transcripts. After being performed for each replicate, each transcript was
assigned a mean ratio between the biological replicates and the highest associated FDR. To
compare data sets, log2 ratios were subtracted and the data median normalised. The data
were analysed as described above to identify genes with significantly different Pol II occu-
pancy. Due to the presence of negative log2 ratios in TaDa transcriptional profiling experi-
ments, these genes were filtered to confirm that any significantly enriched genes were also
bound by Pol II in the experiment of interest.
Transcripts with log2 POL II occupancy intensity ratio of 1 or higher and FDR rate of
0.01 or lower were considered significantly transcribed for comparison experiments. Genes
with a comparison log2 value (after subtraction) of 1 or higher (equivalent to 2 fold changes
between condition A and B) and log2 POL II occupancy binding intensity value of 1 or
higher, as well as FDR rate of 0.01 or lower, were considered significantly upregulated
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under condition A compared to condition B.
8.8 Quantitative Real-Time PCR (Q-PCR)
8.8.1 Primer Design
Primers for Q-PCR were either taken from published literature or designed using the Quant-
Prime online primer design tool (http://www.quantprime.de/). Only intron-spanning primers
were selected.
The following Q-PCR primers were used:
PerlecanTrol: forward, AACGGAGGAAGCTGCAGTGAAC; reverse, CATTGAAGCCCAGTTG-
GAGGTG (QuantPrime).
Dilp6 primers: forward, CGATGTATTTCCCAACAGTTTCG; reverse, AAATCGGTTACGTTCT-
GCAAGTC (Grönke et al. , 2010).
GAPDH: forward, ATTTCGCTGAACGATAAGTTCGT; reverse, CGATGACGCGGTTG-
GAGTA (Chell & Brand, 2010).
Rp49: forward, CCAAGATCGTGAAGAAGCG; reverse, GTTGGGCATCAGATACTGTC
(QuantPrime).
Ork1: forward, GCTGTACATCCTCAAAGTGAAGCC; reverse, TTGGAACGTGGCAGT-
GTGTAGG (QuantPrime).
CG3523: forward,TCGCTGAGCTGATGAGCAATGAG; reverse, ACAGAGTGGCGGATTTCTTGATCG
(QuantPrime).
IsoQC: forward, CGTGCAGACAGCTTTGATAGCC; reverse, CGCTGGGATTGTAGGATATCT-
GTG (QuantPrime).
Sema–5c: forward, CGACAGCGCAGTTGCAACAATC; reverse, AGTTCGTCACTTGGGT-
GCTGATG (QuantPrime).
CG4476: forward, AGCTTGCTTACCATGCGTCCAC; reverse, CCGATACACACCAAC-
CAACAACTC(QuantPrime).
CG30203: forward, ACATTAGGGAGTGCGAAGAGGTTC; reverse, AGTTGGTCCACTCGTTC-
CAAGG (QuantPrime).
CG4825: forward, CATCACCTTGCTGGCTGTTTCG; reverse, ACGTTCGCCTCGTTTCT-
GAC (QuantPrime).
Syx5: forward, ACTGGAGAAGCTCACAATGTTGG; reverse, TGAATCTCCTGCGGTCT-
GTCATC (QuantPrime).
Cct5: forward, ACGCCTGAGAAACTAGGTGTTGC; reverse, TGTCCTTGGATGTTCC-
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GAATGCC (QuantPrime).
8.8.2 RNA Extraction and Preparation of cDNA
For each sample, total mRNA was extracted from approximately 60 first instar CNS. CNS
were homogenised with 200 µl Trizol reagent (Invitrogen) in an Eppendorf tube. The ho-
mogenised sample was topped to 800 µl with Trizol and incubated for 5 min at room tem-
perature. 160 µl of Chloroform (SigmaAldrich) was added to the Eppendorf tube and the
tube was shaken vigorously for 15 seconds. After incubation at room temperature for 3 min,
the sample was centrifuged at 11,000 rpm for 15 min at 4 ºC. Separation should occur into a
lower phenol-chloroform phase, an interphase, and a colourless upper aqueous phase. The
upper phase containing mRNA, was transferred to a fresh tube. To precipitate RNA, 1 µl of
molecular grade glycogen (10 µg/µl) and 400 µl isopropanol were added, and the tube was
incubated at room temperature for 10 min. The mix was centrifuged at 11,000 rpm at 4 ºC
for 10 min. A pellet containing the RNA could be detected at the bottom and was washed
with 1 ml of 70% ethanol, followed by centrifugation at 8000 rpm at 4 ºC for 5 min. The
pellet was left to dry and re-suspend in 20 µl DEPC water.
cDNA was prepared using the QuantiTect Reverse Transcription Kit according to the
manufacturer’s protocol (Qiagen).
8.8.3 Q-PCR Reaction and Quantification
A StepOnePlus™ Real-Time PCR System machine (Applied Biosystems) was used with
SYBR green (Fast SYBR® Green Master Mix, Qiagen) to perform Q-PCR analysis. Re-
sults were calculated using the standard curve method and normalised against the geometric
means of two reference genes: GAPDH and Rp49. Three biological replicates per sample
type were performed and each with three technical replicates.
8.9 RNA in Situ Hybridisation
8.9.1 Primer Design for Riboprobes
The coding region of the gene of interest was found on the Flybase website (flybase.org) and
was entered into the NCBI website primer blast online tool (http://www.ncbi.nlm.nih.gov/
BLAST/). A product size of 900 to 1200 bp was specified, with a minimal primer size of 19
bp, maximal size of 24 bp, and an optimal size of 22 bp. A minimal anealling temperature
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of 55 ºC, maximal temperature of 57 ºC, and an optimal temperature of 60 ºC were selected.
A minimal GC content of 40% and a maximal GC content of 60% were selected. The T7
RNA polymerase promoter sequence was then added to the 5´ end of the reverse primer
sequence.
T7: CAGTAATACGACTCACTATTA






8.9.2 RNA Probe Generation
cDNA fragments of the gene of interest were amplified by PCR from a Drosophila embry-
onic cDNA library (Boris Egger, Brand lab), purified using the Qiaquick PCR Purification
kit (Qiagen), and eluted with DEPC water. These DNA templates were used to synthesise
digoxigenin (DIG)-labelled antisense riboprobes using the Roche DIG RNA Labelling kit
(Roche).
The reaction mix consisted of:
Purified PCR Product from cDNA template: 1 µg to 2 µg
10X Digoxigenin-labelled ribonucleotide mix: 2 µl
10X Transcription buffer: 2 µl
T7 RNA polymerase: 2 µl
RNase Inhibitor (New England Biolabs): 0.2 µl
DEPC H2O: top the total volume up to 20 µl
The in vitro transcription reaction was incubated overnight at 18 ºC. The DNA tem-
plate was removed by incubation with DNaseI for 30 min at 37 ºC. Before degradation,
the volume of purified RNA sample was increased to 30 µl total with DEPC H2O. RNA
probes were degraded to an average length of 500 bp by hydrolysis in carbonate buffer in
order to increase their penetrance. 30 µl of 2X Carbonate Buffer (60 mM Na2CO3, 40 mM
NaHCO3, pH 10.2) was added to the sample and the mixture incubated for approximately
10 min at 60 ºC. The formula for calculating incubation time can be found online (http://
www.roche-applied-science.com/sis/lad/lad_docs/ISH_55–57.pdf).
To stop probe degradation, 3.5 µl 10 % acetic acid and 6.5 µl 6 M sodium acetate
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were added to the reaction. To precipitate the probe, 250 µl 100 % ethanol was added
immediately afterwards and the mixture was incubated for 30 min at –20 ºC. The sample
was centrifuged at 13,000 rpm for 15 min at 4 ºC and the resulting pellet was washed with
70 % ethanol. After further centrifugation at 13,000 rpm for 5 min, the pellet was allowed
to dry and was resuspended in 10 µl DEPC H2O and 0.2 µl RNase inhibitor (Roche). 1 µl
of probe was run on an agarose gel to check the quantity and quality of the RNA probes.
8.9.3 Larval Brain Preparation, Pre-Hybridisation and Hybridisation
Larval CNS were dissected in 1XPBS, and fixed with 4% formaldehyde in PBS containing
0.5mM EGTA and 5mM MgCl2 for 20 min at room temperature. The samples were washed
with PBTw (0.1% Tween–20 (Sigma-Aldrich) in PBS) for 5 X 5 min, followed by a 10 min
wash in a solution containing 50% PBTw and 50% hybridisation buffer (see recipe below)
and a wash in 100% hybridisation buffer for 10 min at room temperature. Afterwards, the
samples were pre-hybridised for at least 1 hour in hybridisation buffer at 65 ºC. The samples
were hybridised with riboprobes in hybridisation buffer at a concentration of 1:500–1:1000
overnight at 65 ºC.
Hybridisation buffer was made up with the following recipe:
50% deionised formamide (Sigma-Aldrich)
5X SSC (0.75 M NaCl, 0.075 M Na3C6H5O7)
0.1% Tween–20 (Sigma-Aldrich)
100 µg/ml E. coli tRNA (stock 25 mg/ml, Sigma-Aldrich)
50 µg/ml heparin (stock 50 mg/ml, Sigma-Aldrich)
The pH of the solution was adjusted to 6.5 using concentrated HCl.
8.9.4 Post Hybridisation and Antibody Detection
Following overnight probe hybridisation, the riboprobes were removed and saved for later
re-use. The post-hybridisation washes were carried out at 65 ºC and the washing solutions
were all pre-warmed at 65 ºC. The CNS were washed in the following order: 1 X 30 min
in hybridisation buffer, 1 X 30 min in 50% hybridisation and 50% PBTw, and 4 X 30 min
in PBTw. After the washes were completed, sheep anti-digoxigenin antibody conjugated to
alkaline phosphatase (Roche) was diluted 1:2000 in PBTw and incubated with the sample
for 2 hours at room temperature.
The antibodies were removed and the samples were washed for 3 X 20 min with PBTw.
The samples were then rinsed with alkaline phosphatase (AP) buffer (see recipe below),
176
and washed for 5 min in fresh AP buffer. The chromogenic antibody detection reaction
was carried out with NBT (nitro-blue tetrazolium chloride, Roche) and BCIP (5-bromo–4-
chloro–3´-indolyphosphate p-toluidine salt, Roche). These two reagents react with alkaline
phosphatase to yield an insoluble dark purple precipitate. CNS were first washed in 300 µl
AP buffer and 1.5 µl NBT for 5 min. The solution was then replaced with 300 µl AP buffer,
1.5 µl NBT and 1 µl BCIP. The brains were transferred to a 12-well tissue culture plate
(Nunclon). The reaction was allowed to progress until dark purple coloration was clearly
detectable under a dissection microscope. The enzymic reaction was stopped by washing
for 3 X 5 min in PBTw. After the tissues were mounted, a Zeiss Axioplan microscope was
used to view the slides and capture images.
AP buffer was made up with the following recipe:




8.10 RNA Fluorescence in Situ Hybridisation
The procedures for fluorescence in situ hybridisation (FISH) were identical to regular in situ
hybridisation prior to post-hybridisation steps, including primer design. After hybridisation,
sample for FISH were washed with PBTw for 15 min at 65 ºC. Endogenous peroxidase
activity was blocked with 3% hydrogen peroxide in PBTw for 1 hour at room temperature.
This was followed by a number of washes: 3 X 5 in PBTw, 5 min in PBS, and 3 X 5 min in
PBSt(0.3% Triton (Sigma-Aldrich) in PBS). Since antibody staining is more effective with
Triton compared to Tween–20 detergent, all washes from this point onwards were carried
out in PBSt. Samples were washed with 10% NGS in PBSt for 30 min at room temperature
to block non specific binding and incubated with primary antibody against digoxigenin,
conjugated with horseradish peroxidase (Roche, diluted 1 in 200), overnight at 4 ºC. All
other primary antibodies were added at this point. The next morning, samples were washed
for 3 X 5 min and 3 X 15 min in PBSt, and were incubated with secondary antibodies for
2 hours at room temperature. After 3 X 5 min and 3 X 15 min washes in PBSt, a tyramide
reaction was carried out according to manufacturer’s protocol (Life Technologies).
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8.11 TUNEL
TUNEL staining was performed with ApopTag Red In Situ Apoptosis Detection Kit (Chemi-
con). The protocol was modified from manufacturer’s recommendations by Pauline Speder
(Brand lab). Larval CNS were dissected in 1XPBS and fixed with 4% formaldehyde in
PBS containing 0.5mM EGTA and 5mM MgCl2 for 20 mins. This was followed by 3 X 5
min washes with PBSt at room temperature. Post-fixation was carried out with pre-cooled
ethanol and PBS (2:1) for 5 mins at –20 ºC, followed by 3 X 5 min washes in PBSt. After-
wards, the sample was pre-treated with 10 mM sodium citrate (pH=6) for 30 min at 70 ºC,
followed by 3 X 5 min washes in PBSt. PBSt was removed and the sample was incubated
in 75 µl of equilibration buffer for 10 min at room temperature, with shaking. The equi-
libration buffer was removed and replaced with 50 µl of 30% terminal deoxynucleotidyl
transferase (TdT) enzyme in reaction buffer (volume/volume) for 3 hours at 37 ºC. TdT
enzyme catalyses a template-independent addition of nucleotide triphosphates to the 3-OH
ends of DNA, created by apoptosis-induced double stranded DNA breaks. The incorporated
nucleotides were partially conjugated with digoxigenin.
The TdT enzyme reaction was stopped by removing the enzyme solution and washing
briefly with 1 ml of 1 X Stop/Wash solution. The sample was incubated in a second volume
of 1 X Stop/Wash solution for 10 min at room temperature, followed by 3 X 1 min washes in
PBTw. Antibody against digoxigenin, conjugated with rhodamine dye, was diluted to 47%
(volume/volume) in blocking solution, so that the final volume per sample would be 100
µl. Other primary antibodies were added to the anti-Dig rhodamine solution at appropriate
dilutions. The sample was incubated in the antibody solution overnight at 4 ºC. The next
morning, antibody solution was removed and the sample was washed 3 X 5 mins with PBSt.
Secondary antibody staining was carried out as normal (see below).
8.12 Immunofluorescence of Larval Tissues
8.12.1 Larval Dissection and Fixation
Larval CNS were dissected in 1X PBS at room temperature and transferred to poly-lysine
coated Menzel-Glaser cover glasses. They were fixed with 4% formaldehyde in PBS con-
taining 0.5mM EGTA and 5mM MgCl2 at room temperature for 20 min. Immediately after
fixation, CNS were washed in PBSt (0.3% Triton-X100 in PBS) 3 X 5 min each and blocked
for 15 min in PBSt containing 10% normal goat serum (Sigma-Aldrich).
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8.12.2 Primary and Secondary Antibody Incubation
Incubation with primary antibodies was conducted in blocking buffer at 4 °C overnight.
After removing primary antibodies with PBSt washes, fluorophore-conjugated secondary
antibodies diluted in PBSt/10% normal goat serum were added and incubated for at least
four hours at room temperature. All secondary antibodies (Invitrogen) were used at a di-
lution of 1 in 200. Secondary antibody was removed by PBSt washes and the larval CNS
was mounted in Vectashield (Vector Laboratories) prior to imaging with Olympus Upright
FV1000 or DeltaVision OMX microscope.
8.12.3 Antibodies Used
The following antibodies were used: guinea pig anti Deadpan (gift from Jim Skeath) at
1:5000; mouse anti Discs Large (DHSB) at 1:70; chicken anti GFP (Abcam) at 1:2000;
rabbit anti Phospho-histone 3 (Upstate) at 1:100; rat anti Phospho-histone 3 (Abcam) at
1:5000; mouse anti Repo (DSHB) at 1: 70; rat anti RFP (Abcam) at 1: 1000; rabbit anti
PerlecanTrol (gift of S. Baumgartner) at 1: 1000; rabbit anti Collagen IVCg25C (gift of John
Fessler) at 1:500; mouse anti Elav at 1:20 (DSHB); Phalloidin (546 conjugated) at 1:200
(Invitrogen); rabbit anti Miranda at 1:200 (gift of Nung Jan Yuh); mouse anti Prospero at
1:30 (DSHB); mouse anti βPS IntegrinMys at 1:30 (DSHB); rat anti Dilp2 at 1:100 (gift of
Pierre Leopold); guinea pig anti Ogre (Innexin1) at 1:200 (gift of Pauline Speder); DAPI at
1:100 (Life Technologies).
8.13 OMX Imaging
Super resolution imaging was performed using DeltaVision OMX BLAZE V3 (Applied
Precision, a GE Healthcare company), a 3D-SIM system equipped with sCMOS cameras.
Images were captured using an Olympus 60x 1.515NA oil objective, 405nm, 488nm and 593
nm laser illumination and standard excitation and emission filter sets. 3D-SIM image stacks
were sectioned using a 125 nm Z-step size. Raw data was reconstructed using softWoRx
6.0 (Applied Precision, a GE Healthcare company) software. Image capture and analyses
were assisted by Nicola Lawrence (Gurdon Institute).
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8.14 Data Analysis and Deposition
Images were processed and captured using ImageJ and Volocity. Adobe Illustrator and
Photoshop were used to generate figures. R was used to perform statistical analysis.
All raw data (gff files) and analysis files of glial and fat body TaDa transcriptional pro-
filing experiments can be found in Gurdon Institute datastore folder: datastore/brand/Brand
group folder/reactivation data share/. Pol II binding profiles in these experiments can be
viewed on the Brand Lab Genome Browser at https://gbrowse/.
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Appendix A
RNAi Lines Used For Screening
Table A.0.1 List of genes unregulated in the fat body encoding for predicted secreted proteins
by Secretome P and/or Signal P
Gene symbol Signal P Secretome P GO Cellular component GO Biological processes
CG14629 y y - -
CG15369 y y - -
Hsc70-3 y y lipid particle sleep
CG11529 y y - proteolysis; neurogenesis
Lsp1beta y y lipid particle lateral inhibition
CG5945 y y - -
CG11425 y n membrane dephosphorylation
CG32829 y n cellular_component -
Crc y n lipid particle central nervous system devel-
opment;olfactory behavior;
brain morphogenesis
CG9269 y n - -
CG6415 n y lipid particle glycine catabolic process
CG15482 n y - -
Pepck n y mitochondrion gluconeogenesis
Nop60B n y nucleolus pseudouridine synthe-
sis;rRNA processing
sta n y lipid particle translation;mitotic spindle
elongation
Uhg1 n y - -
210
w n y ATP-binding cassette
transporter complex
eye pigment precursor trans-
port
RpL23 n y cytosolic large ribosomal
subunit
translation
RpL12 n y cytosolic large ribosomal
subunit
translation
RpL39 n y ribosome translation




RpS5a n y ribosome translation
RpS12 n y ribosome translation
RpL3 n y cytosolic large ribosomal
subunit
translation
RpS27A n y ribosome translation
LanA y n basement membrane central nervous system devel-
opment;heart development
CG11037 y n - proteolysis
CG12491 y n - -
CG13333 y n vesicle neurogenesis
CG13641 y n - -
CG14331 n y - -
CG15021 y n - -
CG15093 y n mitochondrion cellular amino acid metabolic
process;valine metabolic pro-
cess
CG15554 y n - -
RpS20 n y ribosome translation
lectin-33A y n - -
Lip2 y n - lipid metabolic process
Obp99a y n extracellular region olfactory behavior;response
to pheromone
RpS7 n y lipid particle translation
Lsp1alpha y n lipid particle -
RpL40 y n lipid particle translation
CG31659 y n - multicellular organism repro-
duction
211
CG32667 y n extracellular space multicellular organism repro-
duction
l(1)G0320 y n lipid particle -
CheA46a y n cellular_component sensory perception of chemi-
cal stimulus




Cg25C y n collagen type IV dorsal closure;oviduct mor-
phogenesis
CG5493 n y - oxidation-reduction process
Gp93 y n lipid particle protein folding;midgut devel-
opment;response to stress
CG5989 n y - -
Ef1beta n y lipid particle translational elongation
Pdi y n lipid particle protein folding;cell redox
homeostasis
Eip71CD n y - sulfur amino acid metabolic
process;
autophagic cell death
CG7280 n y mitochondrial
intermembrane space
protein catabolic process
RpL10Ab n y cytosolic large ribosomal
subunit
translation
CG8147 y n - response to nico-
tine;metabolic process
CG8157 y n - -
boss y n microvillus R7 cell fate commit-
ment;sevenless signaling
pathway
RpS15 n y lipid particle translation
kek4 y n - negative regulation of epi-
dermal;growth factor recep-
tor signaling pathway





Vkg y y skeletal muscle tissue devel-
opment;Malpighian tubule
morphogenesis
Table A.0.2 VDRC Lines for Fat Body Signal Screen


































































































Table A.0.3 TRiP Glial ECM Receptor Screen












Table A.0.4 TRiP Glial Signalling Pathway Screen




















Gene Lists of Interest From Glial TaDa
Transcriptional Profiling
Table B.0.3 Glial subtype specific genes involved in neurogenesis based on subtype TaDa tran-
scriptional profiling
Gene Symbol Glial subtype Molecular function (GO)
RpI135 SPG DNA-directed RNA polymerase activ-
ity
aop SPG protein binding
Pdsw SPG NADH dehydrogenase (ubiquinone)
activity
CG8086 SPG -
alien SPG signal transducer activity
numb SPG Notch binding
CG4364 SPG -
Srp54 SPG mRNA binding
CG4901 SPG ATP-dependent RNA helicase activity
cdc2 SPG cyclin-dependent protein ser-
ine/threonine kinase activity
da SPG sequence-specific DNA binding tran-
scription factor activity
CG6734 SPG -




Gene Symbol Glial subtype Molecular function (GO)
l(2)35Df SPG ATP-dependent RNA helicase activity





nito SPG mRNA binding
Ggamma1 SPG GTPase activity
Not1 SPG protein binding
CG1671 SPG -
CG12343 SPG -
Cct5 SPG ATPase activity, coupled
UbcD10 SPG ubiquitin-protein ligase activity
Hsf SPG DNA binding
GstE11 SPG glutathione transferase activity
CG15100 SPG methionine-tRNA ligase activity
dom SPG helicase activity
zip SPG ATPase activity, coupled
CG7028 SPG protein kinase activity
CG32344 SPG helicase activity
CG42554 SPG -
pUf68 SPG poly(U) RNA binding
Cdc37 SPG chaperone binding
CG9004 SPG RNA binding
Scsalpha SPG succinate-CoA ligase (GDP-forming)
activity
ida SPG mitotic anaphase-promoting complex
activity
Rpd3 SPG histone deacetylase activity
CG33523 SPG structural molecule activity
SrpRbeta SPG signal recognition particle binding
Use1 SPG -
klu SPG nucleic acid binding
CG32075 SPG -
CG6273 SPG protein heterodimerization activity
Continued. . .
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brm SPG DNA-dependent ATPase activity
Rpn12 SPG endopeptidase activity
Dab SPG SH2 domain binding
Su(z)12 SPG histone methyltransferase activity (H3-
K27 specific) ;
polo SPG protein serine/threonine kinase activity
Hr78 SPG ligand-activated sequence-specific
DNA binding RNA polymerase II
transcription factor activity
Cdk12 SPG cyclin-dependent protein ser-
ine/threonine kinase activity
ctrip SPG ligand-dependent nuclear receptor
binding
mRpL44 SPG structural constituent of ribosome
CG2656 SPG purine nucleotide binding
gfzf SPG glutathione transferase activity
CG10903 SPG S-adenosylmethionine-dependent
methyltransferase activity
Scm SPG sequence-specific DNA binding tran-
scription factor activity
Hrb87F SPG mRNA binding
CG6455 SPG -
CG5857 SPG structural constituent of nuclear pore
CG5808 SPG mRNA binding
CG11859 SPG protein kinase activity
ball SPG protein kinase activity
CG7346 SPG -
nej SPG transcription coactivator activity
Rx CG sequence-specific DNA binding tran-
scription factor activity




Gene Symbol Glial subtype Molecular function (GO)
AdoR PG G-protein coupled adenosine receptor
activity
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Table B.0.1 Top upregulated glial genes under fed conditions 12-36hph
Gene Symbol GO biological processes Log ratio_fed vs st FDR_fed vs st
RpL24 translation 3.62 1.55E-07
CG14756 - 3.33 2.4E-05
RpL13 translation 3.19 1.29E-07
CG17440 - 3.14 7.62E-12
CG11635 - 2.92 1.45E-06
CG17107 - 2.81 3.6E-06
CG42240 - 2.72 1.88E-08
Cfp1 histone H3-K4 methylation 2.64 1.74E-09
lmgA mitotic anaphase 2.61 4.81E-09
lmgB - 2.61 4.81E-09
CG10014 - 2.54 4.90E-09
CG9451 - 2.33 5.33E-08
CG9184 - 2.32 1.4E-04
CG17036 transport 2.24 1.48E-06
CG44044 - 2.17 2.8E-04
Chi axon guidance 2.15 2.80E-06
a6 embryonic development 2.15 2.4E-04
CG42809 - 2.11 6.9E-03
CG17929 transmembrane transport 2.08 8.24E-08
RpS27A translation 2.07 7.43E-08
GstD9 glutathione metabolic process 2.07 1.25E-06
RpL34b translation 2.05 6.50E-05
CG7974 - 2.029 5.24E-05
CG13900 mRNA splicing 1.98 1.55E-07
SmB mRNA splicing 1.98 1.4E-04
CG12848 - 1.98 1.1E-04
CG12985 - 1.94 4.59E-06
CG15459 - 1.93 6.69E-07
CG5036
regulation of G-protein coupled receptor
protein signaling pathway 1.92 4.64E-09
CG42764 - 1.92 1.6E-04
fs(1)K10 dorsal/ventral pattern formation 1.91 1.18E-11
CG18810 protein palmitoylation 1.91 1.8E-04
CG32119 - 1.91 3.52E-05
cola - 1.90 1.98E-05
CG1124 - 1.90 1.82E-09
RpLP0 translation 1.90 2.03E-05
RpS29 translation 1.89 1.3E-04
RpL5 translation 1.89 1.03E-05
eve regulation of axonogenesis 1.88 1.4E-04
NT5E-2 nucleotide catabolic process 1.88 2.22E-12
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Table B.0.2 Top upregulated glial genes under starved conditions 12-36hph
Gene Symbol GO biological processes Log ratio_st vs fed FDR_st vs fed
CG13309 chitin metabolic process 2.07 1.4E-04
CG44037 - 1.82 1.17E-12
CG13541 - 1.58 4.07E-06
Cyp4p3 oxidation-reduction process 1.56 3.44E-09
eater phagocytosis, recognition 1.54 3.20E-10
CG6733 cellular amino acid metabolic process 1.54 1.66E-05
CG42536 - 1.49 2.5E-05
CG3955 - 1.44 3.3E-04
CG7059 glycolysis 1.42 1.23E-05
CG6738 cellular amino acid metabolic process 1.38 2.7E-04
Brd Notch signaling pathway 1.38 1.4E-04
rib regulation of transcription, DNA-templated 1.25 2.57E-12
unk chaeta morphogenesis 1.14 2.69E-09
CG13117 - 1.07 3.1E-03
danr central nervous system formation 1.03 3.4E-02
Ubc84D - 1.00 0.01
CG34194 - 0.96 1.5E-05
CG13857 - 0.93 2.5E-04
CG43230 - 0.91 1.4E-04
mab-21 embryonic organ development 0.89 1.30E-06
CG6398 establishment of glial blood-brain barrier 0.88 7.68E-09
TM4SF - 0.87 9.25E-05
2mit short-term memory 0.84 8.28E-22
CG43921 regulation of establishment of planar Polarity 0.83 1.77E-14
beat-IIIa heterophilic cell-cell adhesion 0.81 1.91E-37
CG33639 G-protein coupled receptor signaling pathway 0.80 2.14E-12
Snmp1 response to pheromone 0.79 6.5E-04
alpha-Est7 determination of adult lifespan 0.78 3.4E-04
CG2269 - 0.78 3.90E-12
CG14989 - 0.75 7.4E-04
CG16787 - 0.70 2.4E-04
slou muscle cell fate determination 0.67 6.62E-08
CG11317 neurogenesis 0.65 2.9E-04
jeb axon guidance 0.62 2.87E-28
VAChT neurotransmitter transport 0.60 5.22E-09
comm axon guidance 0.58 5.15E-06
